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Habilitation à Diriger des Recherches
présentée par
Olivier Dameron
Ontology-based methods
for analyzing life science data
Soutenue publiquement le 11 janvier 2016
devant le jury composé de
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Chapter 1
Introduction
This document summarizes my research activities since the defense of my PhD in Decem-
ber 2003. This work has been carried initially as a postdoctoral fellow at Stanford University
with Mark Musen’s Stanford Medical Informatics group (now BMIR1), and then as an associate
professor at University of Rennes 1, first with the UPRES-EA 3888 (which became UMR 936
INSERM – University of Rennes 1 in 2009) from 2005 to 2012, and then with the Dyliss team
at IRISA since 2013.
First, I will present the context in which my research takes place. We will see that the
traditional approaches for analyzing life science data do not scale up and cannot handle their
increasing quantity, complexity and connectivity. It has become necessary to develop automatic
tools not only for performing the analyses, but also for helping the experts do it. Yet, processing
the raw data is so difficult to automate that these tools usually hinge on annotations and
metadata as machine-processable proxies that describe the data and the relations between them.
Second, I will identify the main challenges. While generating these metadata is a challenge
of its own that I will not tackle here, it is only the first step. Even if metadata tend to be more
compact than the original data, each piece of data is typically associated with many metadata,
so the problem of data quantity remains. These metadata have to be reused and combined,
even if they have been generated by different people, in different places, in different contexts,
so we also have a problem of integration. Eventually, the analyses require some reasoning on
these metadata. Most of these analyses were not possible before the data deluge, so we are
inventing and improving them now. This also means that we have to design new reasoning
methods for answering life science questions using the opportunities created by
the data deluge while not drowning in it. Arguably, biology has become an information
science.
Third, I will summarize the contributions presented in the document. Some of the reasoning
methods that we develop rely on life science background knowledge. Ontologies are the formal
representations of the symbolic part of this knowledge. The Semantic Web is a more general
effort that provides an unified framework of technologies and associated tools for representing,
sharing, combining metadata and pairing them with ontologies. I developed knowledge-
based reasoning methods for life science data.
Finally, I will describe the organization of the manuscript.
1http://bmir.stanford.edu/
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1.1 Context: integrative analysis of life science data
Life sciences are intrinsically complicated and complex [1, 2]. Until a few years ago, both the
scarcity of available information and the limited processing power imposed the double con-
straints that work had to be performed on fragmented areas (either precise but narrow or broad
but shallow) as well as using simplifying hypotheses [3].
The recent joint evolution of data acquisition capabilities in the biomedical field, and of
the methods and infrastructures supporting data analysis (grids, the Internet...) resulted in
an explosion of data production in complementary domains (*omics, phenotypes and traits,
pathologies, micro and macro environment...) [3, 4, 5]. For example, the BioMart community
portal provides a unified interface to more than 800 biological datasets distributed worldwide
and spanning genomics, proteomics and cancer data [6], and the 2015 Nucleic Acids Research
Database issue refers to more than 1500 biological databases [7]. Making data reusable has
been widely advocated [8]. This “data deluge” is the life-science version of the more general “big
data” phenomenon, with the specificities that the proportion of generated data is much higher,
and that these data are highly connected [9].
In addition to the breakthrough in each of these domains, majors efforts have been un-
dertaken for developing the links between them: systems biology2 [10, 11, 12, 13, 14] at the
fundamental level, translational medicine3 [15, 16] for the link between the fundamental and
clinical levels, and more recently translational bioinformatics4 [17, 18, 19, 20] for the link between
what happens at the molecular and cellular levels and what happens at the organ and individ-
ual levels. These links between domains are obviously useful for performing better analyses
of data, but conversely these new connections can sometimes reshape the domains themselves.
For example, translational bioinformatics modifies the definitions of the fundamental notion of
what constitutes a disease by considering sequencing of genes or quantitating panels of RNA in
addition to the traditional nosology [21].
We are witnessing the transition from a world of isolated islands of expertise to a network of
inter-related domains [4, 22]. This is supported by another transition from a world where we had
a small quantity of informations on a lot of people to a world where we have a lot of informations
in related domains (genetics, pathology, physiology, environment) for a small but increasing
number of people. Storage capabilities kept pace with the increasing data generation. However,
the bottleneck that once was data scarcity now lies in the lack of adequate data
processing and data analysis methods. This increasing data quantity and connectivity was
the origin of new challenges.
The stake of data integration consists in establishing and then using systematically the links
between elements from different domains (e.g. from *omics to pathologies, from pathologies to
*omics, or between *omics or pathologies of different species) having potentially different lev-
els of precision [5]. For example, meta-analysis of heterogeneous annotations and pre-existing
knowledge often lead to novel insights undetectable by individual analyses [23, 24]. Systems
2Systems biology aims at modeling the interactions between the elements of a biological system and their
emergent properties. These elements can themselves be composed of sub-elements that can interact among them
or with other elements.
3Translational medicine aims at providing the best treatment for each patient by using the most recent
discoveries in biology, drug discovery and epidemiology (bench to bedside), and conversely to reuse medical data
when performing research (bedside to bench).
4Translational bioinformatics derives from translational medicine and focuses on integrating information
on clinical and molecular entities. It aims at improving the analysis and affect clinical care.
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biology, translational medicine and translational bioinformatics all focus on the systematic or-
ganization of these links.
The systematic exploitation of data permitted by integration requires some kind
of automation. Because of life sciences intrinsic complexity, vast quantities of elements as well
as the numerous links between them that represent their inter-dependencies have to be taken
into account [25, 26].
This systematic exploitation of data is not only massive, it is also complex [4, 27]. The
systematic analysis of the integrated data requires to perform some interpretation,
which hinges on background knowledge [3]. Expertise or domain knowledge can be seen
as the set of rules representing in what conditions data can be used or can be combined for
inferring new data or new links between data (Levesque also provided an excellent more general
article on knowledge representation for artificial intelligence [28]).
The remainder of this document focuses on the third challenge of using knowledge for auto-
matically integrating and analyzing biomedical data in a context covering translational medicine
and translational bioinformatics.
1.2 Challenges: using domain knowledge to integrate and ana-
lyze life science data
Several bottlenecks hamper the automated systematic exploitation of biomedical data:
• it has to take expertise or knowledge into account [29]. This entails both to
represent such knowledge in a formalism supporting its use in an automatic setting, and
that the conditions determining knowledge validity are themselves formally represented.
• it relies on data and knowledge that are obviously incomplete [3, 30]. We are
therefore in the intermediate state where we must develop automatic methods for pro-
cessing vast amount of heterogeneous and inter-dependent data while being limited by the
incomplete and fragmentary aspect of these data.
• it produces results that are so big and so complex that their biological in-
terpretation is at best difficult. Dentler et al. showed that “Today, clinical data is
routinely recorded in vast amounts, but its reuse can be challenging” [31]. Moreover, it
is not only the quantity of data that is increasing, but also the associated metadata that
describe and connect these data. Rho et al. point out that “One important issue in the
field is the growing complexity of annotation data themselves” and that “Major difficulties
towards meaningful biological interpretation are integrating diverse types of annotations
and at the same time, handling the complexities for efficient exploration of annotation
relationships” [24].
As Stevens et al. noted, “Much of biology works by applying prior knowledge [...] to an
unknown entity, rather than the application of a set of axioms that will elicit knowledge. In ad-
dition, the complex biological data stored in bioinformatics databases often require the addition
of knowledge to specify and constrain the values held in that database” [29]. The same holds
for the biomedical domain, e.g. to identify patient subgroups in clinical data repositories [32].
The knowledge we are focusing on is mostly symbolic, as opposed to other kinds of biomedical
knowledge (probabilistic, related to chemical kinetics, 3D models of anatomical entities or 4D
models of processes...). It should typically support generalization, association and deduction.
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There is a long tradition of works in order to come up with an explicit and formal representa-
tion of this knowledge that would support automatic processing. Cimino identified the following
key requirements: “vocabulary content, concept orientation, concept permanence, non-semantic
concept identifiers, polyhierarchy, formal definitions, rejection of ‘not elsewhere classified’ terms,
multiple granularities, multiple consistent views, context representation, graceful evolution, and
recognized redundancy” [33, 34, 35].
This line of work resulted in the now widespread acceptance of ontologies [29, 36] to represent
the biomedical entities, their properties and the relations between these entities. Bard et al.
defined ontologies as “formal representations of knowledge in which the essential terms are
combined with structuring rules that describe the relationships between the terms” [37]. This
covers the main points and encompasses alternative definitions [38, 39].
Ontologies range from fairly simple hierarchies to semantically-rich organization supporting
complex reasoning [36]. There is also a distinction depending on their scope. Top-level ontologies
(or upper ontologies) such as DOLCE or BFO are domain-independent and represent general
notions such as things and processes. Domain ontologies cover a specific domain (e.g. normal
human anatomy for the FMA of the description of gene products for GO) [40].
Ontologies are now a well established field [36, 2] that evolved from concept representa-
tion [41]. In May 2015, there were 442 ontologies referenced by BioPortal, and 10,768 PubMed
articles mentioning “ontology” (Figure 1.1 on the next page). They cover the creation of new
ontologies, data annotation [2], data integration [3, 42], data analysis [5], or ontology as a
proper research field [43]. There are many applications for bio-ontologies themselves, for exam-
ple analysis of cancer *omics data [44], integration and analysis of quantitative biology data for
hypothesis generation [45], biobanks [42], interpretation of complex biological networks [46] or
even analysis of research funding by diseases [47]. Hoehndorf et al. recently performed a review
of the importance of bio-ontologies and their main application domains [48]. Among the main
ontologies are the Gene Ontology (GO; for an analysis of its becoming the most cited ontol-
ogy, see [45]), that provides a species-independent vocabulary for describing gene products, the
NCI thesaurus for describing cancer-related entities, the International Classification of Diseases
(ICD), OMIM for human genetic disorders, SNOMED Clinical Terms, the US National Drug
File (NDF-RT), ChEBI for describing small chemical molecules and UNIPROT for describing
proteins, the Medical Subject Headings (MeSH) for annotating PubMed articles [36].
As noted previously, there are now numerous ontologies that are used in various contexts.
These ontologies can overlap, which hampers data integration as some resources refer to some
entity in an ontology whereas other resources can refer to the corresponding entity in another
ontology. The Unified Medical Language System (UMLS) provides some unifying architecture
between the major biomedical ontologies and terminologies. The problems of ontology dispersion
and overlap found a solution with BioPortal5 [49]. It is an open repository of biomedical
ontologies that offers the possibility to browse, search and visualize ontologies, as well as to
create, to store and to use mappings between these ontologies (i.e. relations between entities
from different ontologies). Bioportal also supports the annotation of data from Gene Omnibus,
clinical trials and ArrayExpress. It should be noted that BioPortal also provides some API and
Web services, so it can also be used by programs.
5http://bioportal.bioontology.org/
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Figure 1.1: Evolution of the number of PubMed articles referencing “ontology”.
The emergence of ontologies in biomedical informatics and bioinformatics happened in parallel
with the development of the Semantic Web in the computer science community [50, 41]. The
Semantic Web is an extension of the current Web that recognizes the need to represent data
on the Web in machine-processable formats and to combine them with ontologies. It aims to
support fine-grained data representation for automatic retrieval, integration and interpretation.
To do so,
• it shifts the granularity from document to each atomic data they contain, identifying them
with specific URIs (now IRIs);
• it represents explicitly the relations linking some of these data by also designating them
with their URIs (whereas we only have untyped href between HTML pages);
• it also encompasses the representation of generalities and of relations between them (e.g.
Alzheimer’s disease is a kind of neurodegenerative disease), as well as the connection
between atomic data (which are anecdotal) and generalities (which are universal) so that
a patient’s disease with all its specificities can be described as an element of the set of the
Alzheimer’s diseases.
The W3C defines several recommendations (that are de facto standards) related to the
Semantic Web initiative for data representation, integration and analysis. RDF6 (Resource
Description Framework) represents data and their relations using triples of URIs (the first
designates the subject that is described, the second represents the relation or predicate, and
the third represents the value of the relation for the subject, and is called the object). RDF
provides a special property (rdf:type) to represent the fact that some data identified by its URI
is an instance of a general class. RDFS7 (RDF schema) and OWL8 (Ontology Web Language)
provide sets of RDF entities with special and formal semantics to represent generalities (so
ontologies). Therefore, RDFS and OWL statements are also RDF triples. RDFS allows to
represent taxonomies, and OWL provides several profiles with a more formal semantics that
6http://www.w3.org/RDF/
7http://www.w3.org/TR/rdf-schema/
8http://www.w3.org/2001/sw/wiki/OWL
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support richer reasoning. RDFS is well adapted to simple reasoning over large data sets, whereas
OWL is adapted to more complex reasoning, at the cost of potentially longer computation
times. These reasoning tasks are supported by several other recommendations. SPARQL9
(SPARQL Protocol and RDF Query Language) is an SQL-like query language for RDF. Note
that SPARQL1.1 can take most of RDFS semantics into account. OWL does not have a query
language but it does not really need one either because OWL inferences consists mostly in
determining whether a piece of data is an instance of a class, or whether a class is a subclass
of another one. Additionally, SWRL10 (Semantic Web Rule Language) allows to represent
inference rules with variables. It should be noted that even if most bio-ontologies are represented
in OWL, very few take advantage of the language expressivity. Most are RDFS ontologies
disguised in OWL (which is possible because OWL is built on top of RDFS, e.g. all OWL
classes are RDFS classes), even if it has been demonstrated that they would benefit from using
OWL’s additional semantics [51, 52, 53]
Life sciences are a great application domain for the Semantic Web [54, 55, 56] and sev-
eral major teams are involved in both, particularly at the W3C Semantic Web Health Care
and Life Sciences interest group (HCLSIG)11. Since 2008, the Semantic Web Applications and
Tools for Life Sciences (SWAT4LS) workshop12 (co-organized by Andrea Splendiani, who was
a postdoc at U936) is an active event, along with conferences such as DILS, ISWC and ESWC.
Semantic Web technologies have become an integral part of translational medicine and trans-
lational bioinformatics [5, 14]. Several works have showed how these technologies can be used
to integrate genotype and phenotype informations and perform queries [57, 58]. More recently,
Holford et al. proposed a Semantic Web framework to integrate cancer omics data and biological
knowledge [44]. The Linked Data initiative [59] and particularly the Linked Open Data project
promotes the integration of data sources in machine-processable formats compatible with the
Semantic Web. Figure 1.2 on the facing page shows the importance of life sciences. In the
past few years, this proved instrumental for addressing the problem of data integration [53, 60].
In this context, the Bio2RDF project13 promotes simple conventions to integrate biological
data from various origins [61, 62, 63]. Moreover, Semantic Web technologies support federated
queries that gather and combine informations from several data sources [62]. The reconciliation
of identifiers is further facilitated by initiatives such as identifiers.org [64].
1.3 Summary of the contributions
My contributions focused on methods for automatic analysis of biomedical data, based on on-
tologies and Semantic Web technologies. This section is organized chronologically for presenting
how the various themes evolved and were applied to different projects. The remainder of the
document is organized thematically.
My PhD dissertation consisted in the creation of an ontology of brain cortex anatomy [65, 66].
At this point, the added value of ontologies for data integration and for reasoning had been
demonstrated by several major projects for many years. However, it was clear that developing
ontologies was a difficult endeavor with a part of craftsmanship. Particularly, one had to keep
track of multiple dependencies between classes [67, 68, 69]. There was also the perception that
the automatic reasoning based on ontologies all too often had to be completed by ad-hoc pro-
9http://www.w3.org/TR/sparql11-overview/
10http://www.w3.org/Submission/SWRL/
11http://www.w3.org/wiki/HCLSIG
12http://www.swat4ls.org/
13https://github.com/bio2rdf
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Figure 1.2: Linked Open Data cloud in August 2014. Nodes are resources. Edges are cross-
references between resources. Life science resources constitute the purple portion in the lower
right corner.
(http://lod-cloud.net/).
gramming extensions either as pre-processing for making the data amenable to reasoning, or as
post-processing. There was no widespread agreement on the format to use for representing on-
tologies at the time: frames were the dominant paradigm but multiple implementations existed
in addition to the Protégé editor [70]; interesting solutions like XML were advocated by the
World Wide Web Consortium (W3C); Description Logics (DL) were gaining acceptance in the
biomedical community thanks to the reasoning capability and the DAML+OIL format being
associated with an open source editor and a reasoner [71].
By the time I started my post-doc at Mark Musen’s Stanford Medical Informatics lab in
Stanford University, DAML+OIL had evolved into the OWL effort, which became a formal
W3C recommendation on February 2004. Holger Knublauch, also post-doc at SMI, had just
started developing an OWL plugin for Protégé [72]. During my stay, I participated in the
Virtual Soldier project.
My main contribution was to develop the symbolic reasoning mechanism for inferring the
consequences of penetrating bullet injuries based on both anatomical knowledge and patient-
specific data [73, 74]. This made extensive use of Description Logics expressiveness to leverage
reasoning capabilities based on classes (generic reasoning for inferring that a class is a subclass
of another one) as well as on instances (data-specific reasoning for inferring that an individual
is an instance of a class). The reasoning relied on rich anatomical knowledge. The Founda-
tional Model of Anatomy (FMA) was the reference ontology but was originally developed and
maintained in frames, fortunately using Protégé.
My second contribution was on ontology modeling and representation. I studied the theo-
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retical aspects of the conversion of the frame-based FMA into an OWL version by preserving
as much as possible of its original semantic richness and by automatically adding features that
were beyond frames expressivity such as necessary and sufficient definitions or disjointness con-
straints [75, 76]. Recognizing that different applications using the FMA may have different
expressivity requirements and that some features may be useful in some context, but may add
an unnecessary computational burden in other contexts, I proposed a modular approach so that
users could import only the features they needed.
My third contribution addressed the need to automate certain operations during ontology
development and ontology usage. For assisting both the development of the reasoning capability
and the conversion of the FMA into OWL, I developed the ProtegeScript plugin [77] (still
included in the distribution of Protégé 3) that added scripting capabilities (mainly Python,
Ruby and BeanShell) to Protégé and was compatible with both the original frames setting and
the OWL plugin. Eventually, I helped organize and teach the first versions of the Protégé Short
Course and Protégé OWL Short Course in 2005, and have been invited back to Stanford to do
so until 2011.
Since I joined Anita Burgun’s team as an associate professor at Rennes 1 university, I con-
tinued working on ontology-based reasoning. Together with Gwenaëlle Marquet, we devel-
oped a semantically-rich reasoning application performing automatic classification of glioma
tumors [78, 79]. This was in direct continuation of the line of work initiated in the Virtual
Soldier project. In both cases, we demonstrated that if the relevant domain ontologies are rich
enough, developing an application-specific reasoning module only requires the creation of a few
classes. In both cases though, this assumption was optimistic. Many works by other teams
focused on improving existing ontologies[2] such as GO [52] or the NCI Thesaurus [80, 81].
As Jim Hendler pointed out, even a little semantics goes a long way [82], and I extended my
work to simpler forms of reasoning. With Julie Chabalier, we created a knowledge source relating
diseases and pathways by integrating the Gene Ontology, KEGG orthology and SNOMED
CT [83, 84, 85, 86]. We proposed an approach combining mapping and alignment techniques.
We used OWL-DL as the common representation formalism and demonstrated that RDFS
queries were expressive enough with acceptable computational performances. From 2008 to
2010, I supervised Nicolas Lebreton’s PhD thesis with Anita Burgun on Web services parameters
compatibility for semi-automatic Web Service composition [87, 88, 89]. The context was that
biologists typically conduct the analysis of their results by building workflows of atomic programs
that run on bioinformatics platforms and grids. They devote a great deal of efforts to building
and maintaining (ad-hoc) scripts that execute these workflow and ensure the necessary data
format conversions. We showed that the WSDL descriptions of Web services only provide a
view on the structure of the services’ input and output parameters, whereas a view on their
nature was necessary for Web services composition. We proposed an algorithm using classes
taxonomic hierarchies of Web services OWL-S semantic descriptions for checking the semantic
compatibility of services parameters and for suggesting compatible parameters pairings between
two Web services semi-automatically. We generated Taverna Xscufl files whenever possible.
Lately, Charles Bettembourg developed GO2PUB as a part of his PhD thesis [90]. GO2PUB is
a tool that uses the knowledge from the Gene Ontology (GO) and its annotations for enriching
PubMed queries with gene names, symbols and synonyms. We used the GO classes hierarchy for
retrieving the genes annotated by a GO term of interest, or one of its more precise descendants.
We demonstrated that the use of genes annotated by either GO terms of interest or a descendant
of these GO terms yields some relevant articles ignored by other tools. The comparison of
GO2PUB, based on semantic expansion, with GoPubMed, based on text-mining techniques,
showed that both tools are complementary.
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With my participation to the Akenaton project, work on semantically-rich reasoning resumed
and shifted to the optimization of symbolic knowledge modeling [91, 92]. The context is the
automatic triage of atrial fibrillation alerts generated by implantable cardioverter defibrillators
according to their severity. There can be up to twenty alerts per patient per day, with around
500,000 current patients en Europe, and an estimation of 10,000 new patients every year in
Europe. Alerts severity depend on the CHA2DS2VASc score, which evaluation requires domain
knowledge for reasoning about the patient’s clinical context. Several modeling strategies are
possible for reasoning on this knowledge. A first work compared ten strategies emphasizing all
the possible combinations of Java, OWL-DL and SWRL to compute the CHA2DS2VASc score.
A second work compared the best of these ten strategies with a Drools rules implementation [93].
The results showed that their limitations are the number and complexity of Drools rules and the
performances of ontology-based reasoning, which suggested using the ontology for automatically
generating a part of the Drools rules.
Together with the previous work on glioma tumor classification, the Akenaton project opened
a new perspective on symbolic reasoning with incomplete information. When we were designing
the reasoning module for grading glioma tumors, we observed that some information were
missing for several patients, and that the module (rightfully) prevented the system from reaching
a conclusion. We showed however that it was possible to narrow the number of possibilities by
excluding the situations that we inferred to be impossible. In the Akenaton project, similarly,
the CHA2DS2VASc score is computed by summing points for each criterion met by the patient.
Missing information can result in under-estimating the real value of the CHA2DS2VASc score.
We proposed as a complementary approach to start from the maximum possible CHA2DS2VASc
score value and to subtract points for each criterion not met by the patient This in turn resulted
in a over-estimation of the score. For a patient, combining the two values allowed us to determine
the range of the possible scores, instead of the false sense of security provided by a value that
may be under-estimated. Building on the experience, my contribution to the Astec project in
2012 was an OWL design pattern for modeling eligibility criteria that leveraged the open world
assumption to address the missing information problem of prostate cancer clinical trial patient
recruitment [94, 95].
Over the years, my interest in bioinformatics grew. In parallel with the previous works, I
started in 2010 a collaboration with Christian Diot at UMR1348 PEGASE (INRA and Agro-
campus Ouest) on knowledge-based cross-species metabolic pathway comparison in order to
study how lipid metabolism was different in chicken human and mouse [96, 97]. Together, we
supervised Charles Bettembourg’s master in 2010 degree and ongoing PhD thesis since 2011.
Our collaboration originated from the observation that when overfed, chicken do not develop
liver steatosis, whereas other animals such as geese, mice and humans do. Liver steatosis can
further evolve into fatty liver disease and cancers, so analyzing the specificities of chicken’s lipid
metabolism is of both agricultural and medical interest. Our approach is based on metabolic
pathways structural comparison in order to identify common and species-specific reactions, and
more importantly on functional comparison in order to quantify how much a metabolic process
is common and species-specific. We improved a semantic similarity measure based on Gene
Ontology and created another metric measuring semantic specificity. This work opened the op-
portunity of another collaboration with Frédéric Hérault on functional analysis and comparison
of gene sets, where we demonstrated the benefits of using semantic similarity for post-processing
and clustering DAVID results [98].
In 2013, I joined the Dyliss team at IRISA. I contributed to the analysis of the candidate
metabolic networks for Ectocarpus siliculosus generated by Sylvain Prigent in the Idealg project
during his PhD [99]. I am also working with Nathalie Théret, Geoffroy Andrieux and Jean
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Coquet (whom I co-supervise) on the analysis of TGF-β signaling pathways and their role in
human cancer [100]. Additionally, I collaborate with Fabrice Legeai, Anthony Bretaudeau,
Charles Bettembourg and Denis Tagu, as well as with Mélanie Jubault and Aurélie Évrard on
representing, storing and querying aphids [101] and Brassicaceae data in RDF. I co-supervise
with Régine Le Bouquin-Jeannès and Bernard Gibaud from LTSI the PhD thesis of Philippe
Finet on the integration and analysis of telemedicine data for monitoring patients with multiple
chronic diseases [102, 103, 104]. I will co-supervise with Nolwenn Le Meur from EHESP the
PhD thesis of Yann Rivault on the analysis of patients’ care trajectories [105]. These works are
still in progress and are further developed in my research perspectives in Chapter 6.
Over the years, the biomedical data and ontologies I have been using evolved from a medi-
cal/clinical context to more general biological one. However, the reasoning primitives remained
the same, so the distinction is not really relevant. From this point, I will refer to life science
data in general.
1.4 Organization of the manuscript
My various contributions belonged to different zones in the reasoning continuum ranging from
the simple exploitation of a taxonomy to sophisticated reasoning involving intricate necessary
and sufficient definitions and the open world assumption.
Chapter 2 presents reasoning based on hierarchy, which is valuable in spite of its simplicity as
a way to circumvent computational limitations and because the task at hand does not require
more elaborate features. Section 2.1 is a summary of RDF and RDFS principles and of the
associated entailments. Section 2.2 emphasizes constraints due to ontologies’ size and presents
an early case study for inferring candidate associations between biological pathways from KEGG
and diseases from SNOMED-CT using the Gene Ontology as a pivot. Section 2.3 focuses on a
method for performing semi-automatic pairing of Web services parameters. Section 2.4 shows
how computation performances support performing on the fly semantic expansion of PubMed
queries.
Chapter 3 presents reasoning based on classification for inferring whether an individual is an
instance of a class or whether a class is a subclass of another one. Section 3.1 is a summary of
OWL main principles and the associated inferences. Section 3.2 shows that OWL both allows
to achieve a higher level of expressivity for representing an ontology of human anatomy, and
simplifies the process of building and maintaining complex ontologies by supporting consistency
constraints. Section 3.3 shows the expressivity of this anatomy ontology supports the complex
reasoning required to infer the consequences of bullet injuries in the region of the heart. Sec-
tion 3.4 focuses on the comparison of OWL and SWRL respective advantages for optimizing
the classification of pacemaker alerts. In all the situations, we showed that if the domain on-
tologies are available and rich enough, combining them and designing the reasoning portion of
the application required a very small amount of work. Unfortunately, we also found repeatedly
that such domain ontologies rarely existed.
Chapter 4 presents how classification can be performed when the available informations
are incomplete. Section 4.1 is a summary of the open world assumption. Section 4.2 presents
a preliminary method for inferring the grade of a tumor according to its description. If the
description is incomplete, a classical classification approach may fail because none of the grades
requirements are filled. Our method then narrows the range of possible grades by ruling out
those incompatible with the information available. Section 4.3 improves the previous method
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and proposes a design pattern for modeling clinical trials’ eligibility criteria in order to increase
patient recruitment.
Chapter 5 presents how ontology can also be used performing semantic similarity-based
reasoning. Section 5.1 summarizes the principles of semantic similarity for comparing elements
or sets of elements. Section 5.2 proposes a method for computing a generic semantic particularity
measure that can be combined with any similarity for a finer interpretation. Section 5.3 presents
a method for determining optimal thresholds for semantic similarity and particularity measures.
Chapter 6 presents my research perspectives for producing, querying and analyzing life
science data.
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Chapter 2
Reasoning based on hierarchies
Outline
Taxonomy-based reasoning is arguably the simplest form of reasoning on an ontology. Neverthe-
less, this simplicity can also be valuable. It is appropriate whenever the ontology is semantically
poor (i.e. a taxonomy or an RDFS hierarchy or polyhierarchy) or when performances are im-
portant (i.e. when short answer time possibly over large hierarchies is required). This chapter
presents the general principles of taxonomy-based reasoning, and three situations where it was
relevant. It demonstrates that even simple reasoning brings added value in situations where
using more elaborate tools would be overkill. Section 2.2 emphasizes constraints due to ontol-
ogy size: it is a use case for generating candidate associations between diseases and pathways
using simple ontologies at a time when OWL reasoners could not load them. Section 2.3 is more
method-oriented for performing semi-automatic pairing of Web services parameters. Section 2.4
focuses on computation performances of an application providing on the fly semantic expansion
of PubMed queries.
2.1 Principle
This section presents why using symbolic data descriptions is a good strategy for analyzing large
interdependent datasets, and provides an overview of the associated requirements. We show that
the situation we are facing in life sciences is a part of a more general problem. Eventually, we
show how RDF and RDFS supports the representation and the analysis of these descriptions.
2.1.1 RDF for describing data
2.1.1.1 Describing data: a generic problem
Annotations as proxies to data Analyzing data can be difficult or time-consuming (usually
both), and the problem is even worse if we have to deal with large quantities of data. Moreover,
for interdependent data, analyzing some of the data can require the prior analysis of other data.
Therefore, saving the result of the interpretation or of the analysis as annotations or metadata
is a good strategy so that the next time we need to retrieve some information we do not need
to perform the analysis all over again. These annotations can then be used as proxies for faster
or more accurate access to results. Naturally, when dealing with large data sets or in order to
promote sharing, saving these annotations in a machine-processable format rather than in plain
text is desirable.
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Data annotation requirements Ideally, these machine-processable data annotations should
support the following requirements:
• describe their nature (i.e. a binary relation between the data and a set of things sharing
some common features): “TGFB1” is a gene, “TGF-β1” is a protein, “apoptosis” is a bio-
logical process, “diabetes” is a disease, “The use and misuse of Gene Ontology annotations”
is an article,
• describe their properties (i.e. a binary relation between a data and some datatype value
such as a string, a number, a date, etc.): “TGF-β1” is 390 amino acids-long, “The use and
misuse of Gene Ontology annotations” was published in 2008,
• describe the relations between them (i.e. a binary relation between two data elements):
“TGFB1” is associated to “Homo sapiens”, it is located in “chromosome 19” and encodes
“TGF-β1”, which interacts with the“LTBP1”protein and is involved in“apoptosis”,“Seung
Yon Rhee” is an author of “The use and misuse of Gene Ontology annotations” which has
for subject the “Gene Ontology”.
• combine the descriptions from different sources either because these sources partially
cover the same topic (e.g. metabolic pathways from Reactome and from HumanCYC) or
because these sources cover complementary topics (e.g. the genes associated to a disease
of interest and the pathways these genes are involved in).
In the previous examples, the resources are typically identified by a string issued by some
de facto or de jure “authoritative source”: the human gene “TGFB1” is preferentially referred
to by “ENSG00000105329” in Ensembl, “Homo sapiens” by “9606” in the NCBI taxonomy of
species, the human proteins “TGF-β1” and “LTBP1” respectively by “P01137” and “Q14766” in
Uniprot, the article “The use and misuse of Gene Ontology annotations” by “PMID:18475267”
in PubMed, and the Gene Ontology by
“http://purl.bioontology.org/ontology/GO” in BioPortal. There is an obvious heterogene-
ity of the identifier patterns among these authorities.
Moreover, what constitutes an“authoritative source”is not always well defined. For example,
apoptosis is described among others as a biological process in the Gene Ontology (GO:0006915),
as a cellular process in KEGG (ko04210), or as pathway in Reactome (REACT 578). Similarly,
“glioma” is identified by “C71” in the 10th version of the International Classification of Diseases
ICD10 (but it was “191” in the 9th version), “DI-02566” in Uniprot, “ko05214” in KEGG...
Eventually, some resources may not have been assigned an identifier: as of today, Seung Yon
Rhee (the author of PMID:18475267) does not appear to have an ORCID1 identifier.
Although all the examples we gave are related to life sciences, the problem is more generic.
2.1.1.2 RDF
The Resource Description Framework2 (RDF) is a W3C recommendation providing a standard
model for data interchange on the Web.
Identify resources using IRIs In RDF, a resource is anything that can be identified. Iden-
tification is performed using Internationalized Resource Identifiers (IRIs), which generalize Uni-
form Resource Identifiers (URIs) to non-ASCII character sets such as kanji, devanagari, cyrillic...
In the remainder of this document we will only use URIs.
1http://orcid.org/
2http://www.w3.org/RDF/
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URIs syntax follows the pattern:
<scheme name>:<hierarchical part>[?<query>][#<fragment>] where <scheme name> is typ-
ically “http” or “urn”.
Note that although URIs having an http scheme name look like URLs, they actually form
a superset of URLs as they may not be dereferenced (i.e. they are identifiers, not addresses
and there is not necessarily an Internet resource at this address). For example, Uniprot generates
URIs for proteins by appending their Uniprot identifier to http://purl.uniprot.org/uniprot/
and these are URLs (and by transitivity, also URIs and IRIs) so that
http://purl.uniprot.org/uniprot/P01137 is dereferenced either to a Web page or to some
RDF description of TGF-β1 depending on the header of the request. Likewise, Gene Ontology
generates URIs for its terms by replacing the colon in their identifiers by an underscore, and
by appending the result to http://purl.obolibrary.org/obo/GO_, but these are not derefer-
enceable: http://purl.obolibrary.org/obo/GO_0006915 is an URI that is not an URL.
Also note that URIs specify how to represent a resource identifier but does guarantee unique-
ness so that anyone is free to forge as many URIs as wanted to identify something (e.g. bio2rdf
uses http://bio2rdf.org/go:0006915 for referring to GO:0006915 whereas the Gene Ontology
uses http://purl.obolibrary.org/obo/GO_0006915). Of course, interoperability encourages
to reuse existing identifiers whenever possible.
As URIs are cumbersome to deal with by humans, we often use the more convenient pre-
fixed version (e.g. uniprot:P01137 ), but this still requires to specify somewhere that the
“uniprot:” prefix is actually associated to “http://purl.uniprot.org/uniprot/”. Prefixed
URIs are always unambiguously expanded into full URIs before being processed.
Describe resources with triples In RDF, resources are described using statements that
are triples composed of a subject, a predicate and an object
(noted <subject> <predicate> <object> . ). The subject is the URI of the described re-
source. The predicate is the URI of the relation (called a property). The object is a value of the
relation for the described resource. This value can be either some URI identifying a resource,
or a literal (i.e. a string with an optional indication of a datatype and an optional indication of
language). Figure 2.1 on the next page presents two RDF triples sharing the same subject; one
of the triples’ object is a resource and the other’s is a literal. These two triples illustrate how
RDF meets respectively the third and the second requirements mentioned in section 2.1.1.1 on
page 21. The subject or the object may also be blank nodes, which we will not cover here as
it has no impact on RDF expressivity. Note that if the relation can have several values for a
resource, this requires as many statements as values.
The fact that some statements can share the same subject (Figure 2.1 on the next page),
the same object or that the object of a statement can be the subject of another statement
(Figure 2.2 on page 25) result in a directed graph structure connecting resources. As mentioned
in the fourth requirement, statements coming from different sources can be combined in a single
expanded graph, provided these sources use the same URIs to identify the same things. For
example, Figure 2.2 on page 25 combine statements from Uniprot and from Reactome.
RDF specifies a special predicate rdf:type3 for describing the nature of a resource (i.e. a
class the resource is a member of). For example the statement
uniprot:P01137 rdf:type uniprotCore:Protein indicates that TGF-β1 (P01137) is an in-
stance of the class Protein. This rdf:type property allows RDF to address the first require-
ment.
Figure 2.2 on page 25 also shows how the use of an unique URI across different data
sources promotes interoperability and allows to combine complementary descriptions. Here,
3http://www.w3.org/1999/02/22-rdf-syntax-ns#type
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Figure 2.1: Two RDF triples describing the same resource (uniprot:P01137). Resources are
represented with ellipses, and literals by strings. Properties linking a subject to an object are
represented with arrows. URI prefixes are the usual ones (http://prefix.cc is your friend).
Uniprot has a triple uniprot:P01137 rdfs:seeAlso reactome:REACT_120727.4 where the
object is the URI corresponding to the “Downregulation of TGF-β receptor signaling” path-
way of Reactome, which in turn allows us to retrieve some additional information about this
pathway. However, in the same example, Uniprot uses the uniprotCore:organism prop-
erty linking to taxo:9606 whereas Reactome uses the biopax3:organism property linking
to http://identifiers.org/taxonomy/9606. This unfortunate use of different properties
for representing the species associated to a protein or a pathway, and of different URIs to
identify Homo sapiens prevents us twice to combine Uniprot and Reactome (e.g. for con-
trolling that Uniprot proteins and the associated Reactome pathways are consistently anno-
tated by the same species or for assisting during this annotation process). Also remember
the part about authoritative sources issuing URIs: in this case, both Uniprot and Reactome
could have used the URI by the NCBI Taxonomy Database (either the Web page or the corre-
sponding BioPortal resource http://purl.bioontology.org/ontology/NCBITAXON/9606). In
this particular case, though, Reactome relies on the identifiers.org service by the NCBI
to provide an additional level of indirection which actually allows to reconcile the Uniprot
and the NCBI taxonomy [106]: the identifiers.org service lists several URIs associated to
http://identifiers.org/taxonomy/9606, including
http://purl.bioontology.org/ontology/NCBITAXON/9606 as the primary one, as well as the
Uniprot one.
2.1.2 RDFS for describing types
While RDF is adapted for describing resources and relations between resources, RDF Schema4
(RDFS) provides a vocabulary for describing resources that are classes or predicates. This
vocabulary is represented in RDF so that any RDFS statement is also a valid RDF statement.
2.1.2.1 RDFS classes
In RDFS, a class is a group of resources, which are its instances (the set of the instances of a
class is called the extension of the class). Instances and their classes are associated with the
rdf:type predicate we have seen in the previous section. Classes are themselves resources, so
they can be identified by some URI, and described by some properties. Note that two different
classes can share the same set of instances (but classes having different sets of instances are
necessarily different).
4http://www.w3.org/TR/rdf-schema/
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In RDFS, rdfs:Class is the class of all the RDFS classes (and is therefore a metaclass). It
is an instance of itself.
RDFS defines the rdfs:subClassOf property between two classes to represent the fact that
the extension of the subject (i.e. the subclass) is a subset of the extension of the object (i.e.
the superclass). A hierarchy of subclasses–superclasses is called a taxonomy.
Figure 2.2 shows some examples of associations between instances and their classes us-
ing rdf:type (e.g. between uniprot:P01137 and uniprotCore:Protein for Uniprot or be-
tween reactome:REACT_120727.4 or reactome:REACT_318.7 and reactome:Pathway). It also
shows an example of taxonomy using rdfs:subClassOf between taxo:9606, taxo:9605 and
taxo:207598. Note that uniprotCore:Taxon is a metaclass as its instances are classes.
Figure 2.2: Graph of RDF triples describing the same resource (uniprot:P01137). Green nodes
come from Uniprot and blue nodes from Reactome. Instances and classes are represented by
ellipses and boxes respectively. This graph shows typical use of RDF relations between instances
or between an instance and a class (rdf:type ), as well as RDFS relations (rdfs:subClassOf
between classes.
2.1.2.2 RDF properties
In RDF, a property is a binary relation from one resource (the subject) to another resource (the
object). The set of the possible subjects (hence a class) for a property is its domain. The set of
the possible objects (hence a class too) for a property is its range. The extension of a property
is a subset of the Cartesian product of its domain and its range.
In RDFS, rdf:Property is the class of all the RDF properties (i.e. the relations between
resources). It is an instance of rdfs:Class.
RDFS defines two properties rdfs:domain and rdfs:range for defining the domain and
the range of RDFS properties (the domain of rdfs:domain and rdfs:range is rdf:Property
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and their range is rdfs:Class).
RDFS defines the rdfs:subPropertyOf property between two properties to represent the
fact that the extension of the subject (i.e. the subproperty) is a subset of the extension of the
object (i.e. the superproperty). Naturally, declaring that a property is a subproperty of another
property implies some additional constraints on their respective domains and ranges.
2.1.3 RDFS entailments
RDF and RDFS support some well-defined entailments which are supported by reasoners and
the SPARQL query language. This section provides a simplified overview, please refer to the
W3C RDF1.1 semantics5 for the normative document and particularly to the chapter 9.26.
RDFS entailment 1 The object of an rdf:type property is an rdfs:Class:
If x rdf:type y then y rdf:type rdfs:Class .
RDFS entailment 2 The instances of a class are also instances of its superclass:
If x rdf:type y and y rdfs:subClassOf z then x rdf:type z .
RDFS entailment 3 rdfs:subClassOf is reflexive:
If x rdf:type rdfs:Class then x rdfs:subClassOf x .
RDFS entailment 4 rdfs:subClassOf is transitive:
If x rdfs:subClassOf y and y rdfs:subClassOf z then x rdfs:subClassOf z .
RDFS entailment 5 The relations of a property also hold for its superproperties:
If x R1 y and r1 rdfs:subPropertyOf r2 then x r2 y .
RDFS entailment 6 rdfs:subPropertyOf is reflexive:
If r rdf:type rdf:Property then r rdfs:subPropertyOf r .
RDFS entailment 7 rdfs:subPropertyOf is transitive:
If r1 rdfs:subPropertyOf r2 and r2 rdfs:subPropertyOf r3 then r1 rdfs:subPropertyOf r3 .
Note that by combining RDFS entailments 2 and 4, the instances of a class are also instances
of all its ancestors. Similarly, by combining RDFS entailments 5 and 7, a property between a
subject and an object can be generalized to all the ancestors of the property.
2.1.4 Typical uses of RDFS entailments in life science
2.1.4.1 Classes hierarchies
Classes hierarchies are the most common structure of ontologies, not only in life sciences. A
notable example is Linnaeus’ taxonomy of species and the related NCBI taxonomy7 of all the
organisms in the public sequence databases (Figure 2.3 on the facing page). Similarly, life science
ontologies from the major repositories OBO Foundry8 and Bioportal9 are typically organized
as classes hierarchies.
5http://www.w3.org/TR/rdf11-mt/
6http://www.w3.org/TR/rdf11-mt/#rdfs-entailment
7http://www.ncbi.nlm.nih.gov/taxonomy
8http://www.obofoundry.org/
9http://bioportal.bioontology.org/
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Figure 2.3: The NCBI Taxonomy of species is a (deep) tree-like hierarchy.
Most ontologies are polyhierarchies (i.e. a class can have zero or several direct superclasses
such as in Figure 2.4), and few have a tree structure (i.e. all the classes but the root have
exactly one superclass such as in Figure 2.3).
Figure 2.4: The superclasses of acetoin in ChEBI show a polyhierarchy.
Most ontologies have an intricate and deep taxonomy. Some exceptions are“flat”hierarchies,
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such as the Online Mendelian Inheritance in Man10 (OMIM) with a maximal depth of 2, the
Enzyme Commission number11 (EC number) classifies enzymes according to the reactions they
catalyze and is organized in 4 levels, or the KEGG Orthology with the first two levels describing
pathways categories and the third level pathways (c.f. section 2.2.3.1).
Taxonomy-based reasoning with these ontologies typically involves RDFS entailment rules 2
and 4. Both are used for reconciling the granularity differences between precise annotations and
more general queries.
2.1.4.2 Properties hierarchies
Property hierarchies are more seldom used in life science ontologies than classes hierarchies.
A typical example is the Gene Ontology (GO) that specifies a regulates property with two
subproperties negatively regulates and positively regulates . These three properties
are used in a pattern with rdfs:subClassOf . The regulates property associates a GO class
“Regulation of X” with the corresponding GO class “X” (using an OWL existential restriction
covered in section 3.1.5). The class “Regulation of X” has two subclasses “Positive regula-
tion of X” and “Negative regulation of X”, respectively associated to “X” by negatively
regulates and positively regulates (Figure 2.5).
Figure 2.5: Usage of the negatively regulates and positively regulates subproperties
of regulates in the Gene Ontology.
Reasoning based on properties hierarchy typically involves RDFS entailment rules 5 and
7. Like classes hierarchies, both are used for handling different levels of precision in the data
descriptions. Figure 2.6 on the facing page shows the possible generalizations of “Positive
regulation of leukocyte migrations” and of ‘Leukocyte migrations” as well as the cor-
responding regulation relations.
2.1.4.3 Application to annotations
Reasoning based on classes and properties hierarchies is often used for reconciling annota-
tions with different granularities [45]. Because of the definitions of rdfs:subClassOf and
of rdfs:subPropertyOf , if a data element is annotated by a class, then we can infer that
this data element is also annotated by the superclasses. Because of the transitive nature of
rdfs:subClassOf and of rdfs:subPropertyOf , we can also infer that the data element is also
annotated by all the ancestors. In the Gene Ontology, this principle is known as the “True path
rule”. For example, the gene product uniprot:P55008 (AIF1, Allograft inflammatory factor
10http://bioportal.bioontology.org/ontologies/OMIM
11http://www.chem.qmul.ac.uk/iubmb/enzyme/
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Figure 2.6: Complex mix of rdfs:subClassOf hierarchies and of rdfs:subPropertyOf
hierarchies based on regulates , positively regulates and negatively regulates as-
sociating the GO class Positive regulation of leukocyte migration and its ances-
tors to the GO class Leukocyte migration and its ancestors (Image by QuickGO
http://www.ebi.ac.uk/QuickGO/).
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1) is annotated (among others) by GO:0002687 (Positive regulation of leukocyte migration) in
Homo sapiens. The GO hierarchy (cf. Figure 2.6 on the previous page) allows us to infer that
AIF1 is also involved in “cell migration” and in “immune system process”. Several articles pro-
vide more information on the GO annotations and the related inferences[107, 108]. Livingston
et al. also provided an interesting work on the representation of annotations [109].
The “True path rule”-like reasoning is useful in two situations: for analyzing the annotations
of data elements, and for querying the data elements annotated by some ontology class. In the
first case, we proceed from the data element to its annotations, and in the second case from the
annotations to the data elements. To comply with the semantics, reasoning consists in moving
up along the hierarchy in the first case, and moving down in the second case.
A typical first case scenario consists in comparing two gene products by analyzing the
common GO terms or the ones specific to one of the gene products: comparing their lists
of direct annotations is likely to miss some common terms due to the granularity differences,
and one should compare the lists of indirect annotations (i.e. the direct annotations and their
ancestors).
A typical second case scenario consists in performing some query expansion for retrieving
the data elements annotated directly or indirectly by some annotation of interest (e.g. the
gene products involved in “immune system process” with GO, or the articles about “infectious
diseases” with the MeSH). Retrieving the data elements directly annotated is a trivial database
query. However, we should also look for the data elements annotated by some descendant of
these annotations, as the true path rule indicates that the annotation of interest is also valid
for them.
2.1.5 Synthesis
As we have seen, RDFS-compliant reasoning consists mainly in computing the transitive closure
of rdfs:subClassOf and rdfs:subPropertyOf . Of course, typical reasoning patterns usually
involve combining both. Dedicated RDFS reasoners and query engines have been perfected
over the years. The simplicity of the task have allowed them to gain far better performances
than ad-hoc solutions based on classic programming languages, or relational engines that are
notoriously bad at handling transitive closures.
In the remainder of this chapter, section 2.2 shows how an RDF(S) query engine allows
to combine multiple ontologies and to query them whereas each of these ontologies was too
large to be loaded by an OWL reasoner (even if these ontologies were merely polyhierarchies).
This demonstrated that not all tasks on ontologies require an OWL reasoner... and using one
can even be counter-productive. Section 2.3 focuses on a reasoning method that fully exploits
subclasses and subproperties for pairing Web services parameters. Section 2.4 shows that even
for a large ontology such as the Gene Ontology, RDFS reasoning is compatible with on the fly
PubMed query enrichment as the time spent enriching the query is negligible compared to the
time spent by PubMed for answering the query.
Overall, this chapter shows that RDFS reasoning is valuable even if the medical ontology
community was mostly focusing on OWL reasoners (on semantically-simple ontologies).
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2.2 Case study: integrating diseases and pathways
This case study focuses on the integration of overlapping ontologies covering different
aspects of life science. We created a biomedical ontology associating diseases and path-
ways using mapping and alignment techniques over KEGG Orthology, Gene Ontology
and SNOMED-CT. We represented this ontology in OWL and demonstrated that
RDFS queries were expressive enough with acceptable computational performances.
In retrospect, this work is interesting because it identified the need for a posteriori
resource integration (the linked open data initiative originated around 2007, and ontol-
ogy alignment and mapping became a very active field in this period), and highlighted
the need for using reasoning tools adapted to the task at hand (in those days, DL
reasoners could hardly load an ontology, so loading several ontologies was out of ques-
tion; it would have been overkill anyway because these ontologies are mostly simple
taxonomies that hardly use DL features).
This work was a collaboration with Julie Chabalier who was a postdoctoral fellow. It was sup-
ported by a grant from Région Bretagne (PRIR) and was originally published in Julie Chabalier,
Olivier Dameron, and Anita Burgun. Integrating and querying disease and pathway ontologies:
building an OWL model and using RDFS queries. In Bio-Ontologies Special Interest Group,
Intelligent Systems for Molecular Biology conference (ISMB’07), 2007 [85].
2.2.1 Context
Use of ontologies within the biomedical domain is currently mainstream (e.g. the Gene Ontol-
ogy GO [110]). Within a few years, the success of bio-ontologies has resulted in a considerable
increase in their number (e.g Open Biological Ontologies12). While some of these bio-ontologies
contain overlapping information, most of them cover different aspects of life science. How-
ever, an application may require a domain ontology which spans several ontologies.
Rather than to create a new ontology, an alternate approach consists of reusing, combining and
augmenting these bio-ontologies in order to cover the specific domain [111].
Associations between classes of genes and diseases as well as associations be-
tween pathways and diseases are key components in the characterization of dis-
eases. Different phenotypes may share common pathways and different biological processes
may explain the different grades of a given disease. However, this information remains absent in
most existing disease ontologies, such as SNOMED CT. Pathway-related information is present
in other knowledge sources. The KEGG PATHWAY database is a collection of pathways maps
representing our knowledge on the molecular interaction and reaction networks for metabolism
and cellular processes [112]. As the GO does not provide direct association with pathways,
Mao et al. have proposed to use the KEGG Orthology (KO) as a controlled vocabulary for
automated gene annotation and pathway identification [113]. At that time, information about
the pathways involved in human diseases has been added to KO.
A major step for addressing this issue is “ontology integration”, which sets up relations
between concepts belonging to different ontologies. It encompasses several notions: merging
consists in building a single, coherent ontology from two or more different ontologies covering
similar or overlapping domains, aligning is achieved by defining the relationships between some
of the terms of these ontologies [114] and mapping corresponds to identifying similar concepts
or relations in different sources [115].
12http://obofoundry.org/
31
The automatic exploitation of the knowledge represented in integrated ontologies requires an
explicit and formal representation. Description Logics, and OWL (Web Ontology Language) in
particular, offer a compromise between expressivity and computational constraints [116]. How-
ever, for leveraging its expressivity, ontologies should contain features such as necessary and suf-
ficient definitions for classes whenever possible, as well as disjointness constraints. While recent
works put forward a set of modeling requirements to improve the representation of biomedical
knowledge [117, 51], current biomedical ontologies are mostly taxonomic hierarchies with sparse
relationships. Even though, dedicated reasoners are hardly able to cope with them.
2.2.2 Objective
The objective of this study was to infer new knowledge about diseases by first inte-
grating biological and medical ontologies and finally querying the resulting biomed-
ical ontology. We hypothesized that most typical queries do not need the full ex-
pressivity of OWL and that RDFS is enough for them. In this study, we used the term
’pathway’ for metabolic pathways, regulatory pathways and biological processes. The approach
presented here consisted in developing a disease ontology using knowledge about pathways as
an organizing principle for diseases. We represented this disease ontology in OWL. Following
an integration ontology methodology, pathway and disease ontologies have been integrated from
three sources: SNOMED CT, KO, and GO. To investigate how information about pathways can
serve disease classification purposes, we compared, as a use case, glioma to other neurological
diseases, including Alzheimer’s disease, and other cancers, including chronic myeloid leukemia.
2.2.3 Linking pathways and diseases using GO, KO and SNOMED-CT
2.2.3.1 KEGG Orthology
The KEGG PATHWAY database was used as the reference database for biochemical pathways.
It contains most of the known metabolic pathways and some regulatory pathways. KO is a
further extension of the ortholog identifiers, and is structured as a directed acyclic graph (DAG)
hierarchy of four flat levels. The top level consists in the following five categories: metabolism,
genetic information processing, environmental information processing, cellular processes and
human diseases. The second level divides the five functional categories into finer sub-categories.
The third level corresponds to the pathway maps, and the fourth level consists in the genes
involved in the pathways. The first three levels of this hierarchy were integrated in the disease
ontology.
KO hierarchy is provided in HTML format. We extracted the three upper levels of this hier-
archy. Each KO class was represented by an OWL class respecting the subsumption hierarchy.
2.2.3.2 Gene Ontology
Gene Ontology is composed of three independent hierarchies representing biological processes
(BP), molecular functions (MF) and cellular components (CC). A biological process is an ordered
set of events accomplished by one or more ordered assemblies of molecular functions (e.g. cellular
physiological process or pyrimidine metabolism). Since we consider all pathways as biological
processes, the biological process hierarchy was used to enrich the pathway definitions. The GO
BP hierarchy is more detailed than that of KO. It is composed of 27,127 terms spanning 16
levels; for more details about GO structure see [118].
We retrieved the OWL version of GO from the Gene Ontology website13.
13http://geneontology.org/page/download-ontology
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2.2.3.3 SNOMED CT
SNOMED CT was used as reference source for disease definitions because it is the most compre-
hensive biomedical terminology recently developed. We used SNOMED to enrich the definitions
of human diseases provided by KO.
SNOMED CT is not freely available. However, it is part of the UMLS knowledge Sources [119].
Therefore, we extracted the relevant concepts and their parents, as well as their relations, from
the SNOMED CT part of the UMLS. The concepts and relations were respectively represented
as OWL classes and properties.
2.2.3.4 Ontology integration
The ontology integration process was based on ontology alignment, which defines relationships
between terms, and on ontology mapping, which is a restriction of ontology alignment by taking
into account only equivalence relationships between terms.
Figure 2.7 presents an overview of the integration principle. See the original article for details
about the method (including the automatic decomposition of KO terms such as “Fructose and
mannose metabolism” so that it could be mapped to GO “Fructose metabolic process” and
“Mannose metabolic process”) and the quantitative results.
The resulting ontology connected diseases from the SNOMED-CT ontology to biological
processes from the GO using the hasPathway relationship.
Figure 2.7: Integration of the Gene Ontology (GO), KEGG Orthology (KO) and SNOMED-CT,
and the resulting hasPathway relations between diseases and pathways. KO is used as a pivot
between the GO biological processes for the pathways and diseases from SNOMED-CT.
2.2.4 Querying associated diseases and pathways
Queries can be used either for checking the consistency or for exploiting the resulting integrated
bio-ontology.
Typical consistency queries consist in detecting if a specific pathway and a more general
one are associated with a same disease. Such an imprecision of granularity can either come from
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one faulty ontology or from the integration of the knowledge from two ontologies with different
granularity.
Typical queries for exploiting the ontology involve 1) retrieving the pathways common
to several diseases, 2) retrieving the pathways associated with one disease but not with another
one, or 3) retrieving the diseases associated with the pathways associated with one class of
diseases.
Computing the solutions for both kinds of queries only requires following explicit relations.
It does not require OWL-based classification, and can be performed using only the RDFS
semantics. RDF repository, and represented the queries using the SeRQL language.
At the time of this study in 2007, we loaded the ontology in a Sesame RDF repository and
used SeRQL which was the query language designed by Aduna for the Sesame triplestore [120].
SeRQL advantages over SPARQL (which became a W3C recommendation in 2008) were that
it was the query language for the popular Sesame, and that it supported RDFS. Nowadays,
SPARQL would be the query language of choice. RDFS support in SPARQL is achieved using
property path (e.g. rdfs:subClassOf+ indicates“follow one or more rdfs:subClassOf ”) which
appeared in 2013 when SPARQL1.1 became a W3C recommendation. We present the SPARQL
equivalent of the original SeRQL queries.
2.2.4.1 Redundant disease–pathway associations
When a disease is associated with a pathway, we can infer automatically that it is also associated
with all the superclasses subsuming (directly or indirectly) this pathway (Figure 2.8).
Figure 2.8: The association between SomeDisease and Pathway2 can be inferred using the
pathway hierarchy and therefore does not need to be stated explicitly.
The following query retrieves the (disease, pathway) couples linked by a redundant has-
Pathway relation.
1 SELECT DISTINCT ?disease ?redundantPathway
2 WHERE {
3 ?disease dp:hasPathway ?precisePathway .
4 ?disease dp:hasPathway ?redundantPathway .
5 ?precisePathway rdfs:subClassOf+ ?redundantPathway .
6 }
2.2.4.2 Pathways common to two diseases
The following query retrieves the pathways directly associated to two diseases :
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1 SELECT DISTINCT ?commonDirectPathway
2 WHERE {
3 ?disease1 dp:hasPathway ?commonDirectPathway .
4 ?disease2 dp:hasPathway ?commonDirectPathway .
5
6 BIND ( snomed:393564001 as ?disease1) # Glioma
7 BIND ( snomed:44054006 as ?disease2) # Type 2 diabetes mellitus
8 }
Figure 2.9: None of the three diseases share any direct pathway. However, considering the
GO hierarchy allows to recognize that Disease1 is associated with a pathway more specific
than that of Disease3, and therefore Monosaccharide metabolic process and its ancestors
are all common to both diseases (idem for Disease2 and Disease3). Similarly, Disease1 and
Disease2 are associated with Hexose metabolic process and its ancestors.
The previous query is similar to what we could do using a relational database. However, it
fails to take the pathway hierarchy into account. If the two diseases are associated with different
pathways (e.g. “Fructose metabolic process” for the first and “Mannose metabolic process” for
the second) they do not have any direct pathway in common, whereas we could infer from
GO that both diseases are associated with the common ancestors of these two terms (in this
example “Hexose metabolic process” and its ancestors), as seen in Figure 2.9. The following
query retrieves the pathways directly or indirectly associated to two diseases (lines 3 and 4 could
have been simplified to ?disease1 dp:hasPathway/rdfs:subClassOf* ?commonPathway but
I kept the verbose version for the sake of clarity; idem for lines 6 and 7):
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1 SELECT DISTINCT ?commonPathway
2 WHERE {
3 ?disease1 dp:hasPathway ?pathway1 .
4 ?pathway1 rdfs:subClassOf* ?commonPathway .
5
6 ?disease2 dp:hasPathway ?pathway2 .
7 ?pathway2 rdfs:subClassOf* ?commonPathway .
8
9 BIND ( snomed:393564001 as ?disease1) # Glioma
10 BIND ( snomed:44054006 as ?disease2) # Type 2 diabetes mellitus
11 }
The same principle allows to take the hierarchy of diseases into account in order to retrieve
the pathways directly or indirectly associated with a class of diseases. Note that in this case we
consider the pathways associated with the disease class or at least one of its subclasses (and not
the pathways common to all the diseases of the class). This is mostly because the associations
between diseases and pathways are far from being exhaustive, and if one of the diseases is not
associated with any pathway, then the entire class would not be either (see chapter 4 for further
details about reasoning with incomplete information).
The following query retrieves the pathways directly or indirectly associated with two classes
of diseases or one of their subclasses:
1 SELECT DISTINCT ?commonPathway
2 WHERE {
3 ?disease1 rdfs:subClassOf* ?diseaseClass1 .
4 ?disease1 dp:hasPathway ?pathway1 .
5 ?pathway1 rdfs:subClassOf* ?commonPathway .
6
7 ?disease2 rdfs:subClassOf* ?diseaseClass2 .
8 ?disease2 dp:hasPathway ?pathway2 .
9 ?pathway2 rdfs:subClassOf* ?commonPathway .
10
11 BIND ( snomed:55342001 as ?diseaseClass1) # Neoplastic disease
12 BIND ( snomed:126877002 as ?diseaseClass2) # Disorder of glucose metabolism
13 }
2.2.4.3 Pathways specific to a disease
The following SPARQL query retrieves the pathways directly or indirectly associated with a
disease (glioma) but not with another disease (type 2 diabetes mellitus):
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1 SELECT DISTINCT ?disease1SpecificPathway
2 WHERE {
3 ?disease1 dp:hasPathway ?pathway1 .
4 ?pathway1 rdfs:subClassOf* ?disease1SpecificPathway .
5
6 FILTER NOT EXISTS {
7 ?disease2 dp:hasPathway ?pathway2 .
8 ?pathway2 rdfs:subClassOf* ?disease1SpecificPathway .
9 }
10
11 BIND ( snomed:393564001 as ?disease1) # Glioma
12 BIND ( snomed:44054006 as ?disease2) # Type 2 diabetes mellitus
13 }
Note that this query can be modified like we did for the common pathways in order to
retrieve the pathways directly or indirectly associated with a class of diseases but not with
another class of diseases.
2.2.4.4 Pathways connecting a disease and a class of diseases
The following query retrieves the diseases associated directly or indirectly with the pathways
associated with one class of diseases. Note that in this case it is important to consider only
the pathways directly associated with the class of diseases or at least on of its subclasses, but
that the pathways hierarchy should still be exploited to analyze the pathways associated with
relatedDisease.
1 SELECT DISTINCT ?relatedDisease
2 WHERE {
3 ?disease rdfs:subClassOf* ?diseaseClass .
4 ?disease dp:hasPathway ?pathway .
5
6 ?relatedDisease dp:hasPathway ?pathway2 .
7 ?pathway2 rdfs:subClassOf* ?pathway .
8
9 BIND ( snomed:55342001 as ?diseaseClass) # Neoplastic disease
10 }
2.2.4.5 Leukemia, glioma and Alzheimer’s disease use-case
For being able to manually check that our queries returned correct results, we considered three
diseases: chronic myeloid leukemia, glioma, and Alzheimer’ disease. First, we performed some
RDFS queries for checking the consistency of the integrated ontology. Among the pathways
associated with one disease, 87 are more general than some other pathway associated with
this disease (47 for leukemia, 29 for glioma and 10 for Alzheimer’s disease). We removed the
least specific pathways. We then performed some RDFS queries for comparing diseases by
their associated pathways. First, we compared two neurological disorders, namely glioma and
Alzheimer’s disease (Figure 2.10 on the next page). 8 direct pathway classes involved in glioma
were also associated to Alzheimer’s disease (86 indirect classes). Then we compared glioma and
leukemia; 44 direct pathway classes were shared by these two cancers (165 indirect classes).
Finally, 37 pathways are specific to these two cancers (97 indirect classes). Furthermore, the
three diseases are associated with pathways themselves associated with glioma.
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Figure 2.10: Pathways (red ellipses) associated with diseases (blue rectangles): Alzheimer’s
disease (bottom left) and glioma (center top).
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2.3 Methodology: Web services composition
This study focuses on using semantic annotations for helping a user pairing Web
services parameters for creating a workflow. From our experience, biologists usually
have a rather precise idea of the goal they want to achieve and of the services to
use, but they can use some help for the technical aspect of service orchestration. We
assumed that the services composing the workflow are known, as well as their relative
order. We demonstrated that parameter pairing should not only rely on the type of
the parameters (e.g. a string or a date), but also on their nature (e.g. a family name,
a city or a creation date as opposed to a validation date). We determined whether
pairs of parameters are semantically compatible by examining if they have the same
nature or if the output parameter of a service is subsumed by the input parameter of
the next service.
In retrospect, this work is interesting because while at that time most of the other
works on this domain focused on determining the succession of Web services, we fo-
cused on the “next step”, i.e. pairing the parameters once this succession is known.
Although we made a clear distinction between determining the succession of Web ser-
vices and pairing the parameters in order to differentiate our work from the others,
parameters semantic compatibility could provide some relevant information for guiding
the proposition of a succession of Web services.
This work was carried out by Nicolas Lebreton, who I supervised with Anita Burgun. It
was originally published in Nicolas Lebreton, Christophe Blanchet, Daniela Barreiro Claro,
Julie Chabalier, Anita Burgun, and Olivier Dameron. Verification of parameters semantic
compatibility for semi-automatic Web service composition: a generic case study. In Proceedings
of the 12th International Conference on Information Integration and Web-based Applications
and Services (iiWAS2010), pages 845–848, 2010 [89].
2.3.1 Context
Creating a workflow of Web services is a difficult task [121]. Currently, this is a manual and
time-consuming process requiring different expertises. The first step is the selection of the Web
services and their arrangement in a sensible order. It requires domain expertise and is typically
done by end-users who have an idea of the succession of tasks to perform. Service selection
relies on the notion of goal, which is typically represented in task ontologies. The second step
consists in pairing the output of a service with one of the inputs of the next one in the workflow.
It requires technical expertise for connecting each service input parameters to data or to the
output of some other service. Parameter pairing relies on the nature of the parameters, which
is typically represented in domain ontologies.
Annotations help automating this tedious process. When present, the WSDL (Web Services
Description Language) description of the service is useful, but it only addresses the syntactic
level of interoperability (e.g. the input parameter is a string). Parameter pairing based on their
type (not their nature) is prone to two kinds of errors:
• it misses correct pairings when the parameters are in different formats and would only
require a conversion (e.g. the first service output is of type xsd:date whereas the second
service input is a xsd:string);
• it generates incorrect pairings when the parameters are of different natures but represented
in the same format (e.g. the first service output is family name of type xsd:string and
the second service input is a city of type xsd:string).
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Recognizing the two previous kinds of errors from the correct situations requires some com-
bined reasoning on the type of the parameters (e.g. using XML schemas) and on the nature of
the parameters independently from the way they are represented (e.g. a date, a name, a city).
OWL-S [122] is the de facto standard to represent semantic descriptions of the various Web
services. Semantic Web services composition is the act of taking several semantically-annotated
Web services and binding them together to meet the needs of the user.
However, semantic description of Web services are scarce and are not really exploited by
applications. A well-known tool for multi-domain data analysis is currently Taverna [123] and
its workflow language Xscufl (XML Simple Conceptual Unified Flow Language). Taverna allows
the user to configure and combine the relevant Web services in a workflow. The Xscufl syntax
is used by the Taverna project to store and retrieve workflow definitions. Setting all Taverna’s
parameters requires a significant knowledge of the Web services and this information is generally
not accessible in a software-compatible format that would support automatic assistance. The
services combination and the pairing of parameters have to be performed manually, only the
execution of the workflow is automated.
2.3.2 Objective
We focused on the use of the semantic annotations to check the compatibility of Web services
parameters in a workflow where the order of execution of the Web service is already known.
We demonstrated that OWL-S is expressive enough to support these pairings, and that once
the pairings have been decided, an Xscufl file representing the workflow can be automatically
generated so that Taverna can execute the workflow.
2.3.3 Semantic compatibility of services parameters
During workflow composition, we assume that the user has already defined the Web services
ordering. During each transition from one Web service to the next, we examine all the possible
combinations of an output of the first Web service with an input of the next one. Four situations
can arise (Figure 2.11 on the facing page):
• Identical match: the input and the output have exactly the same kind;
• Generalization match: the input is more general than the output of the previous service;
• Specialization match: the input is more specific than the output of the previous service.
It is up to the user to make sure that in his conditions of use, the first service will always
return results that are semantically compatible with the next service input;
• Incompatibility : the input cannot be reconciled with the output of the previous service.
This is either because the pairing has to be ruled out, or because the ontology is incomplete.
Compatibility is inferred in case of identical match or generalization match.
Compatibility is possible but not guaranteed in case of specialization match. In this case,
the type of the output is more general than the type of the next service’s input. As the output
may not be compatible with the required input type, it is up to the user to determine whether
the particular conditions of application guarantee a safe execution.
2.3.4 Algorithm for pairing services parameters
We assumed that the order of the Web services in the workflow is known. We proposed an
algorithm for semi-automatically determining which output parameter of a Web service can be
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Figure 2.11: Semantic compatibility of a Web service output with the next Web service input
depending on the parameters’ nature. Compatibility is inferred in case of identical match or
generalization match. Compatibility is possible but not guaranteed in case of specialization
match. Otherwise, compatibility is ruled out.
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paired with which input parameter of the next service. For each input parameter, the algorithm
returns a set (possibly empty) of semantically-compatible output parameters, and a set (possibly
empty) of potentially-compatible output parameters. Optionally, both sets can be converted to
lists if the difference of granularity between the output and the input parameter is considered.
For each pair of connected services, we determine all the pairwise semantic compatibilities of
an input parameter of the second service with an output parameter of the first services. Three
configurations can arise (Table 2.1 summarizes the possible actions):
• the Web service input is semantically compatible with exactly one output of a previous
Web service (either through identical match or through generalization match), and no
specialization match was detected. The correct pairing can be validated by the user.
• the Web service input is either semantically compatible with more than one output of a
previous Web service (either through identical match or through generalization match),
or at least one specialization match was detected. Both lists of candidate pairings are
presented to the user who can reject them all or select one ;
• the Web service input is not semantically compatible with any of the outputs of a previous
Web service (either through identical match or through generalization match), and no
specialization match was detected. The situation cannot be resolved automatically and
the user should decide if the problem lies in the workflow itself or in the ontology used to
describe the parameters.
Nb semantically-compatible parameters
0 1 >1
Specialization 0 No compatibility Validation required Reject or select one
match >= 1 Reject or select one Reject or select one Reject or select one
Table 2.1: Pairing services parameters.
Note that it is important to focus on the input parameters. Parameter pairing consists in
choosing one of the outputs of a previous service as the value for the input parameter (and this
value is obviously unique, whereas the output of a service can be paired with several inputs of
following services). Figure 2.12 on the facing page shows a situation where the input of service S3
is semantically-compatible with the output of service S1 and in a specialization match with the
output of service S2. In this case, the user will have to make a choice between the semantically-
compatible pair < O1, I3 > and a potentially-compatible pair < O2, I3 > (the former being the
most likely candidate). If we had focused on output parameters, we would have determined
that O1 was most likely paired with I3, and independently that O2 was most likely paired with
I3 without realizing that both pairs are concurrent; moreover, in addition to I3, O1 could also
be paired with the input of another service in addition to S3.
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Figure 2.12: Pairing services parameters is performed by considering all the combinations lead-
ing to an input parameter and applying Table 2.1 on the facing page.
2.4 Application: ontology-based query expansion with GO2PUB
This application automatically enriches PubMed queries with gene names, symbols
and synonyms annotated by a Gene Ontology (GO) term of interest or one of its
descendants. GO2PUB is based on a semantic expansion of PubMed queries using
the semantic inheritance between GO terms. We demonstrated that this approach
yields some relevant articles ignored by the other tools and can be generalized to any
biological processes.
In retrospect, this work is interesting because even if the MeSH and the Gene Ontology
are arguably the two ontologies that had the greatest impact on the life science com-
munity, their integration was original and provided some added value. It should also
be noted that the current implementation relies on the GOA databases in a relational
format, as they were provided by the EBI. Now that the bio2rdf project released some
RDF versions of GOA, the semantic expansion part of GO2PUB could be elegantly
rewritten as much simpler SPARQL queries.
This work was initiated and carried out by Charles Bettembourg during his Master’s degree
internship and then at the beginning of his PhD thesis because he needed to perform PubMed
queries on lipid metabolism but found serious limitations with PubMed.
It was originally published in Charles Bettembourg, Christian Diot, Anita Burgun and
Olivier Dameron. GO2PUB: Querying PubMed with semantic expansion of gene ontology
terms. In Journal of Biomedical Semantics 2012, 3:7 [90].
GO2PUB is available at http://go2pub.genouest.org/.
2.4.1 Context
The development of high-throughput methods of gene analysis requires to deal with lists of
thousands of genes while researchers were used to search the literature only for a few genes at a
time. The information retrieval process becomes an increasingly difficult task and needs to be
redesigned to provide literature concerning biological problems raised by the gene analyses.
PubMed is the most comprehensive public database of biomedical literature. It comprises
more than 21 million entries for biomedical literature from MEDLINE, life science journals, and
online books14. The typical PubMed user has to read several dozens to hundreds of abstracts
14http://www.ncbi.nlm.nih.gov/pubmed
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to select the relevant ones. More than 4 million articles were added in the last 5 years 15.
A well defined query is important to retrieve as many relevant articles as possible with as
few irrelevant ones as possible. Such a query is often more complex than the few loosely-coupled
keywords used by most users. There is a need for automatic tools helping the users to build
such complex queries that minimize silence and noise [124, 125].
Although PubMed supports MeSH-based query expansion [126], other literature search tools
have been developed [127, 128, 129, 130] and evaluated [131]. These can be classified into three
major approaches. The first approach, exemplified by tools like SLIM [132], is based on an
intuitive interface to set some filters on PubMed queries in order to obtain a better precision
than with the basic PubMed querying system. A good proficiency with PubMed advanced search
brings similar results.
The second approach developed in SEGOPubMed uses a Latent Semantic Analysis (LSA)
framework. It is based on a semantic similarity measure between the user query and PubMed
abstracts [133]. The authors of SEGOPubMed state that the LSA approach outperforms the
other approaches when using well-referenced keywords. Unfortunately, no implementation of
SEGOPubMed is currently available. Moreover, this method requires that a corpus of well-
referenced keywords be constituted and maintained before the search. Such a corpus is not
available (in the biomedical domain) either.
The third approach is based on query enrichment using controlled vocabularies and ontolo-
gies. An ontology is a knowledge representation in which concepts are described both by their
meaning and their relations to each other [37]. Ontologies are useful to find information relevant
to a given topic, particularly through a query expansion process[134]. The automatic handling
of the query complexity facilitates query formulation. Expanded queries applied to the Web
information retrieval show a systematic improvement over the unexpanded ones [135]. QuExT
performs a concept-oriented query expansion to retrieve articles associated with a given list of
genes symbols from PubMed and to prioritize them [136].
A frequent goal of gene-related analyses (e.g. transcriptomics) is to identify the genes with
different expression across samples analyzed. Thereafter, scientists link their list of genes to
more synthetic keywords and functions using Gene Ontology (GO) terms [137] associated to
genes thanks to the Gene Ontology Annotation database [138]. At this stage of the gene-related
analyses, the keywords to search the literature are not gene names anymore but GO terms.
Therefore, tools querying literature with GO terms seem appropriate. GoPubMed [139] uses
a text extraction algorithm to mine PubMed abstracts with GO terms. It relies on a local
string alignment to compare the GO terms and the abstracts. GoPubMed selects the abstracts
containing at least a significant part of the semantic of the GO terms. However, GoPubMed
does not follow GO strict rules conveying the semantics of terms. If the annotation of a gene
product gp by a Gene Ontology term t is true, then the annotation of gp by any parent of
t is equally true [138]. All transitive relation (is a, part of) have to be followed to retrieve
these parents. As GoPubMed does not follow this rule, its recall decreases whenever inferences
about gene annotations yield new relevant results [140]. None of the existing tools supports a
combination of semantics-based and of synonym-based PubMed query enrichment.
2.4.2 Objective
In this study, we hypothesized that the name of the genes annotated by a GO term of interest
or one of its descendants can be used as keyword in gene-oriented PubMed queries. The descen-
dants of a GO term are defined according to the Gene Ontology specifications of reasoning about
15http://www.nlm.nih.gov/bsd/licensee/baselinestats.html
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relations. The genes annotated with GO terms are provided by the Gene Ontology Annotation
database.
In our system GO2PUB, we propose a new approach that considers not only the genes
annotated with a GO term of interest, but also those annotated by a descendant of this GO
term, complying with the semantic inheritance properties of GO. GO2PUB’s user inputs a list
of GO terms of interest, one or more species, and a list of keywords. It generates a PubMed
query with the names, symbols and synonyms or aliases of these genes, the species and the
keywords and processes PubMed results.
We also performed a qualitative relevance study on our domain of expertise using three
queries related to lipid metabolism. In this manuscript, I focus on GO2PUB query expansion.
Please refer to [90] for details on the relevance study.
2.4.3 Semantic expansion
Semantic expansion consists in following the semantic inheritance through the GO graph in
order to also consider all the descendants of the GO terms specified by the users. Then, the
process retrieves the gene names annotated with these terms.
GO2PUB uses these gene names and their synonyms as additional keywords for PubMed
queries. Figure 2.13 shows that the expansion identifies five genes associated with the regulation
of fatty acid metabolic process, instead of two if the semantic inheritance is ignored.
Regulation of fatty acid 
metabolic process (GO:0019217)
Regulation of fatty acid biosynthetic process
(GO:0042304)
Negative regulation of 
fatty acid biosynthetic 
process (GO:0045717)
Positive regulation of 
fatty acid biosynthetic 
process (GO:0045723)
PPAR
CAV1
BRCA1 ChREBP APOA1
Figure 2.13: Keyword semantic enrichment. For a literature search about the regulation of
fatty acid metabolic process, we want to enrich the query with the associated genes. The
two genes PPAR and CAV1 are directly annotated by the GO term “Regulation of fatty acid
metabolic process” (GO:0019217). However, Gene Ontology inheritance properties say that
every term inherits the meaning of all its ancestors. Consequently, genes annotated by at least
one descendant of the original term (BRCA1, ChREBP and APOA1) should also be considered.
2.4.4 Query generation
GO2PUB creates an expanded PubMed query with the name, symbol and synonyms of genes
annotated by one or several GO terms provided by the users, for one or several species. Fig-
ure 2.14 on the following page presents the process. The users provide one or several GO terms
and species. To further restrict their query, they can also provide as many MeSH terms key-
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words as wanted. Furthermore, a “free text” field supports the use of all the other PubMed tags,
like [Author], [Journal], etc., and keywords from MeSH terms or free text.
(G1 U G2 U G3 U ...................... Gw U Gx U GyU U Gz)
GO1
GO11
Other terms
and their
descendants
GOα
GOα
GOα
GOα1 2
3
U
 β species
(S1 U ... U Sβ)
U
 
 γ keywords
(K1 U ... U Kγ)
Figure 2.14: GO2PUB Query composition process using the parameters provided by the user.
(1) the initial α GO terms (purple boxes) are enriched by their descendants. (2) the genes (here
noted G1 to Gz) annotated by the GO terms are retrieved. (3) the query is composed using the
names, symbols and synonyms of the genes, the β species (S) and the γ MeSH or free keywords
(K).
The first part of each query involves one or more GO terms. The users can enter either the
name or the identifier of the GO terms. These terms are suggested when the users start to fill
the field. The exact GO term is suggested if the users provide one of its GO synonyms. For
example, GO2PUB will search for “lipid biosynthetic process” if the users provide “lipogenesis”.
When two or more GO terms are entered, GO2PUB makes the union of them (“OR” connector).
Then, the users select one or several species using a name (common or scientific names and
their synonyms are allowed) or a NCBI taxon code16. In this case, the users can choose to
join them (using “OR”) or intersect them (using “AND”). Logical connectors “AND” and “OR”
are set by default to make the union of species and intersection of keywords, but this can be
modified.
Next, the users can enter additional MeSH terms to specify their query. MeSH terms asso-
ciated to the articles by PubMed are not all of same importance, some of them being classified
as “Major topic” (MAJR). We can qualify each keyword as a simple MeSH term or a Major
topic. Again, the users can specify the connector between keywords.
GO2PUB retrieves all gene names annotated by each GO term, directly or indirectly through
the semantic inheritance properties. It then builds a query on the model“(n gene names, symbols
or synonyms separated by OR) AND (m species) AND (p MeSH terms)”. The name, symbol
and synonyms of each gene compose the first part of the query. They will be searched in title
and abstract. Species and keywords chosen by the users make up the second part of the query.
Finally, GO2PUB submits to PubMed a query composed of gene names annotated directly or
indirectly by the GO terms chosen by the users (name OR symbol OR Synonym), at least one
species and some MeSH terms and free keywords. This big query is split into several smaller
ones if it exceeds PubMed server URL length limitation. GO2PUB compiles the results and
displays all citations numbered and sorted by date.
Figure 2.15 on the next page shows the respective results of PubMed, GoPubMed and
GO2PUB for a query about“Lipogenesis in chicken liver”. Overall, the comparison of GO2PUB,
based on semantic expansion with GoPubMed, based on text mining techniques showed that
both tools are complementary.
16http://www.ncbi.nlm.nih.gov/Taxonomy
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GO2PUB
(a) Repartition of all results for Q1
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considered as relevant
among (a)
Figure 2.15: Comparison of the PubMed, GoPubMed and GO2PUB results for query “Lipogen-
esis in chicken liver”. (a) displays the repartition and intersections of these results. (b) displays
the repartition and intersections of the results considered as relevant.
2.5 Synthesis
What the three studies have in common All three studies require simple taxonomy-based
reasoning on OWL ontologies. However, in these cases, this simplicity was well adapted to the
situation.
It should be noted that in the first half of the 2000’s, OWL reasoners were perceived as the
preferred solution for querying OWL ontologies even if (1) most ontologies were essentially RDFS
taxonomies represented in OWL, (2) the reasoners could hardly manage to load medium-size on-
tologies and (3) classification was extremely slow if it successfully terminated (even considering
the ontologies simplicities). This can be explained by the fact that unfortunately, few connec-
tions existed within the semantic Web community between the people focusing on biomedical
ontologies who were mostly DL-oriented, and the people developing RDF and SPARQL. Open
source ontology editors such as OILed and Protégé have been coupled with DL reasoners since
the early 2000’s, but have not supported simple and efficient connections with query languages
from the triplestore community until recently (contrary to TopBraid composer). Nowadays,
ontologies have mostly evolved in size but not in semantic complexity [118].
Therefore, even if the topics of the first two studies seem outdated now, the principle is still
all the more relevant that major life science data sources such as Uniprot17 or the EBI18 are
providing their data as RDF and offer dedicated SPARQL endpoints, and initiatives such as
bio2rdf[61] and the NCBO BioPortal[49, 141, 142] provide an integrated access in RDF to life
science datasets and ontologies. Other initiatives such as purl19 and identifiers.org20 provide
solutions for perennial and location-independent identifiers [106, 64].
17http://beta.sparql.uniprot.org/
18https://www.ebi.ac.uk/rdf/
19htts://purl.org
20http://identifiers.org/
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Integration of diseases and pathways Using SNOMED-CT and the Gene Ontology for
integrating diseases and pathways combined the hierarchies of these two ontologies. It was
then possible to identify pathways or families of pathways shared by two diseases even if these
diseases are directly associated to different pathways, provided the pathways have some common
ancestor. Conversely, two pathways may be associated to different but similar diseases.
Current analysis techniques go beyond the simple detection of shared common elements
and focus on whether the number of shared elements is greater than what we could expect by
random selection [143].
If all the resources had existed in RDFS or OWL, the current version of this work would
have consisted in producing an OWL version of the mappings between SNOMED-CT diseases
and GO biological processes, and in performing SPARQL federated queries over SNOMED-CT,
GO and the mappings.
Composition of Web services We proposed a simple generic algorithm compatible with
any annotation framework such as WSMO, OWL-S or SAWSDL. The major limitations for its
deployment were the lack of appropriate domain ontology, as well as (understandably given the
lack of ontologies) the lack of semantic annotations for Web services and particularly for their
parameters [144].
Our semantic compatibility algorithm was only tested on linear workflow. Its generalization
to more complex control structures remains to be studied.
Semantic query expansion with GO2PUB GO2PUB performs a semantic expansion of
the GO terms of interest complying with the semantic inheritance through the GO graph before
retrieving the corresponding genes to enrich the query. Using the semantic inheritance properties
of the GO graph was useful, as the more descendants a GO term has, the more relevant results
GO2PUB yields.
GoPubMed does not follow the semantic inheritance properties of GO. We manually ex-
panded GoPubMed queries and compared it to GO2PUB. This showed that query expansion
would be a valuable extension for GoPubMed.
Both GO2PUB and GoPubMed retrieved relevant articles ignored by PubMed. As most of
the results obtained by GO2PUB and GoPubMed are relevant in the qualitative study and in
the generalization study, the intersection of GoPubMed and GO2PUB results decreases noise.
As each tool yields relevant articles ignored by the other, the union of their results also decreases
silence.
GO2PUB seems less suited for queries involving either general GO terms or GO terms with
few or no descendants. Indeed, with general GO terms, GO2PUB considers a lot of descendants,
and therefore a lot of genes. We expect this to increase the noise as some of the genes will be
irrelevant. Conversely, GO terms having few or no descendants are associated with few genes.
We do not expect semantic expansion to benefit these highly specific queries yielding only a few
PubMed results.
Overall, GO2PUB performed better than GoPubMed and PubMed. GO2PUB brought rele-
vant results ignored by GoPubMed even when adding a manual query expansion for GoPubMed.
Conversely GoPubMed text mining approach found relevant articles ignored by GO2PUB. This
demonstrates GO2PUB relevance and its complementarity with GoPubMed.
What we learned
• Ontologies are getting bigger much more than they are becoming semantically richer
(see [118] for the Gene Ontology). Even though, DL-based reasoners can hardly keep up
with the size, so reasoning on rich ontologies is still prohibitive nowadays.
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• OWL-based reasoning is not necessary in all situations.
• SPARQL is increasingly well adapted in terms of expressivity and of capability of dealing
with large quantities of information (the linked data initiative is soaring).
• The fact that SPARQL is well adapted is a good news in the short term as it obviously
fills a need but it may also be a bad news in the longer term as it may turn people away
from the endeavor of producing semantically-richer ontologies (which may or may not be
a bad thing).
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Chapter 3
Reasoning based on classification
Outline
RDFS requires to explicitly state that a resource is an instance of a class or that a class is a
subclass of another class. However, we should be able to recognize both situations from the
class characteristics. This then brings the need to formalize class characteristics. This formal
representation of class characteristics can even be used during the the ontology maintenance
process for ensuring completeness and internal consistency (like some non-regression tests) [145].
I proposed a rule-based solution for maintaining the internal consistency of the brain cortex
anatomy ontology I developed during my PhD [69]; as this was before the availability of OWL,
it was not included in this manuscript.
Description Logics (DL) provides semantically-rich constructs such as disjointness, existen-
tial and universal restrictions as well as necessary and sufficient definitions necessary for per-
forming inferences beyond simple taxonomy-based reasoning [38, 71, 116, 146, 147, 51, 43, 54].
All these reasoning capabilities require that ontologies actually implement these various fea-
tures, which was not the case in the early days of OWL. Section 3.2 shows the difficulty of
generating an OWL version of the ontology of human anatomy from a frame-based represen-
tation (which fortunately for us was the result of an elaborate and rigorous modeling effort by
Cornelius Rosse and his team).
Section 3.3 shows that a portion of this OWL version of the human anatomy ontology was
instrumental in the Virtual Soldier project for inferring the consequences of bullet injuries in
the region of the heart.
Section 3.4 focuses on the comparison of OWL and SWRL-based reasoning for optimizing
the classification of pacemaker alerts.
3.1 Principle
Description Logics (DL) are formal languages allowing to represent characteristics for sets of
objects [146, 147]. They were created to remedy semantic networks and frame languages lack
of formally-defined semantics [148]. There are several DL languages with different expressivity.
This section focuses on the OWL language, which was developed in the Semantic Web context.
OWL1.0-DL was based on SHOIN (D) [116] (OWL1.0 also defined OWL-Full, which did not
belong to the DL family in order to support metaclasses ; except when specified otherwise, we
focus on DL). Its limitations led to the development of OWL2.0, which extends OWL1.0-DL and
is based on SROIQ(D) [149]. This section presents an overview of OWL main characteristics
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that were used for biomedical data analysis. It is a summary of “OWL2 direct semantics”1 and
“OWL2 RDF-based semantics”2.
3.1.1 OWL Classes
DL represent “concepts” or “classes” as sets of individuals defined in intension. The function
that associates a class and a set of individuals is the interpretation function, noted I.
∆ is the set of all individuals for a particular domain. For a set of classes, there can be many
∆, and therefore many interpretation functions. Neither ∆ nor I are usually completely known.
As the notion of genericity is a key aspect of ontologies, ontologies specify characteristics of
classes and relations between them that are valid for all sets of individuals and all interpretation
functions.
Note that two classes can be associated to the same set of individuals by an interpretation
function I1 in a particular domain, but to different sets by an interpretation function I2 in an-
other domain. Classes that are associated to the same set of individuals for all the interpretation
functions are equivalent (but each retains its identity). Similarly, a class can be associated to
an empty set of individuals according to I1 but not according to I2. A class that is associated
to an empty set of individuals for all interpretation functions is unsatisfiable or inconsistent.
Having a set-based definition for DL classes allows to define a semantics based on set op-
erations on their interpretation. This formally-defined semantics is useful because it supports
reasoning. On counterpart, this means that we will focuses on the classes that comply with this
semantics. Because rdfs:Class was loosely defined as the range of the rdf:type property,
OWL introduces the notion of owl:Class (note how prefixes are useful for distinguishing the
two) for designating classes that are sets of individuals (so metaclasses are not allowed, contrary
to RDFS).
owl:Class rdfs:subClassOf rdfs:Class
OWL also defines two special classes: owl:Thing (also noted top or >) and owl:Nothing
(also noted bottom or ⊥).
owl:Thing rdf:type owl:Class
>I = ∆
owl:Nothing rdf:type owl:Class
⊥I = ∅
Of course, the RDFS definition of rdfs:subClassOf (noted v between classes) remains
valid for OWL classes. In this case, for all interpretation function, the set of instances of the
subclass is a subset of the set of instances of the superclass. This is used in ontologies for
representing the characteristics shared by all the instances of the class by making the class a
subclass of some logical expression combining the instances of other classes.
C1 rdfs:subClassOf C2
⇔
C1I ⊆ C2I
1http://www.w3.org/TR/owl2-direct-semantics/
2http://www.w3.org/TR/owl2-rdf-based-semantics/
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OWL also provides an owl:equivalentClass property (noted ≡ between classes) to specify
that for all interpretation function, the two classes have the same set of instances. This is used
extensively in (semantically-rich) ontologies to provide at least one necessary and sufficient
definition for a class by making it equivalent to some logical expression combining the instances
of other classes. A class with a necessary and sufficient definition is called a “defined class” by
opposition to “primitive classes”.
C1 owl:equivalentClass C2
⇔
C1I = C2I
3.1.2 Union and intersection of classes
The union (resp. intersection) of two classes, noted t (resp. u) is a class which set of instances
is the union (resp. intersection) of the sets of instances of the two classes.

owl:unionOf(C1, C2) rdfs:subClassOf owl:Class
⇔
(C1 t C2)I = (C1I ∪ C2I)

owl:intersectionOf(C1, C2) rdfs:subClassOf owl:Class
⇔
(C1 u C2)I = (C1I ∩ C2I)
For example, this can be used to define the class Finger by making it an equivalent class to
the union of Thumb, Index, etc. Similarly, we can define the class LeftThumb as the intersection
of Thumb and LeftSideOrgan.
3.1.3 Disjoint classes
OWL relies on the open world assumption (cf. Section 4.1), so by default, two classes can share
some instance with an interpretation function, and not have any instance in common with an-
other interpretation function. The disjointWith property specifies that two classes can never
have any instance in common. When designing ontologies, sibling classes are usually disjoint
(e.g. the five subclasses of Finger: Thumb, , MiddleFinger, RingFinger and LittleFinger are
pairwise disjoint) but not always (e.g. if we also consider the two other subclasses LeftFinger
and RightFinger, which are also pairwise disjoint but should not be assumed to be disjoint
from the five others).
Stating explicitly that two classes are disjoint is useful both for avoiding logical inferences
that would not be consistent with the domain knowledge and for ruling out options in case of
partially-known information. Several examples are presented in Chapter 4

C1 owl:disjointWith C2
⇔
(C1I ∩ C2I) = ∅
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3.1.4 Negation: complement of a class
The negation of a class (noted ¬) is a class which set of instances is the complement of the set
of instances of the original class (i.e. the set of individuals that are not instances of the class).
By definition, a class and its negation are disjoint.

owl:complementOf(C) rdfs:subClassOf owl:Class
⇔
(¬C)I = (∆ \ CI)
For example, the intersection of the class Patient and of the negation of its subclass Di-
abeticPatient represents the non-diabetic patients (we will see in section 3.1.5 how to define
DiabeticPatient as the patients suffering from diabetes)
3.1.5 Existential and universal restrictions
An existential restriction (noted ∃ property . Class) is the class which instances are the
individuals related to at least an instance of Class (direct or indirect) through property (or
a subproperty). For example ∃ suffersFrom Diabetes is the set of the individuals being the
subject of a triple which predicate is suffersFrom and which object is an instance of Diabetes.
(∃property .Class)I = {i ∈ ∆|∃j ∈ ClassI , (property I)(i, j)}
An universal restriction (noted ∀ property . Class) is the class which instances are the
individuals for which property (or a subproperty) only leads to instances of Class (direct or
indirect), i.e. the individuals not related through property to anything that is not an instance
of Class. Individuals not related to anything through property also qualify as instances of the
universal restriction. For example, ∀ hasMedication Anticoagulant is the set of individuals
whose only medications are anticoagulant, including those who do not have any medication.
(∀property .Class)I = {i ∈ ∆|∀j ∈ ∆, (property I)(i, j)⇒ j ∈ ClassI}
Existential and universal restrictions are typically used:
• as superclasses for representing characteristics shared by all the instances of a class. In
this case, the reasoning is “if you are an instance of the class, then you match the condi-
tion”. For example, all the ventricular cavities are filled with blood (and other anatomical
structures can also be filled with blood) VentricularCavity @ (∃ filledWith . Blood).
If you are an instance of VentricularCavity, then you are related to at least one instance
of Blood through filledWith . Even if the relation is not explicitly stated, we know that
there must be at least one.
• as equivalent classes for representing characteristics that define a class. In this case, the
reasoning can be either“if you are an instance of the class, then you match the condition”or
“if you match the condition, then you are an instance of the class”. For example, a diabetic
patient is an individual who suffers from diabetes DiabeticPatient ≡ (∃ suffersFrom .
Diabetes).
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3.1.6 Cardinality restrictions
A minimum cardinality restriction (noted min x property . Class) is a class which instances
are the individuals related to at least x instances of Class through property .
A maximum cardinality restriction (noted max x property . Class) is a class which
instances are the individuals related to at most x instances of Class through property .
An exact cardinality restriction (noted exactly x property . Class) is a class which in-
stances are the individuals related to exactly x instances of Class through property .
(min x property .Class)I = {i ∈ ∆ | card(j ∈ ClassI |property I(i, j)) ≥ x}
(max x property .Class)I = {i ∈ ∆ | card(j ∈ ClassI |property I(i, j)) ≤ x}
(exactly x property .Class)I = {i ∈ ∆ | card(j ∈ ClassI |property I(i, j)) = x}
Because of the open world assumption, cardinality restrictions are a good complement to
existential and universal constraints. For the class Hand, one could use six existential constraints
on hasPart to specify that a hand has a palm, a thumb, an index, etc. This would still allow
an instance of Hand to have another part that would be an instance of Lung. For preventing
this, one could add a closure axiom to hasPart , saying that Hand is a subclass of the the things
having only parts in the union of Palm, Thumb, Index, etc. However, it would still be acceptable
to have an instance of hand with seven palms, three thumbs and two of each other fingers. The
right solution here would be to replace the six existential constraints by six exact cardinality
constraints and to retain the closure.
3.1.7 Property chains
A property chain (noted R1 o R2 ) is a property formed by following R1 and R2 .
(R1 oR2 )I = {(i, j) ∈ ∆2 | ∃k ∈ ∆, (i, k) ∈ (R1 )I ∧ (k, j) ∈ (R2 )I}
For example, property chains are used in the Gene Ontology (not otherwise known for its
semantic richness) for modeling inference3. Figure 3.1 on the next page shows the inference
pattern “if A positively regulates B and B is part of C, then A positively regulates C”. It uses a
property chain for modeling the condition and rdfs:subPropertyOf for modeling the inference.
3.1.8 Synthesis
As we have seen, Description Logics provide the formal foundation for explicitly representing
constraints and definitions about classes, as well as relations between classes.
In the remainder of this chapter, section 3.2 shows how rich these formal descriptions can be.
It follows that building a semantically-rich ontology can be difficult, but conversely that adopting
design patterns can (and should) also simplify both design and maintenance. Section 3.3 shows
that once semantically-rich ontologies are available, complex reasoning can be incorporated
into an application with minimal development. Finally, section 3.4 compares several modeling
strategies in term of complexity and performance.
3http://geneontology.org/page/ontology-relations
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Figure 3.1: Property chain in the Gene Ontology: if x positively regulates y and y part
of z, then we can infer that x positively regulates z.
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3.2 Methodology: Description-logics representation of anatomy
This study focuses on converting the frame-based representation of the ontology of
normal human anatomy (the FMA) into OWL, which is more adapted to the reasoning
task we envisioned (c.f. section 3.3). The challenges were (1) preserving and possibly
extending the semantic richness of the original ontology (contrasting with the other
ontologies we have seen previously that were mostly taxonomies) and (2) dealing with
the large size of the ontology, which placed it out of reach for the reasoners. We
showed that perfect conversion was impossible: we had to forgo some the the frame-
specific aspects, but on the other hand we could add some OWL-specific ones such as
disjointness or coverage. We recognized that the computational constraints required
some simplification for the resulting ontology to be usable by applications, but that
these simplifications were application-specific. We proposed a solution that delivers
an OWL-Full representation as expressive as possible, and a “Virtual FMA-OWL”
mechanism (detailed in the original article) providing access to the FMA on a concept-
by-concept basis for further simplifications and adaptations.
In retrospect, this work is interesting because it showed that even if Description Log-
ics offer some highly desirable knowledge modeling primitives, using these primitives
consistently and systematically during ontology design is difficult and in turn requires
some automation. At that time I mostly used dedicated ad hoc scripts on the FMA [76]
or on the ontology of brain cortex anatomy I developed during my PhD [69], but this
problem was later addressed by others in more principled approaches such as ontol-
ogy design patterns[43] or more recently the SPINa and Shape Expressionb (ShEx)
languages for expressing constraints on RDF(S) graphs.
ahttp://spinrdf.org/
bhttp://www.w3.org/2001/sw/wiki/ShEx
This work was originally published in: Olivier Dameron, Daniel L. Rubin, and Mark A. Musen.
Challenges in converting frame-based ontology into OWL: the Foundational Model of Anatomy
case-study. In American Medical Informatics Association Conference AMIA05, pages 181–185,
2005 [75] and later extended in: Olivier Dameron and Julie Chabalier. Automatic generation of
consistency constraints for an OWL representation of the FMA. In 10th International Protégé
Conference, 2007 [76].
3.2.1 Context
In the medical domain, anatomy is a fundamental discipline that underlies most medical fields [150].
The Foundational Model of Anatomy (FMA) is the most complete ontology of canonical (i.e.
healthy) human anatomy [151]. It strictly follows a principled modeling approach and included
more than 70,000 concepts and 1.5 million relationships at the time of the study in 2004.
The FMA is represented in a frame language [152]. However, for some applications it is
desirable to use an OWL representation of the FMA, either for reasoning purposes [73] or
for integrating it with other OWL ontologies, such as the NCI thesaurus [153]. The problem
is that frames’ semantics is not as precisely defined as Description Logics’ one. Moreover,
although superficially similar, these two approaches rely on fundamentally different modeling
assumptions, and there is no direct mapping between them. Protégé4, the ontology editing
platform that was used to build the FMA supports both formalisms. The frame-based mode has
an “export to OWL” option. However, this option only performs a straightforward translation
4http://protege.stanford.edu/
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that ignores all the features that do not have a direct equivalent. Moreover, it does not take
advantage of all the OWL-specific features that are the basis of the language strength. For these
two reasons, the resulting translation would not be usable for reasoning.
3.2.2 Objective
We analyze some theoretical and computational issues of representing the FMA in OWL-DL. To
address the expressiveness limitation, we propose to use a more expressive formalism ensuring
application independence while meeting the expressiveness requirements. To address the com-
putational limitations, we propose a “Virtual FMA-OWL” architecture based on a Web Service
that returns the OWL-Full representation of a concept given its identifier. Eventually, we advo-
cate the use of this architecture for continuing to maintain the FMA in the current frame-based
form while making it accessible to the Semantic Web. Note that the intention of this article is
not to discuss the modeling of the FMA [151], but rather to examine different representation
formalisms considering the computational requirements of the applications that use them.
3.2.3 Converting the FMA into OWL-DL
The FMA is currently composed of more than 70,000 anatomical items called concepts, hav-
ing more than 1.5 million relationships (such as composition, neighborhood or blood supply)
between them. The concepts are identified by a unique number called the FMAID, and are
associated with one or more designation (e.g. the string “Heart” for the concept 7088 corre-
sponding to the heart), which allows to handle synonyms or multiple languages. The concepts
are strictly organized in a principled specialization hierarchy [152].
3.2.3.1 Basic concept representation: identifiers and designations
We represented the FMA concepts as OWL classes, and relationships as OWL properties.
Classes were identified by their FMAID, relative to the FMA namespace5. This allows us
to avoid any potential ambiguity with another ontology having a concept with the same iden-
tifier, as different ontologies have different namespaces. We used RDF labels to represent the
concept designation, explicitly mentioning the language. This is illustrated by the Figure 3.2,
in which the identifier is interpreted against the default namespace, which is declared at the
ontology level to be the FMA one).
1 <owl:Class rdf:ID="7088">
2 <rdfs:label xml:lang="en">Heart</rdfs:label>
3 <rdfs:label xml:lang="fr">Coeur</rfds:label>
4 ...
5 </owl:Class>
Figure 3.2: Representation of the FMA identifiers and designations in OWL-DL.
3.2.3.2 Taxonomy and metaclasses
The FMA features a complex structure of superclasses and subclasses [152]. For example,
“Physical anatomical entity” is an instance of “Anatomical entity template”, and a subclass of
both “Anatomical entity template” and “Anatomical entity”.
5http://sig.biostr.washington.edu/fma#
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The representation of the original FMA taxonomy in OWL was straightforward. The
subclasses—superclass relation between frames was represented by the rdfs:subClassOf rela-
tion. The resulting hierarchy is homologous to the original FMA one (see Figure 3.3).
OWL-DL does not support metaclasses, so we needed to remove them.
Figure 3.3: Taxonomy of the OWL-DL representation of the FMA.
3.2.3.3 Disjointness
Description Logics’ modeling principles are slightly different from those of frames. These differ-
ences have to be taken into account during conversion. Particularly, the FMA is organized in
a hierarchy of mutually-disjoint concepts. However, in Description Logics (hence in OWL-DL),
classes are not disjoint by default (i.e. there can exist an individual that is an instance of both
classes). Therefore, in order to respect the FMA modeling principles, we assume that unless
specified otherwise by multiple inheritance, all the direct subclasses of a class are mutually
disjoint. For example, Esophagus and Stomach are two direct subclasses of “Organ with organ
cavity” and they are disjoint (an instance of “Esophagus” cannot be also an instance of “Stom-
ach”). However, “Left breast”, “Right breast”, “Male breast” and “Female breast” should not
be specified as disjoint (although they are automatically because “Left female breast” is only
described as a subclass of “Female breast”, and not also of “Left breast”). This point will be
further discussed in section 3.2.5.
Note that this knowledge was implicit in the frames version of the FMA and is made explicit
in its OWL version.
3.2.3.4 Closure
Another difference between frames and Description Logics is that the latter relies on the “open
world assumption” [146] whereas the former assumes a closed world. In a closed world, every-
thing that is not explicitly stated is assumed to be false.
Consequently, when the FMA describes the parts of an anatomical structure such as the
hand, the fact that the structures other than the palm or the finger are not said to be parts
of the hand is interpreted as “they are not part of the hand”. However, in Description Logics,
providing a list of the possible parts of the hand does not prevent other structures to be also
parts of the hand. Therefore, we have to add an extra constraint saying that the structures in
the list are the only possible parts of the hand. This is called introducing a closure axiom [154],
and it has to be done for all the relationships (for an example see [73]).
However, generating closures is much more complicated than it may seem at first sight. For
example, the possible parts of the hand are the palm and the five fingers. Now, we have to
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take overloading by subclasses into account so that the possible parts of the “Left hand” are
“Left palm”, “Left thumb”, . . . , “Left little finger” (note that the closure does not mention non-
lateralized concepts such as “Thumb” anymore). However, the same approach cannot be applied
to the lungs: a lung has an upper lobe and a lower lobe as parts. Its subclass “Right lung” not
only has parts “Upper lobe of right lung” and “Lower lobe of right lung” (same approach as for
the hand), but also a middle lobe that does not exist for the left lung. As a consequence, it
would be incorrect to generate a closure for the lung based on its parts, whereas it should be
done for the hand. The first situation occurs when the child overloads its parent. The second
one occurs when subclasses introduce new properties. Unfortunately, real world situations can
mix these two situations.
In order to automate the systematic generation of closures, we have to check if all the classes
that define the range of a relation for a concept are subclasses of the range of this relation for
the superclasses of the concept. This point will be further discussed in section 3.2.5.
3.2.3.5 N-ary and attributed relationships
N-ary relationships associate more than two entities. Particularly, this is extensively used in
the FMA to qualify a relation between two entities. Those attributed relationships are used
to qualify part or continuity relationships for example (the lung is continuous medially to the
pulmonary veinous tree).
The modeling in Description Logics of such relationships has been studied by the W3C
Semantic Web Best Practice working group, and we followed their recommendation [155].
3.2.4 Addressing expressiveness and application-independence: OWL-Full
From the previous section, we have seen that some of the FMA features are simply out of the
scope of OWL-DL. We propose a two-layered approach. The first layer consists of a generic
conversion tool that generates a representation of the FMA in OWL-Full. The second layer
consists of several application-specific optimization tools that simplify the OWL-Full represen-
tation of concepts into OWL-DL ones by removing all the features unnecessary according to the
application context.
OWL-Full does not suffer from the expressiveness limitations of OWL-DL. For example, it
supports metaclasses. Figure 3.4 shows that the “Heart” (FMAID: 7088) can be represented in
OWL-Full both as a subclass and as an instance of“Organ with cavitated organ parts” (FMAID:
55673), which complies with the original FMA structure.
1 <owl:Class rdf:ID="7088">
2 <rdfs:label xml:lang="en">Heart</rdfs:label>
3 <rdfs:label xml:lang="fr">Coeur</rfds:label>
4 <rdfs:subClassOf rdf:resource=
5 "http://sig.biostr.washington.edu/fma#55673"/>
6 <rdfs:type rdf:resource=
7 "http://sig.biostr.washington.edu/fma#55673"/>
8 ...
9 </owl:Class>
Figure 3.4: Representing the original FMA metaclasses and subclasses structure in OWL-Full
(concept 7088 is the heart; concept 55673 is “Organ with cavitated organ part”).
OWL-Full allows us to generate a layer that has all the expressiveness we may need and that
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is application-independent. Moreover, this approach promotes interoperability: any application
that requests the concept 7088 gets the same description in OWL-Full. The application is then
free to modify this description internally according to its specific needs (namely simplify it to
meet its computational requirements), but at least, the communication between applications
refers to a shared representation.
3.2.5 Pattern-based generation of consistency constraints
This section summarizes a collaboration with Julie Chabalier between 2006 and 2007, and is
therefore posterior to the initial work from 2004. Previous works showed that some features
are implicit or cannot be represented in frames but are crucial for leveraging the specificities of
OWL [75, 156, 157, 158]. It would be possible to address this point by manual processing, but the
task is likely to be cumbersome, error-prone, and would increase the workload of maintaining the
original FMA. Moreover, the organization of the FMA follows a strict and principled approach
that could be exploited.
We identified in the original FMA a set of patterns reflecting situations with an underlying
modeling principle that could not be partially or totally represented in frames, and is therefore
missing. We wrote a set of Python scripts for detecting these patterns among the classes of the
original FMA and generating the corresponding OWL constraints.
3.2.5.1 Representing multiple inheritance
The FMA taxonomy follows a very principled approach. We duplicated this taxonomy in OWL
(cf. section 3.2.3.2). However, because the original FMA only uses single inheritance and
because the distinction between single and multiple inheritance is not relevant in OWL, we
generated some additional taxonomic relationships.
Due to the single inheritance constraint, the following situations incompletely account for
the subclass—superclass structure:
• left/right and male/female: 3 classes (Breast, Areola, Nipple)
• left/right and enumeration: 65 classes (e.g. Left first cervical nerve)
• upper/lower and enumeration: 5 classes (e.g. Upper first molar socket)
For example, Breast has four direct subclasses: Left breast, Right breast, Male breast
and Female breast. Each of Male breast and Female breast have one left and one right
direct subclass. Consequently, Left male breast is a subclass of Male breast, but not of Left
breast. Moreover, classes such as Intercostal lymph node combine the last two patterns.
3.2.5.2 Disjointness
In the original FMA, by default, all the sibling classes are disjoint. For example, the direct
subclasses of Cell are Nucleated cell and Non-nucleated cell, and it is clear that a cell
cannot be at the same time nucleated and non-nucleated. This feature can be made explicit in
OWL with disjointness constraints.
However, systematically making all the sibling classes mutually disjoints requires to rule out
situations where all the direct subclasses of a class are not mutually exclusive. In the previous
example, Left breast and Right breast, as well as Male breast and Female breast are
disjoint, but Left breast and Male breast are not. Similarly, the class Region of chest
wall has seven direct subclasses, including Anterior chest wall, Superficial chest wall,
Anterior superficial chest wall, Lateral chest wall and Lateral superficial chest
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wall. The problem was then to distinguish among the siblings the pairs of disjoint classes from
those that are not.
Rather than risking some inconsistency or some trivial satisfiability of the ontology, we chose
the conservative approach of only generating the disjointness constraints we are certain of. This
lead us to the identification of some other patterns among sibling classes:
• Left X/Right X: 3736 classes (e.g. Left lung)
• X left Y/X right Y: 13989 classes (e.g. Skin of right breast)
• Male X/Female X: 25 classes (e.g. Male breast)
• X male Y/X female Y: 75 classes (e.g. Right side of male chest)
• enumeration: XX classes (e.g. First cervical nerve)
• upper/(middle)/lower: YY classes (e.g. Upper lobe of lung)
Figure 3.5: Disjointness axiom for LeftBreast stating that it is disjoint from RightBreast. It
was generated with the Left X/Right X pattern.
3.2.5.3 Necessary and sufficient definition
Coverage The FMA aims at completeness. It is assumed that for each class, its subclasses
provide a complete decomposition (i.e. there are no X-Other nor X-Unspecified subclasses of
the X class). For example, the two direct subclasses of Organ are Solid organ and Cavitated
organ. The intended meaning is that each organ is either solid or cavitated, and that there is
no third possibility. In OWL, this can be made explicit by a coverage definition. In the previous
example, Organ would be defined as the union of Solid organ and Cavitated organ.
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A naive approach would consist in generating a coverage definition for each class using the
union of its direct subclasses. This would successfully generate the definition that a lobe of
lung is either an upper lobe of lung or a middle lobe of lung or a lower lobe of lung. The result
would always be correct from a logical point of view. However, in some situations, it can still
be refined. If we return to the class Breast, we could further specify that a breast is either a
left breast or a right one, and also that it is either a male breast or a female one.
In order to generate coverage definitions as specific as possible, we reused the patterns
identified for generating multiple inheritance (Section 3.2.5.1) and disjointness (Section 3.2.5.2).
For each of the matching pattern, we generated the corresponding coverage (this is what allows
us to generate two definitions for Breast, cf. Figure 3.6). We also generated a coverage definition
with the classes matching none of the patterns (e.g. for Lobe of lung).
Figure 3.6: Two coverage axioms for Breast represented as necessary and sufficient definitions
for Breast. They were generated with the Left X/Right X and the Male X/Female X patterns.
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3.3 Methodology: diagnosis of heart-related injuries
This study aims at improving diagnosis and prognosis of battlefield injuries in the
region of the heart. It focuses on a reasoning method based on the FMA for (1)
determining which parts of the heart muscle will become partially or totally ischemic in
case of an injury involving a coronary artery, and (2) determining whether a perforation
of the wall of the heart will lead to massive bleeding or will be (temporarily) contained
by the surrounding cavity. Both scenarios perform some semantically-rich reasoning.
The first one involves class-based reasoning, and the second one involves instance-based
reasoning. Together, they cover most of OWL1.0 constructs.
In retrospect, this work is interesting because it demonstrated that semantically-rich
ontologies represented in Description Logics actually support advanced reasoning. It
also showed that once the ontologies are available (which is a critical limitation, we
have covered some of the related difficulties in section 3.2), developing the application-
specific part does not require a large amount of work (it was a matter of hours).
Eventually, the encapsulation of the symbolic reasoning into a Web service was relevant
in terms of software architecture and showed that the end user does not have to operate
an ontology editor.
This work was a contribution to DARPA’s Virtual Solder project6 during my postdoc with
Mark Musen. It was originally published in: Daniel L. Rubin, Olivier Dameron, and Mark
A. Musen. Use of Description Logic classification to reason about consequences of penetrating
injuries. In American Medical Informatics Association Conference AMIA05, pages 649–653,
2005 [73]. It was also a contribution to: Daniel L. Rubin, Olivier Dameron, Yasser Bashir,
David Grossman, Parvati Dev, and Mark A. Musen. Using ontologies linked with geometric
models to reason about penetrating injuries. Artificial Intelligence in Medicine, 37(3):167–176,
2006 [74].
3.3.1 Context
The Virtual Soldier project developed complex mathematical models to create physiological
representations of individual soldiers that can be used to improve medical diagnosis on and off
the battlefield. Soldiers would be equipped with “P tags” that are USB-like storage devices
containing their 3D anatomical information, as well as physiological and biological parameters,
their genetic information and their medical record. They would also be typically equipped with
“intelligent” battledress and sensors that monitor their vital signs and physiological parameters
and would also be able to record the location of a bullet entry and exit points as well as some
associated parameters such as bullet velocity. All these informations can be collected by medical
teams in the field and provided to some remote diagnosis and prognosis decision support system.
Primary penetrating injuries concern the anatomical structures directly impaired by the
internal trajectory of a bullet. They can be determined with spatial geometric models of in-
jured subjects by computing the intersection of the bullet’s cone of damage with the organs.
Secondary injuries are consequences of primary injuries. Typically, if the cone of damage im-
pairs an artery, the organs perfused by the artery will experience ischemia. The determination
of secondary injuries relies on background knowledge about anatomy (e.g. the Foundational
Model of Anatomy [151]) and physiology (e.g. The Foundational Model of Physiology [159]).
A challenge in creating new decision support systems is to incorporate medical knowledge and
to apply that knowledge in flexible ways [160]. In most reasoning systems that use ontologies, the
6http://www.virtualsoldier.us/
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knowledge used to guide reasoning (control knowledge) is embedded in the application code or
in rules used in conjunction with the domain ontology [161]. We believe that it is advantageous
to use Description Logics in biomedical applications to represent both the domain knowledge
and the control knowledge needed for reasoning. Thus, we construe the reasoning problems in
the domain as classification tasks.
3.3.2 Objective
Given a set of anatomic structures that are directly injured by a projectile, we want to create a
reasoning application that deduces secondary injuries of two types: (1) regions of myocardium
that will be ischemic if a coronary artery is injured, and (2) propagation of injury as bleeding
occurs into damaged anatomic compartments that surround the heart.
We modeled these tasks as classification problems. We describe our approach to creating
reasoning services that fulfill the above desiderata using OWL. In this work we exploit the
automated reasoning capability provided by OWL.
3.3.3 Reasoning about coronary artery ischemia
We created a reasoning service to infer the myocardial ischemic consequences of coronary artery
injury (“Cardiac Ischemia Reasoner”). This service relied on class-based reasoning, i.e. we
modeled the query as a set of defined classes, and we checked which anatomical entities were
inferred to be subclasses of these defined classes.
3.3.3.1 Modeling blood vessels
We added necessary and sufficient conditions to classes in our base OWL ontology of anatomy
to encode the dependency of downstream arterial branches on the upstream arteries, and to
represent the regions of the heart myocardium supplied by the coronary artery branches (Fig-
ure 3.7 on the following page). For example, we represented the composition of the coronary
arteries using the hasSegment relation , and the tree-like structure of the blood vessels with
the isContinuousWithOutputOf .
We created a new primitive class SeveredBloodVessel as a subclass of BloodVessel. This
class will serve as an input for the reasoning service: when the geometric analysis detects that
a primary injury involves a blood vessel, we declare that the corresponding class is a subclass
of SeveredBloodVessel (therefore it remains an indirect subclass of BloodVessel).
SeveredBloodVessel @ BloodVessel
We created a new defined class FunctionallyImpairedBloodVessel to infer that all the
blood vessels downstream a severed blood vessels are also affected. Figure 3.8 on the next page
shows that after declaring that the second segment of the right coronary artery was injured, all
its downstream branches are inferred to be functionally impaired.
FunctionallyImpairedBloodVessel ≡

SeveredBloodVessel
t
(∃isContinuousWithOutputOf
FunctionallyImpairedBloodVessel)
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Figure 3.7: Schema of the coronary arteries and their branches, and cast of the
coronary arteries (yellow: right coronary artery; red = left coronary artery) show-
ing the regions of the myocardium they provide blood to. Left schema is from
http://en.wikipedia.org/wiki/File:Coronary_arteries.svg under the CC-BY-SA li-
cense. Right image is from http://en.wikipedia.org/wiki/File:Coronary_Arteries.tif
and is in the public domain.
Figure 3.8: Inference that all the downstream branches of the second segment of the right
coronary artery are functionally impaired after it has been injured.
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3.3.3.2 Describing blood supply to organs
To represent the coronary arteries that supply the lateral part of the wall of the left ventricle,
we added restrictions to the class LateralPartOfWallOfLeftVentricle that specify values for
the isSuppliedBy property, such as LeftCircumflexArtery (Figure 3.9). Note the closure
axiom indicating that the left circumflex artery, the ramus intermedius and the diagonal branch
of the left coronary artery are the only blood vessels supplying the lateral part of the wall of
the left ventricle.
Figure 3.9: OWL Ontology of coronary anatomy and regional myocardial perfusion. Classes of
anatomic structures are shown in the left panel, and logical definitions of the concepts are on
the right. The class LateralPartOfWallOfLeftVentricle contains six restrictions representing
the necessary conditions for this class. Some of these assertions specify the coronary arterial
branches that supply this structure.
3.3.3.3 Modeling ischemia
We created a defined class IschemicAnatomicalEntity as an AnatomicalEntity that is sup-
plied by at least one functionally impaired blood vessel.
IschemicAnatomicalEntity ≡

AnatomicalEntity
u
(∃isSuppliedBy FunctionallyImpairedBloodVessel)
An organ may be supplied by more than one artery, in which case damage to one of the feed-
ing arteries will cause partial (not complete) impairment of blood flow to the organ. To repre-
sent these types of ischemia, we refined IschemicAnatomicalEntity into two defined subclasses
IschemicAnatomicalEntityPartially and IschemicAnatomicalEntityTotally. Figure 3.10
on the next page shows the inferred ischemic anatomical entities after the second segment of
the right coronary artery has been severed. The posterior wall of the left ventricle is partially
ischemic because it is also supplied by the left coronary artery. Note that two anatomical enti-
ties (right atrium and posterior wall of the right ventricle) are correctly inferred to be ischemic
but the system could not determine whether they were partially or totally ischemic. For these
two anatomical entities, we had omitted to specify a closure axion (cf. Fig 3.9) on purpose
to demonstrate why closure is important when using open-world reasoning (more on this in
chapter 4)
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IschemicAnatomicalEntityPartially ≡

IschemicAnatomicalEntity
u
(∃isSuppliedBy FunctionallyNonImpairedBloodVessel)
IschemicAnatomicalEntityTotally ≡

IschemicAnatomicalEntity
u
(∀isSuppliedBy FunctionallyImpairedBloodVessel)
Figure 3.10: Cardiac Ischemia OWL ontology updated with the knowledge that the second
segment of the right coronary artery has been injured. After automatic classification, particular
anatomic classes (circled) are reclassified, suggesting the ischemic regions of myocardium that
occur as a consequence of the right coronary artery injury.
3.3.4 Reasoning about pericardial effusion
We created a second reasoning service to infer the cavities affected by bleeding after an injury
(“Injury Propagation Reasoner”). The heart is surrounded by two membranes – the pericardium
and the pleura, that determine two cavities enclosed inside each other (the heart is enclosed
in the pericardial cavity, which is enclosed in the pleural cavity) and are normally filled with
serous fluid. The (abnormal) presence of blood in these cavities is known as hemopericardium
and hemothorax (Figure 3.11 on the next page). In certain cases, the increased pressure can
limit hemorrhage.
This service relied on instance-based reasoning, i.e. we modeled the patient’s condition by
creating instances of all the relevant anatomical structures and by linking these instances with
the appropriate relations. We modeled the query as a set of defined classes, and we checked
which anatomical entities were inferred to be instances of these defined classes.
We first indicated in the ontology that blood vessels and cardiac cavities (the left and right
atrium and ventricles) are filled with blood (Figure 3.12 on the facing page).
In order to represent a perforation in the wall of the heart, we created an instance of the class
AddedConduit, and added values to the continuousWith property to describe that this conduit
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Figure 3.11: Blood loss through a punctured cardiac membrane fills
the pericardial cavity. This can lead to a massive hemorrhage or
on the contrary provide some temporarily containment. Schema from
http://en.wikipedia.org/wiki/File:Blausen_0164_CardiacTamponade_02.png under
CC-BY license.
Figure 3.12: Blood vessels and cardiac cavities are filled with blood (and this is normal).
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connects the cavity of the left ventricle and the pericardial space (Figure 3.13). The contin-
uousWith property represents spatial continuity between adjacent hollow anatomic structures
that have been injured. It is symmetric and transitive. These two property characteristics are
needed to infer that, given a perforation in the wall of the left ventricle (HoleInWallOfHeart)
and pericardium (HoleInPericardium) creating conduits that connect the surrounding cavities,
the conduits, pericardial cavity, and pleural cavity will be in continuity with the cavity of the
left ventricle (Figure 3.14).
Figure 3.13: Knowledge representation in OWL of a hole in the heart wall. An instance of the
AddedConduit class is created, having values of the continuousWith property specifying the
anatomic compartments connected by this conduit.
Figure 3.14: Inferred knowledge after asserting a cardiac injury comprising a hole in the left
ventricle and classifying the Injury Propagation OWL ontology. The pericardial cavity and
pleural cavity are inferred to be in continuity with the left ventricle.
We created a defined class BloodFlow (Figure 3.15 on the next page). The necessary and
sufficient condition of the BloodFlow class defines that any anatomical cavity continuous with
something filled with blood is an instance of BloodFlow. The necessary condition indicates that
if an individual is an instance of BloodFlow, then it is itself filled with blood. The combination
of these two conditions models the rule “if a cavity is continuous with something filled with
blood, then it is itself filled with blood”. In order to check that the reasoning was correct, we
70
created a defined probe class to retrieve the anatomical entities filled with blood (Figure 3.16).
For the cardiac cavities, being filled with blood is a good thing, whereas for the pericardial and
the pleural cavities, this is abnormal. In order to detect cavities abnormally filled with blood,
we defined the class Hemopericardium as a pericardial cavity that happens to be filled with
blood, and we make it a subclass of the things abnormally filled with blood (Figure 3.17 on
the next page). We repeated the process with the pleural cavity and created a Hemothorax
class. Note that we used the same rule pattern as with BloodFlow. Eventually, we created the
class AnatomicalConceptWithEctopicBlood to retrieve the places abnormally filled with blood
(Figure 3.18 on the following page).
Figure 3.15: The BloodFlow class uses a necessary and sufficient definition and a necessary
condition to model the rule “if a cavity is continuous with something filled with blood, then it
is itself filled with blood”.
Figure 3.16: A probe class indicates the anatomical entities filled with blood. Note that the
system inferred correctly that after the injury the pericardial and the pleural cavities are filled
with blood.
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Figure 3.17: Hemopericardium is defined as a pericardial cavity filled with blood. The necessary
condition ensures that any instance of this class is then inferred to be abnormally filled with
blood.
Figure 3.18: The AnatomicalConceptWithEctopicBlood retrieves the anatomical entities ab-
normally filled with blood.
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3.4 Optimization: modeling strategies for estimating pacemaker
alerts severity
This study focuses on the determination of the best modeling strategy (in terms of
correctness and performances) for predicting the severity level of a pacemaker alert.
Contrary to the previous studies, this application potentially involved processing a
large number of alerts, so performances became important. The previous section
with the Virtual Soldier project already demonstrated that some problems can be
modeled with class-based or instance-based OWL reasoning, but provided no hint on
whether one of them is better than the other. It is not even clear that statements such
as “class-based reasoning is faster than instance-based reasoning” actually make any
sense, as the outcome may depend on the problem at hand. This empirical study went
one step further by considering SWRL rules in addition to OWL, and by exploring
systematically all the combinations of modeling strategies. The results showed that
both OWL and SWRL-based ontology modeling techniques can reliably perform the
reasoning necessary to propose a severity level associated with pacemaker alerts. The
best performances were not obtained by using exclusively OWL nor SWRL but by
combining their respective advantages, using OWL to reduce the number of SWRL
rules and making them simpler.
In retrospect, this work is interesting because it was the first hands-on systematic eval-
uation of modeling strategies. While applications usually use exclusively SPARQL,
OWL or SWRL, optimizing performances suggests to combine their various strength.
By extrapolation, this suggests a more formal approach for designing complex reason-
ing tasks as workflows instead of monolithic entities, which allows to choose the best
technology for each module and to promote their reuse.
This study was a contribution to the Akenaton7 project (ANR-07-TECS-0001). It was orig-
inally published in: Olivier Dameron, Pascal van Hille, Lynda Temal, Arnaud Rosier, Louise
Deléger, Cyril Grouin, Pierre Zweigenbaum, and Anita Burgun. Comparison of OWL and
SWRL-based ontology modeling strategies for the determination of pacemaker alerts severity.
In Proceedings of the American Medical Informatics Association Conference AMIA, page 284,
2011 [92], where it was shortlisted for the best article award.
It was later extended in: Pascal van Hille, Julie Jacques, Julien Taillard, Arnaud Rosier,
David Delerue, Anita Burgun, and Olivier Dameron. Comparing Drools and ontology-based
reasoning approaches for telecardiology decision support. Studies in health technology and in-
formatics, 180:300–304, 2012 [93] where we also considered Drools rules. Drools rules are not
capable of handling the granularity gap between precise patients data and more general crite-
ria, so I do not present this later work here. We had to generate Drools rules that mimicked
ontology-based reasoning. The conclusion was that the limitations of ontology-based reasoning
were the reasoner’s performances, whereas the limitations of Drools were the number and com-
plexity of rules. This suggested using ontology for automatically generating some of the Drools
rules.
3.4.1 Context
Patients suffering from heart failure are increasingly treated with implantable cardioverter de-
fibrillators (ICD) and benefit from home monitoring [162]. In this context of telecardiology,
ICDs send remote alerts about arrhythmic episodes to physicians, who have to determine their
7http://www.agence-nationale-recherche.fr/?Project=ANR-07-TECS-0001
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emergency level and potentially take the required actions [163, 164]. Some automatic triage of
the alerts according to their emergency level is instrumental to keep up with this overwhelm-
ing flow of alerts (from zero most of the time up to as many as twenty alerts per patient per
day; with an estimation of 500.000 new patients every year) efficiently. However, this is an
intrinsically difficult task because the risk associated with an alert depends on multiple inter-
dependent factors such as the patient’s medical history, his current pathologies and his current
treatment [165]. For example, in case of atrial fibrillation (AF), the risk of thrombo-embolism
is estimated by the CHA2DS2VASc score as well as by additional parameters that can either
increase the risk (e.g., if the patient is a smoker or is obese) or lower it (e.g., if the patient is
currently treated with an anticoagulant) [166, 167].
The goal of the AKENATON project is to improve ICD alert management by automatically
associating each alert with a severity level [91]. This requires (i) to extract the relevant data from
the alerts transmitted by ICDs and from the patient’s clinical context, (ii) to integrate them, (iii)
to reconcile them with the severity criteria, and (iv) to compute the alert severity. Extracting
data relies on queries on the hospital patient database as well as on Natural Language Processing
techniques for mining free text and structured documents. Integrating data and reconciling
the granularity gap with more general severity criteria requires symbolic domain knowledge
represented as ontologies (e.g., in order to automatically recognize that a patient suffering from
a right iliac artery stenosis will match the vascular disease CHA2DS2VASc criterion). Deducing
the alert severity from the various criteria is a combination of ontology-based and rule-based
inferences. The ontology model plays a central role in several steps and ensures the general
coherence. It can be represented using different combinations of OWL [168] and SWRL [169].
Each combination implies specific modeling decisions which may have consequences on the
performance of the system. Currently, no guideline exists to decide which strategy best fits our
particular problem.
3.4.2 Objective
This study focuses on the determination of the best ontology modeling strategy to integrate
data and to fill the granularity gap between data and the CHA2DS2VASc score criteria for
patients with an atrial fibrillation alert.
First, we identified the CHA2DS2VASc criteria that potentially require reference to domain
knowledge to be reconciled with patient data. Second, we identified ten modeling strategies
covering all the possible combinations of Java, OWL-DL and SWRL. For each strategy, we
assessed the modeling effort by counting the number of OWL classes, properties and SWRL
rules. Third, we validated each strategy by verifying that they computed the correct score for
all of the 192 possible combinations of criteria. Fourth, we compared the performances of the
ten strategies by measuring the computation time for each 192 cases of the validation set. Fifth,
we evaluated all the strategies over a corpus of 62 actual patients by repeating steps three and
four.
3.4.3 CHA2DS2VASc score
CHA2DS2VASc is a new recommendation of the European Society of Cardiology to deter-
mine stroke risk for patients with non-valvular fibrillation [166, 167, 170]. The higher the
CHA2DS2VASc score, the higher the risk of thrombo-embolism [166, 167]. It is a major deter-
minant for deciding whether or not an anticoagulation therapy is required in order to prevent
potential stroke caused by stasis of blood in the heart, which may lead to the formation of a
thrombus that can dislodge into the blood flow. A CHA2DS2VASc score of zero is associated
with a low risk, a score of one is associated with an intermediate risk, and a score of two or
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more is associated with a high risk [167]. Table 3.1 presents the criteria required to compute the
CHA2DS2VASc score. Some of them such as age or sex category can be directly computed from
the patient’s administrative data. Medical criteria such as congestive heart failure or vascular
disease are more general. They encompass several diseases and are therefore unlikely to be
present as such in the patient’s data. Reconciling the patient’s data with the CHA2DS2VASc
criteria consists in interpreting the data according to some domain-specific knowledge, typically
represented in ontologies.
Criterion Points
Congestive heart failure / left ventricular dysfunction 1
Hypertension 1
Age ≥ 75 y.o. 2
Diabetes mellitus 1
Stroke / transient ischemic attack / thromboembolism 2
Vascular disease 1
65 ≤ Age < 75 1
Sex category (ie, female gender) 1
Total 0 ≤ score ≤ 9
Table 3.1: CHA2DS2VASc score criteria (from [167]).
Computing the value of each criterion and adding these values into the global CHA2DS2VASc
score can both be achieved with different combinations of Java, OWL-DL 2.0 and SWRL. First,
accessing the value of each criterion associated to a patient requires to follow several properties
(typically dolce:has-quality from the patient to the CHA2DS2VASc score, then dolce:has-
quale from the score to each criterion, then has-integer-value from each criterion to its
value). Following the properties can be done either explicitly, or by using OWL-DL property
chains. Second, some criteria values such as gender or the age thresholds can either be com-
puted by a rather simple Java function, or using the ontology, which in turn can be achieved
using OWL-DL features (e.g., a necessary and sufficient condition on a datatype property for
the age) or SWRL (using built-ins). Third, adding the criteria values to compute the global
CHA2DS2VASc score can also be performed by a Java function or by the swrlb:add() SWRL
built-in. Some choice for one of the three previous steps may exclude some other choices in an-
other step. For example, using Java to compute the age and gender criteria values only makes
sense if the addition of the eight criteria values is itself done in Java. We systematically com-
bined the Java, OWL and SWRL features for the three previous steps and derived ten possible
strategies (cf. section 3.4.4 on the following page).
For each CHA2DS2VASc criterion, we manually determined whether reference to domain
knowledge was necessary to reconcile the granularity gap with patient data (Table 3.2 on the
next page).
We generated a validation set of 192 dummy patients representing all the combinations
of values for the CHA2DS2VASc criteria. We validated each strategy by having it compute
the CHA2DS2VASc score of each patient and comparing it to the solution. The solution is
straightforward to compute separately by a program because when creating each patient from
the validation set, the value of each criterion is known. For each strategy, we also measured
the number of OWL classes, properties and SWRL rules used, as well as the CPU usage for
each dummy patient. For each strategy, we measured the computing time on the evaluation
set 50 times. Measurements were performed on a Dell Precision T3400 workstation with an
Intel core 2 quad Q6600 64 bits 2,4 GHZ processor, 4 Gb RAM and Hitachi Ultrastar disk
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criterion ontology
required
data example
Congestive heart
failure
yes “Diastolic heart failure”, subclass of
“Congestive heart failure” (patient 52)
Hypertension yes
Age no
Diabetes mellitus yes “Type-2 diabetes”, subclass of “Dia-
betes mellitus” (patient 72)
Stroke yes “Ischemic stroke”, subclass of “Stroke”
(patient 57)
Vascular disease yes “Lower extremity occlusive peripheral
heart disease”, subclass of “Peripheral
artery disease”, which is in turn sub-
class of “Vascular disease” (patient 15)
65 ≤ Age < 75 no
Sex category no
Table 3.2: Ontology requirement for computing the value of CHA2DS2VASc criteria. Patient
numbers in the ”Example” column refer to the evaluation set patients.
15K300 (300 Gb 15000 RPM). The test program was developed in Java on a Linux Ubuntu
11.04 (kernel 2.6.35-24) machine with open jdk 1.6.0 20, OWL API 3.2.08 and Pellet reasoner9
API 2.2.1 [171].
We generated an evaluation set of patients implanted with an ICD and having an atrial
fibrillation alert from the Paradym cohort10. Out of 74 patients, we selected the 62 patients
having at least one document. We automatically calculated their CHA2DS2VASc score and
recorded the performances of the ten strategies. We repeated the measurement 50 times. A
physician (AB) manually calculated the reference CHA2DS2VASc score for each patient, and
the result was double-checked by a cardiologist electrophysiologist (AR) for complex cases.
3.4.4 Modeling strategies
The systematic combination of Java, OWL and SWRL features to (i) access the value of each
criterion, (ii) determine the value of some of the criteria and (iii) add the criteria values resulted
in ten possible modeling strategies. Figure 3.19 on the facing page presents the decision tree
explaining how each strategy was derived.
Some of the strategies can be constructed by adding defined classes or SWRL rules to other
strategies (cf. original article [92] for details). Figure 3.20 on page 78 illustrates the dependencies
between the various strategies.
Table 3.3 on the facing page illustrates the 10 strategies complexity by presenting their number
of classes, properties and SWRL rules.
8http://owlapi.sourceforge.net/
9http://clarkparsia.com/pellet
10http://clinicaltrials.gov/ct2/show/NCT01169246
76
yes yes yesyesyes nono no no no
Java OWL SWRL OWL SWRL
Java SWRL
CHA2DS2VASc
total score
age and gender
criteria evaluation
age and gender
criteria evaluation
Property chainsProperty chains Property chains Property chains Property chains
Str  6
(j,j,p)
Str  5
(j,j,-)
Str  4
(j,o,p)
Str 10
(j,o,-)
Str  9
(j,s,p)
Str  3
(j,s,-)
Str  2
(s,o,p)
Str  8
(s,o,-)
Str  1
(s,s,-)
Str  7
(s,s,p)
Figure 3.19: Decision tree combining the 10 possible strategies for modeling the CHA2DS2VASc
criteria.
Strategy Classes Obj. prop. datatype prop. SWRL rules
1 0 0 3 12
2 2 1 0 9
3 0 0 0 8
4 2 1 0 8
5 0 0 0 5
6 0 1 0 5
7 0 1 0 9
8 2 0 3 12
9 0 1 0 8
10 2 0 0 8
Table 3.3: Complexity of the ten strategies in terms of number of additional classes, properties
and SWRL rules over the base patient.owl model.
3.4.5 Comparison of the strategies’ performances
On the validation set, all ten strategies computed the correct CHA2DS2VASc score for each
192 possible combination of criteria values. For each strategy, we computed the total time to
process the 192 patients from the validation set. We then divided this total by 192 to determine
the average computation time by patient so that it can be compared with the measures on the
evaluation set, which is smaller. We repeated the operation 50 times. Figure 3.21 on page 79
shows the average computation time of a patient’s CHA2DS2VASc score for each strategy.
On the evaluation set, all ten strategies computed the correct CHA2DS2VASc score for
each of the 62 patients. Figure 3.22 on page 79 shows the average computation time of a
patient’s CHA2DS2VASc score for each strategy. Figure 3.23 on page 80 compares the average
performance of each modeling strategy over the validation and evaluation sets.
All strategies computed the correct CHA2DS2VASc score for all the patients from the val-
idation and evaluation sets. This demonstrates that both OWL and SWRL-based ontology
modeling techniques can reliably perform the reasoning necessary to propose a severity level
associated with ICD alerts.
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Figure 3.20: Dependencies between the common model (patient.owl) and the various strategies.
Table 3.3 on the preceding page and Figure 3.23 on page 80 show that the number of classes,
properties and rules is not a good prediction of a strategy’s performance, so this systematic study
was relevant.
The comparison of the ten strategies showed that the best performances were not obtained
by using exclusively OWL nor SWRL but by combining their respective advantages, using OWL
to reduce the number of SWRL rules and making them simpler. Figure 3.23 on page 80 shows
that the ranking of the strategies according to their performance is identical on the validation
and evaluation set. For each strategy, the performance on the validation set was always better
than on the evaluation set. This can be explained by the fact that there was no granularity-
related reasoning involved in the validation set, whereas some patients from the evaluation set
were associated with data more precise than the CHA2DS2VASc criteria. For example, patient
72 from the evaluation set had type 2 diabetes; a similar patient in the validation set would
have been described as having diabetes. Another factor explaining the difference could be that
the distributions of patients for each CHA2DS2VASc score were different for the validation and
evaluation sets (cf. original article).
The modeling approach presented in this article potentially under-estimates a patient’s
CHA2DS2VASc score. If no information concerning a criterion is available, the criterion was
assigned the value 0. We could have used a dual approach that over-estimates the score by
assigning an initial value of 1 or 2 to each criterion and then setting it to 0 when there is some
evidence that the criterion is not met. However, this would have had several drawbacks. First,
clinical records typically mention what the patient has, and seldom mention what he has not, so
except for the age and gender criteria, this lack of explicit information would result in assuming
that almost all the criteria are met for all the patients. Second, the risk of thrombo-embolism
is low for a CHA2DS2VASc score of 0, moderate for a score of 1 and high for a score between
2 and 9. The previous point would then result in important false positives, with almost all the
patients being associated with a high risk. Eventually, combining the two approaches would
provide an interval of validity for the CHA2DS2VASc score.
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Figure 3.21: Boxplots representing the average computation time of the CHA2DS2VASc score
of patients from the validation set. The boxplots were generated by repeating the measure 50
times.
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Figure 3.22: Boxplots representing the average computation time of the CHA2DS2VASc score
of patients from the evaluation set. The boxplots were generated by repeating the measure 50
times.
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Figure 3.23: Average computation time of the CHA2DS2VASc score of the patients from the
validation and evaluation sets.
3.5 Synthesis
What the three studies have in common In all three studies, we found that the lack
of semantically-rich ontologies was a major limitation for building applications that involve
reasoning more complex than retrieving the ancestors or the descendants of a class. Even if
most biomedical ontologies from repositories such as BioPortal are available in OWL format,
they are basically mere RDFS taxonomies. Few of them contain disjointness, existential or
universal constraints, or even (correctly) defined classes as we will see in section 4.2.3.
This is all the more regrettable that all three studies also repeatedly demonstrated that
once semantically-rich ontologies are available, developing the application-specific part of the
reasoning only required the addition or the modification of a limited number of classes and
could be done in a matter of hours.
Representation of anatomy The effort for converting the FMA in OWL was part of a
subsequent larger research effort involving several teams [156, 158, 172]. Overall, this experiment
triggers several observations. First it confirmed that the OWL language was well designed, as all
its constructs found an application for modeling anatomy. Second and somehow paradoxically,
it showed that the additional effort required for using more expressive constraints contributed
to make the job easier as it supported using design patterns and integrity constraints. Third,
new initiatives such as SPIN and ShEx offer new research perspectives for representing these
constraints and using them during ontology development and maintenance.
Diagnosis of injuries Using the anatomy ontology to perform some automatic inference of
indirect injuries showed that provided the semantically-rich ontologies are available, developing
some application-specific reasoning can be quite simple.
It was also a first attempt at comparing class-based and instance-based reasoning for a
more principled modeling approach. It showed that both worked equally well. Instance-based
reasoning was more appealing from a modeling point of view but was also more difficult to
implement whenever closure were required.
This work is also interesting because it marked the transition to reasoning with incomplete
information, which will be covered in chapter 4.
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Modeling strategies of pacemaker alerts severity This study compared OWL and SWRL-
based reasoning for classifying pacemaker alerts. It showed that the optimal modeling strategy
combined features of OWL and of SWRL. Nowadays, this study should also cover SPARQL and
SPIN11.
As we mentioned, our approach potentially under-estimates a patient’s CHA2DS2VASc
score. Conversely, assuming the worse case scenario and decrementing the CHA2DS2VASc
score when we find evidence that a criterion is not met would over-estimate the score. Combin-
ing both approaches would provide a confidence interval. This typically raises the problem of
reasoning with incomplete information, which will be further discussed in chapter 4.
What we learned
• Formalizing knowledge is difficult.
• It is useful for maintaining large ontologies; we have seen it for the FMA, and the Gene
Ontology Next Generation is another example.
• It is useful for performing rich queries [173].
This lack of available semantically-rich ontologies can be partially explained by the fact
that to a certain extent, ontology editing tools such as Protégé or TopBraid and the associated
tutorials have succeeded too well. Domain experts are able to create and maintain their on-
tologies (which is good) with a minimal understanding of knowledge representation principles
and of Semantic Web technologies. The latter point would not be so bad if people from the
knowledge representation community (myself included) had not been less and less involved in
ontology development over the last decade. I observed this trend in all the research teams I
have been involved in since my PhD (included), as more recently when I contributed to the
development of the ATOL livestock ontology [174, 175, 176]. Contributing to ontology develop-
ment is highly time consuming, and extremely difficult to convert into high impact publications.
Moreover, the large part of craftsmanship and informatics skills involved in the design patterns,
the consistency constraints and grasping DL are understandably perceived as too difficult by
the domain experts. This is strikingly the case for the Gene Ontology consortium that for years
keep on using their idiosyncratic OBO formalism which is suboptimal in terms of interoperabil-
ity, expressivity, maintenance and reasoning [177], and that chose to ignore efforts such as the
OWL-based Gene Ontology Next Generation [52]. I have the feeling that when ontologies gained
a mainstream status in life science in the second half of the 2000’s (cf. Figure 1.1 on page 13),
the knowledge representation community failed to create a pool of “knowledge representation
engineers” who would have been recognized as key partners and could have taken over when
the “knowledge representation researchers” gradually shifted their research efforts. Now these
engineers are sorely missed and even if their input is valuable, few perceive it as such. The data
deluge may be our next opportunity to patch things up if we (as researchers) both succeed in
developing in time sound data management plans for E-Science (cf. my research perspectives in
section 6.1.1.2), and if we succeed to avoid the previous mistake by having these plans adopted
by the life science community. Ontologies will probably be key components for handling the
large quantities of data and metadata. I am eager to see whether these will be mere taxonomies
or semantically-rich ontologies.
11http://spinrdf.org/
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Chapter 4
Reasoning with incomplete
information
Outline
This chapter elaborates on situations we have encountered earlier where an incomplete descrip-
tion lead to imprecise or biased results. In the Virtual Project, we had intentionally failed
to provide a closure axiom for some anatomical entities in oder to demonstrate that (cf. sec-
tion 3.3.3.3 on page 67). These entities were correctly inferred to be ischemic when necessary,
but the system could not decide whether they were partially or totally ischemic. The Virtual
Soldier project demonstrated that the reasoning system can gracefully handle missing informa-
tion by using more general superclasses as a kind of “degraded mode”.
Subsequent works went one step further and sought to restrict the set of solutions by focusing
on the things that can be inferred to be false when no conclusion can be reached concerning
the things that can be inferred to be true. When the description of the world is exhaustive, the
reasoner will always be able to recognize the situations where a condition is satisfied. When
the description of the world is incomplete however, we may not be able to make the distinction
between the situations where we do not know whether the condition is true, and the situations
where we know that the condition is not true. Therefore, the general idea was to generate
automatically negated versions of conditions of interest, with necessary and sufficient definitions
referring to the original condition, and then to check whether data are classified as instance or
as subclasses of the conditions or of their negated version.
Section 4.2 shows how this principle was first applied to the problem of grading tumors. A
tumor grade is either 1, 2, 3 or 4, so each grade was a distinct condition. In case of incomplete
information, we may not be able to reach a conclusion as to which grade qualifies, so none of
them is proposed. However, even if it is incomplete, the available information may be sufficient
to rule out some of the grades, and we can therefore narrow the possible solutions.
With tumor grades, the only constraints were that the conditions are mutually-exclusive
and that each tumor has a grade (even if we do not know which one). Section 4.3 focuses on
determining the clinical trials a patient may be eligible to. In this case, conditions were the
trials eligibility criteria and a patient’s eligibility is defined by a conjunction of criteria or their
negation, so the overall outcome is more complex to infer. We showed that not taking incomplete
information into account leads to over-estimating patients rejection, and we proposed a design
pattern for modeling clinical trial that addresses this issue.
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4.1 Principle
As we have seen in section 3.1, OWL constraints must hold for any interpretation function.
Therefore, during knowledge modeling, one not only has to specify the constraints that must
be met (e.g. a hand has to have a thumb, an index, etc.), but also the relations that cannot
exist (e.g. a heart can never be a part of the hand). As we have seen in section 3.2.3.4, this is
typically done with closure constraints representing “the only possible values for this property
must be instances of these classes”.
Although the open world assumption imposes an additional burden, it has two major benefits
over the closed world assumption [28]. First, it supports a finer description, with the possibility
to distinguish mandatory values from optional values. For example, an individual hand may not
have a thumb in case of amputation or of abnormality, or it may even have additional fingers
in case of polydactily, but it has to have exactly one palm. Second, as we will see throughout
this chapter, it supports correct reasoning even if the domain is not described exhaustively.
4.2 Methodology: grading tumors
This study focuses on determining the grade of brain tumors. This was motivated by
the need to reuse the patients data from one study in order to compare them with data
from another study, with the two studies relying on slightly different grading systems.
We applied the classification techniques seen in the previous chapter to automate
the process. However, as often, the patients data were sometimes incomplete, which
introduced a bias if we use closed world reasoning, and lead OWL-based reasoning
unable to propose any grade for these patients. We proposed a method based on
the logical negation of each tumor grade in order to determine the grades that were
incompatible with what we knew of the patients, thus narrowing the set of possible
grades.
In retrospect, this work is interesting because in addition to another example of how
semantically-rich ontologies can be reused by applications, it shows that semantically-
rich ontologies can handle gracefully incomplete data, which are ubiquitous in life
sciences.
This study was originally published in: Gwenaëlle Marquet, Olivier Dameron, Stephan Saikali,
Jean Mosser, and Anita Burgun. Grading glioma tumors using OWL-DL and NCI thesaurus.
In Proceedings of the American Medical Informatics Association Conference AMIA’07, pages
508–512, 2007 [79]. It elaborates on a previous work on grading lung tumors: Olivier Dameron,
Élodie Roques, Daniel L. Rubin, Gwenaëlle Marquet, and Anita Burgun. Grading lung tumors
using OWL-DL based reasoning. In 9th International Protégé Conference, 2006 [78].
4.2.1 Context
Brain tumors represent 2.4 percent of all cancer deaths. Among tumor variables, tumor grade
and histology appear to have the greatest effect on survival. Glioblastoma, with median survival
shorter than twelve months, is a highly malignant (grade IV) glioma, which has the propensity to
infiltrate throughout the brain in contrast to pilocytic astrocytoma of the posterior fossa, which
does not spread and can be cured by surgery [178]. Traditionally, the grading (classification) of
a tumor is determined by the evaluation of tumor characteristics by a pathologist.
The process of determining the grade of a tumor consists in checking if it meets a set
of requirements. There are numerous systems for grading the glioma tumors. The reference
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grading system is the World Health Organization (WHO) grading system [179]. This system
assigns a grade from 1 to 4 to glioma, grade 1 being the least aggressive and grade 4 being the
most aggressive. This classification is based on five histopathology criteria that are related to
the degree of anaplasia: cellular density, nuclear atypia, mitosis, endothelial proliferation and
necrosis. The WHO malignant grades are described as follows:
• WHO Grade IV: cellular density high, nuclear atypia marked, high mitotic activity,
necrosis present, endothelial proliferation present.
• WHO Grade III: cellular density increased, distinct nuclear atypia, mitotic activity
marked, necrosis absent, endothelial proliferation absent.
• WHO Grade II: cellular density moderately increased, occasional nuclear atypia, mi-
totic activity absent or 1 mitosis, necrosis absent, endothelial proliferation absent.
Grading tumors is typically a classification task. The grading system requires domain knowl-
edge in order to fill the granularity gap between the tumor descriptions and the grade descrip-
tions. However, applications such as decision support for pathologists or integration of data
graded using different systems require some formal representations of the grade definitions and
the background knowledge. Such representations are typically achieved using ontologies. For
the past years, a lot of biomedical ontologies have been developed including NCI thesaurus [153]
(NCIT) a major resource in the cancer research domain. The NCIT provides descriptions for the
brain tumors. It also has classes for the grades. However, those classes have neither proper de-
scriptions nor definitions. Therefore, they can not be used for the automatic grading of tumors,
which requires an explicit and formal representation.
4.2.2 Objective
The goal of this study is to show how the version of the NCIT in OWL (Web Ontology Language)
can be extended to automatically perform classification of glioma using histological descriptions.
We have focused our study on the malignant grade. For that, we have developed an ontology of
the glioma tumors based on the World Health Organization grading system [179]. In this study,
we focus on the reasoning tasks. We provide an overview of the TNM grading system. We then
analyze the NCIT and conclude that it has to be extended in order to perform automatic tumor
grading. We present the method that we used and the results obtained during the classification
of a set of tests generated and the classification of eleven reports provided by a pathology
department.
4.2.3 Why the NCIT is not up to the task
The NCI Thesaurus is a public domain Description Logic-based terminology to meet the needs
of the cancer research community[153]. Its goal is to provide unambiguous codes and definitions
for concepts used in cancer research. The NCIT has been converted into OWL-Lite [81]. The
current version (07 01d) is composed of 55,458 named classes and 113 OWL properties. Among
these classes, 18 % are defined classes, i.e. they have at least one necessary and sufficient
constraint, and 82 % are primitive classes, i.e. they can have constraints, but do not have any
necessary and sufficient definitions.
The classes representing the grades according to the WHO system have no restriction and
are not semantically defined (Figure 4.1 on the next page). Therefore, they are just placehold-
ers as nothing can be inferred to be a subclass or an instance of these classes. Because of the
open-world-assumption underlying the OWL semantics, if the grade of a tumor cannot be un-
equivocally inferred, the tumor will not be classified under any grade. For example, tumors that
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could be grade I or grade II tumors are not classified anywhere. There is no explicit difference
between the grades the tumor belongs to (here I and II) and those it cannot belong to (here III
and IV).
Figure 4.1: The WHO grades in the NCIT are primitive subclasses of
ncit:Disease_Grade_Modifier. The intermediate classes Grade_1 to Grade_4 are placehold-
ers allowing to take the multiple grading systems into account.
In the NCIT, the glioma tumors have been described as Central Nervous System Neoplasms.
Each kind of tumors has been defined by necessary and sufficient conditions. For example,
glioblastoma has been defined by the intersection of 17 restrictions. In Figure 4.2 on the facing
page we present some conditions used to define the glioblastoma class.
Such definitions cannot be logically exploited to achieve any reasoning for several reasons.
First, we see that being a grade 4 tumor is one of the conditions of the definition. Since the
NCIT does not provide any definition for the grades, the grade cannot be inferred from the
description of the tumor, which leaves to the user the task of stating the grade when describing
the tumor... and if he knows the grade at this point, he probably does not need a reasoner to
figure whether the tumor is a glioblastoma. Second, the constraint concerning the grade is a
universal constraint (∀), and again, leaves it to the user to make sure that the tumor is neither
a grade 1, nor 2, nor 3. Moreover, such a restriction is difficult to represent with instances
when describing a tumor. Third, the extensive use of “Disease_May_Have_... in existential
constraints of the definition is deeply disturbing.
4.2.4 An ontology of glioblastoma based on the NCIT
The ontology we developed is based on the NCIT. A specific relevant part of the NCIT has been
extracted using eleven terms corresponding to the names of the glioma tumors and nine terms
that correspond to subclasses of atypia and mitotic activities. We first retrieved the NCIT
classes corresponding to these terms and all their parents. For each of these classes, we followed
all their relations and recursively retrieved the fillers and their parents.
Several operations have been necessary to address the issues mentioned in the previous
sections and enhance the extracted portion of the NCIT. First we provided definitions for all
WHO grades. Second, we added new classes (and new properties) for filling the granularity gap
between the histologic features described in the WHO and the classes present in the NCIT. For
handling the open-world-assumption, we also introduced the negations of each grade (namely
nograde, cf. section 4.2.5 on page 89).
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Figure 4.2: The ncit:Glioblastoma class has a necessary and sufficient definition. However,
this definition cannot be logically exploited.
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WHO_CNS_GRADE_II ≡

nci:Disease_Grade_Modifier
u
(∃hasCellularDensity Moderate_Increased_Cellularity_Present)
u
(∃hasAtypia (Occas._Nucl._Atypia_Present t Dist._Nucl._Atypia_Present))
u
(∀hasMitoticActivity Low_Mitotic_Activity)
u
(hasNecrosisActivity = 0)
u
(hasVascularProliferation = 0)
WHO_CNS_GRADE_III ≡

nci:Disease_Grade_Modifier
u
(∃hasCellularDensity Increased_Cellularity_Present)
u
(∃hasAtypia (Occas._Nucl._Atypia_Present t Dist._Nucl._Atypia_Present))
u
(∃hasMitoticActivity Marked_Mitotic_Activity)
u
(hasNecrosisActivity = 0)
u
(hasVascularProliferation = 0)
WHO_CNS_GRADE_IV ≡

nci:Disease_Grade_Modifier
u
(∃hasCellularDensity High_Cellularity_Present)
u
(∃hasAtypia Marked_Nuclear_Atypia_Present)
u
(∃hasMitoticActivity High_Mitotic_Activity)
u
(∃hasNecrosisActivity Necrotic_Change)
u
(∃hasVascularProliferation Vascular_Proliferation)
The generated ontology is composed of 243 classes, among which 33 are defined. Among the
243 classes, 234 classes correspond to NCIT classes, 5 classes have been added for the description
of the histologic criteria and 4 classes have been added for the description of nogrades. We reused
24 class definitions from the NCIT and created the remaining 9.
Two sets of classification tests have been created. The validation set (15 tests) has been gen-
erated for representing plausible combinations of the histologic criteria. Each test corresponds
to a prototypical tumor. The evaluation set corresponds to eleven pathologic reports provided
by the pathology department of the Rennes hospital. Each report was represented as a subclass
of Disease_Grade_Modifier. This step was performed manually. Each report is read and the
corresponding Tumor class has been built manually. For each test, the description of its histo-
logic criteria was done by existential restrictions for indicating the presence of a criterion, and
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by cardinality restriction to zero for indicating the absence of a criterion. Figures 4.3 and 4.4
show the case of Tumor10, which is correctly inferred to be a grade IV tumor. All tumors from
the validation set were correctly graded. Ten of the eleven tumors from the evaluation set were
correctly graded. The remaining tumor’s description only mentioned four of the five WHO
criteria, so it was not classified as a subclass of any of the four grades.
Figure 4.3: The Tumor10 from the evaluation set is defined according to its characteristics.
Figure 4.4: The Tumor10 from the evaluation set is correctly inferred to be a grade IV tumor.
4.2.5 Narrowing the possible grades in case of incomplete information
We completed the ontology by making WHO_CNS_GRADE_I, WHO_CNS_GRADE_II, WHO_CNS_GRADE_III
and WHO_CNS_GRADE_IV mutually-disjoint and by adding a coverage axiom to Disease_Grade_Modifier:
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Disease_Grade_Modifier ≡

WHO_CNS_GRADE_I
t
WHO_CNS_GRADE_II
t
WHO_CNS_GRADE_III
t
WHO_CNS_GRADE_IV
Eventually, we added the four NoGrade classes according to the template:
NO_WHO_CNS_GRADE_I ≡

Disease_Grade_Modifier
u
¬WHO_CNS_GRADE_I
Figure 4.5 shows that Tumeur4, which grade could not be determined because of its incom-
plete description, was (correctly) classified as a subclass of both NO_WHO_CNS_GRADE_III and
NO_WHO_CNS_GRADE_IV. This shows that even incomplete information can be valuable because
it can be exploited to reduce the space of solutions. Here we could not infer the grade of the
tumor, but the nograde classes allowed us to rule out grades 3 and 4 (the worse).
Figure 4.5: The Tumor4 from the evaluation set only has a partial description that covers 4 out
of 5 WHO grade criteria (A). This prevents the reasoner to infer its grade (B). However, the
NO_WHO_CNS_Grade classes are useful for ruling out grades 3 and 4 (C).
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4.3 Methodology: clinical trials recruitment
This study focuses on patient recruitment in clinical trials. This task requires the
matching of a large volume of information about the patient with numerous eligibility
criteria, in a logically-complex combination. Moreover, some of the patient’s informa-
tion necessary to determine the status of the eligibility criteria may not be available
at the time of pre-screening. We showed that the classic approach based on negation
as failure over-estimates rejection when confronted with partially-known information
about the eligibility criteria because it ignores the distinction between a trial for which
patient eligibility should be rejected and trials for which patient eligibility cannot be
asserted. We have also shown that 58.64% of the values were unknown in the 286
prostate cancer cases examined during the weekly urology multidisciplinary meetings
at Rennes’ university hospital between October 2008 and March 2009. We proposed
an OWL design pattern for modeling eligibility criteria based on the open world as-
sumption to address the missing information problem.
In retrospect, this work is interesting because it shows that the approach we developed
for the grade of brain tumors is actually more general and can be adapted to other
situations.
This study was a contribution to the Astec1 project (ANR-08-TECS-0002) and was related
to the EHR4CR2 project (IMI 115189). It was originally published in: Olivier Dameron, Paolo
Besana, Oussama Zekri, Annabel Bourdé, Anita Burgun, and Marc Cuggia. OWL model of clin-
ical trial eligibility criteria compatible with partially-known information. Journal of Biomedical
Semantics, 4(1), 2013 [95].
4.3.1 Context
Patient recruitment is a major focus in all clinical trials. Adequate enrollment provides a
base for projected participant retention, resulting in evaluative patient data. Identification of
eligible patients for clinical trials (from the principal investigator’s perspective) or identification
of clinical trials in which the patient can be enrolled (from the patient’s perspective) is an
essential phase of clinical research and an active area of medical informatics research. The
National Cancer Institute has identified several barriers that health care professionals claim in
regard to clinical trial participation3. Among those barriers, lack of awareness of appropriate
clinical trials is frequently mentioned.
Automated tools that help perform a systematic screening either of the potential clinical
trials for a patient, or of the potential patients for a clinical trial could overcome this barrier [180].
The ASTEC (Automatic Selection of clinical Trials based on Eligibility Criteria) project aims
at automating the search of prostate cancer clinical trials to which patients could be enrolled
to [181]. It features syntactic and semantic interoperability between the oncologic electronic
medical records and the recruitment decision system using a set of international standards
(HL7 and NCIT), and the inference method is based on ERGO [182]. The EHR4CR project
aims at facilitating clinical trial design and patient recruitment by developing tools and services
that reuse data from heterogeneous electronic health records. The TRANSFoRm project has
similar objectives for primary care [183, 184].
All these studies on data and criteria representation, integration and reasoning are moti-
vated by the requirement to have the necessary information available at the time of processing
1http://www.agence-nationale-recherche.fr/?Project=ANR-08-TECS-0002
2http://www.ehr4cr.eu/
3http://www.cancer.gov/clinicaltrials/learningabout/in-depth-program/page7
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the patient’s data, and assume that somehow, that will be the case. Missing information that
is required for deciding whether a criterion is met leads to recruitment being underestimated.
Solutions for circumventing this difficulty consist either in making assumptions about the unde-
cided criteria, or in having a pre-screening phase considering a subset of the criteria for which
patient’s data are assumed to be available. Bayesian belief networks have been used to address
the former [185] but require a sensible choice of probability values and may lead to the wrong
assumption in particular cases. The latter leaves most of the decision task to human expertise,
which provides little added value (if an expert has to handle the difficult criteria, automatically
processing the simple pre-screening ones is only a little weight off his shoulders) and is still
susceptible to the problem of missing information for the pre-screening criteria.
4.3.2 Objective
We propose an OWL design pattern for modeling clinical trial eligibility criteria. This design
pattern is based on the open world assumption for handling missing information. It infers
whether a patient is eligible or not for a clinical trial, or if no definitive conclusion can be
reached.
4.3.3 The problem of missing information
4.3.3.1 Modeling clinical trial eligibility
A clinical trial can be modeled as a pair < (Ii)
n
i=0, (Ej)
m
j=0 > where (Ii)
n
i=0 is the set of the
inclusion criteria, and (Ej)
m
j=0 is the set of the exclusion criteria. All the eligibility criteria from
(Ii)
n
i=0 ∪ (Ej)mj=0 are supposed to be independent from one another (at least in the weak sense:
the value of criterion Ck cannot be inferred from the combined values of other criteria). Each
criterion can be modeled as an unary predicate C(p), where the variable p represents all the
information available for the patient. C(p) is true if and only if the criterion is met.
A patient is deemed eligible for a clinical trial if all the inclusion criteria and none of the
exclusion criteria are met.
patient eligible⇔
n
∧
i=0
Ii(p) ∧ ¬(
m
∨
j=0
Ej(p)) (4.1)
Before making the final decision on the list of clinical trials for which a patient is eligible
for, there are intermediate pre-screening phases where only the main eligibility criteria of each
clinical trial are considered. Such pre-screening sessions rely on subsets of (Ii)
n
i=0 and (Ej)
m
j=0,
but the decision process remains the same.
For the sake of clarity, in addition to the general case, we will consider a simple clinical trial
with two inclusion criteria I0 and I1, and two exclusion criteria E0 and E1.
patient eligible⇔ I0(p) ∧ I1(p) ∧ ¬(E0(p) ∨ E1(p)) (4.2)
For example, these criteria could be:
• I0: evidence of a prostate adenocarcinoma;
• I1: absence of metastasis;
• E0: patient older than 70 years old;
• E1: evidence of diabetes.
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According to equation 4.2, a patient would be eligible for the clinical trial if and only if he has
a prostate adenocarcinoma and has no metastasis and is neither older than 70 years old nor
suffers from diabetes.
Because of De Morgan’s laws, equation 4.1 is equivalent to:
patient eligible⇔ (
n
∧
i=0
Ii(p)) ∧ (
m
∧
j=0
¬Ej(p)) (4.3)
Even though equation 4.1 and equation 4.3 are logically equivalent, the latter is often pre-
ferred because it is an uniform conjunction of criteria. Note that the negations in front of the
exclusion criteria are purely formal, as both inclusion and exclusion criteria can represent an
asserted presence (e.g. prostate adenocarcinoma for I0 or of diabetes for E1) or an asserted
absence (e.g. metastasis for I1).
For our example:
patient eligible⇔ I0(p) ∧ I1(p) ∧ (¬E0(p)) ∧ (¬E1(p)) (4.4)
According to equation 4.3, a patient would be eligible for the clinical trial if and only if he
has a prostate adenocarcinoma and has no metastasis and is not older than 70 years old and
does not suffer from diabetes.
4.3.3.2 Patients who we know are not eligible and those who we do not know
whether they are eligible
When a part of the information necessary for determining if at least one criterion is met is
unknown, the conjunction of equation 4.3 can never be true. This necessarily makes the patient
not eligible for the clinical trial, whereas the correct interpretation of the situation is that the
patient cannot be proven to be eligible. This is different from proving that the patient is not
eligible, and indeed, in reality the patient can sometimes be included by assuming the missing
values (cf. next section).
For our fictitious clinical trial, we consider a population of nine patients covering all the
combinations of “True”, “False” or “Unknown” for the inclusion criterion I1 and the exclusion
criterion E1. Table 4.1 on the next page presents the value of equation 4.4 and correct inclusion
decision for the nine combinations. Among the five patients (p2, p5, p6, p7 and p8) for which at
least a part of the information is unknown, three (p2, p7 and p8) illustrate a conflict between
the value of equation 4.4 and expected inclusion decision. A strict interpretation of equation 4.4
leads to the exclusion of the eight patients:
• for three of them (p0, p3 and p4), all the information is available;
• for two of them (p5 and p6), some information is unknown, but the available information
is sufficient to conclude that the patients are not eligible;
• for the three others (p2, p7 and p8), however, the cause of rejection is either because one of
the inclusion criteria cannot be proven (I1 for p7 and p8) or because one of the exclusion
criteria cannot be proven to be false (E1 for p2 and p8).
In the case of unknown information, equation 4.3 alone is not enough to make the distinction
between the patients we know are not eligible (the first two categories, so this also includes
patients for whom a part of the information is unknown) and those we do not know if they are
eligible (the third category). This is a problem because patients from the first two categories
should be excluded from the clinical trial, whereas those from the third category should be
considered for inclusion.
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Patient I0 I1 E0 E1 I0 ∧ I1 ∧ ¬E0 ∧ ¬E1 Decision
p0 T T F T F Exclude
(E1)
p1 T T F F T Include
p2 T T F ? F Propose
cannot assert ¬E1 (assume ¬E1)
p3 T F F T F Exclude
(both ¬I1 and E1)
p4 T F F F F Exclude
(¬I1)
p5 T F F ? F Exclude
(¬I1)
p6 T ? F T F Exclude
(E1)
p7 T ? F F F Propose
cannot assert I1 (assume I1)
F
p8 T ? F ? cannot assert I1 Propose
cannot assert ¬E1 (assume both I1 and ¬E1)
Table 4.1: Evaluation of equation 4.4 and correct inclusion decision for all the possible values
of I1 and E1, with possibly unknown information.
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One solution could be to assume the values of the unknown criteria in order to go back to
a situation where inclusion or exclusion could be computed using equation 4.3. In this case:
• inclusion criteria for which the available information is not sufficient to compute the status
are considered to be met;
• exclusion criteria for which the available information is not sufficient to compute the status
are considered not to be met.
Therefore, in the case where the available information is not sufficient to compute the status of a
criterion, a different status is assumed depending on whether the criterion determines inclusion
or exclusion. Referring to our fictitious clinical trial, the lack of information about the absence
of metastasis would lead to the assumption that I1 is true, whereas the lack of information
about diabetes would lead to the assumption that E1 is false.
This situation raises several issues:
• a different status is assumed depending on whether the criterion determines inclusion or
exclusion;
• the assumed status depends on the nature of the criterion (i.e. inclusion or exclusion) and
not on its probability;
• one has to remember that the value for at least a criterion has been assumed in order to
qualify the inferred eligibility (adamant for p0 or p1 vs “under the assumption that...” for
p2, p7 and p8);
• this qualification can be difficult to compute (the status of E1 is unknown for both p2 and
p5, but p5 can be confidently excluded whereas p2 can be included assuming E1).
4.3.4 Eligibility criteria design pattern
• for each criterion, create a class C_i (at this point, we do not care if it is an inclusion
or an exclusion criterion, or both) and possibly add a necessary and sufficient definition
representing the criterion itself (or use SWRL);
• for each criterion, create a class Not_C_i defined as
Not_C_i ≡ Criterion u¬ C_i.This process can be automated;
• for each clinical trial, create a class Ct_k (placeholder);
• for each clinical trial, create a class Ct_k_include as a subclass of Ct_k with a necessary
and sufficient definition representing the conjunction of the inclusion criteria and of the
exclusion criteria (cf. equation 4.3) (Ct_k_include ≡
n
u
i=0
I_i u
m
u
j=0
Not_E_j);
• for each clinical trial, create a class Ct_k_exclude (placeholder) as a subclass of Ct_k;
• for each clinical trial, create a class
Ct_k_exclude_at_least_one_exclusion_criterion as a subclass of
Ct_k_exclude with a necessary and sufficient definition representing the disjunction of
the exclusion criteria
(Ct_k_exclude_at_least_one_exclusion_criterion ≡
m
t
j=0
E_j );
95
• for each clinical trial, create a class
Ct_k_exclude_at_least_one_failed_inclusion_criterion as a subclass of Ct_k_exclude
with a necessary and sufficient definition representing the disjunction of the negated in-
clusion criteria
(Ct_k_exclude_at_least_one_failed_incl_criterion ≡
n
t
i=0
Not_I_i );
• represent the patient’s data with instances (Figure 4.6 and 4.7). For the sake of simplicity,
we will make the patient an instance of as many C_i as we know he matches criteria, and as
many Not_C_j classes as we know he does not match criteria, even if this is ontologically
questionable (a patient is not an instance of a criterion). How the patient’s data are
reconciled with the criteria by making the patient an instance of the criteria is not specified
here: it can be manually, or automatically with OWL necessary and sufficient definitions
or SWRL rules for the C_i and Not_C_j classes.
Figure 4.6: A patient for who all the information is available.
4.3.5 Reasoning
If all the required information is available, after classification, for each criterion the patient
will be an instance of each C_i or Not_C_i, and therefore will also be instantiated as either
Ct_k_include (like p1 in Figure 4.8 on the facing page),
Ct_k_exclude_at_least_one_exclusion_criterion or
Ct_k_exclude_at_least_one_failed_inclusion_criterion (so at least we are doing as well
as the other systems).
If not all the information is available, because of the open world assumption, there will be
some criteria for which the patient will neither be classified as an instance of C_i nor of Not_C_i
(e.g. in Figure 4.7 on the next page, p2 is neither an instance of E_1 nor of Not_E_1), so he will
not be classified as an instance of Ct_k_include either. However, the patient may be classified
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Figure 4.7: A patient for who some information is unknown (here about E1).
Figure 4.8: The class modeling clinical trial inclusion after classification (here patient p1 can be
included).
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as an instance of
Ct_k_exclude_at_least_one_exclusion_criterion or of
Ct_k_exclude_at_least_one_failed_inclusion_criterion. As both are subclasses of Ct_k_exclude,
we will conclude that the patient is not eligible for the clinical trial. We will even know if it is
because he matched an exclusion criterion (like p0, p3 and p6 in Figure 4.9), because he failed
to match an inclusion criterion (like p3, p4 and p5 in Figure 4.10), or both (like p3).
Figure 4.9: The class modeling clinical trial exclusion because at least one of the exclusion
criteria has been met after classification (here patients p0, p3 and p6 match the definition).
Figure 4.10: The class modeling clinical trial exclusion because at least one of the inclusion
criteria failed to be met after classification (here patients p3, p4 and p5 match the definition).
If the patient is neither classified as an instance of Ct_k_include nor of Ct_k_exclude (or
its subclasses), then we will conclude that the patient can be considered for the clinical trial,
assuming the missing information will not prevent it (like p2, p7 and p8, who do not appear in
Figs. 4.8, 4.9 and 4.10, consistently with Table 4.1 on page 94). By retrieving the criteria for
which the patient is neither an instance of C_i nor of Not_C_i, we will know which information
is missing.
4.4 Synthesis
What the two examples have in common The approach developed in this chapter and
exemplified by the two reasoning applications could certainly be applied to many other contexts.
Missing or incomplete information is pervasive in life sciences, and this is an inner characteristics.
The study on clinical trials demonstrated the extent of the phenomenon, with about 68 % of
patients data not specified, and none of the 286 patients having all the required fields for any
of the four clinical trials we considered. I do not expect this trend to decrease, as we will
keep on needing to combine patches of informations from different natures and different origins.
However, part of what is causing the problem is also the solution: this integration endeavor
is supported by new technologies that inherently take missing information into account. As
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we are making the transition from the information silo paradigm to the linked data paradigm,
we are switching from query languages such as SQL that rely on the closed-world assumption
over well groomed and exhaustive data to reasoners capable of making the distinction between
assertions that we know are false and assertions that are undecided (e.g. with “MINUS” and
“NOT EXISTS” in SPARQL) or supporting the open-world assumption (OWL). I have the
impression that these features are not exploited to their full potential yet, but insisting on using
the former query languages on data that do not fulfill the exhaustivity requirement anymore
does not seem sensible.
A conclusion of the chapter on reasoning based on classification was that modeling the
domain-specific part of the reasoning task required a very little amount of work, provided that
semantically-rich ontologies are available. Again, the availability of these ontologies turned out
to be a limiting factor and we had to fix manually the imperfections of the NCIT.
Eventually, in both examples of grading tumors and of determining patients eligibility, the
extra amount of work dedicated to handle missing information was again minimal. Moreover,
both examples suggest that this additional work can be automated at least partially: the gen-
eration of the NO_WHO_GRADE classes and their definitions followed a simple pattern that was
independent from the definitions of the grades. Similarly, the generation of the Ct_exclude and
of the negated criteria classes as well as their definition were only formal manipulations relying
on the definition of the corresponding Ct_include.
Grading tumors This application elaborates on a situation encountered in the Virtual Soldier
project. It took me several years before I realized that what I considered then to be a concrete
example of why closure axioms are useful in OWL (explaining the open world assumption in
OWL was a major point during the Protégé Short Course and on the mailing list) was actually
a part of a more general topic that proved to be valuable for modeling and reasoning over
biomedical data.
Assessing patients eligibility to clinical trials This application is in turn a transposition
of the tumor grading method. It could have implications in the more general efforts to formalize
and standardize the representation of clinical trials eligibility criteria.
However, even if the solution I developed was adequate, I have since then replicated the
reasoning mechanism using SPARQL instead of OWL. However, this mechanism only focuses on
combining the status of the various eligibility criteria. Determining the status of each criterion
typically remains a classification task for which OWL is best suited. Comparing the original
solution with an approach relying on OWL for determining each criterion status and on SPARQL
for combining the criteria remains to be done. It would be along the line of the optimization
study from section 3.4.
What we learned
• Failing to explicitly address incomplete information may lead to biased results.
• The modeling overhead for taking incomplete information into account was marginal in
both examples, and so was the additional computing cost.
• Just because some piece of information is incomplete does not mean that it is useless, as
it can be exploited to reduce the space of solutions.
• The problem of incomplete information is pervasive in life science; however so far data
sources and applications seldom take it into account, which make it a relevant field of
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research. Primmer et al. made an in depth analysis of the Gene Ontology and its relevance
for analyzing non-annotated genomes using what is known on model species [30]. It should
be noted that Chen et al. developed a similarity measure among genes with shallow
annotations [186]. Moreover, the Gene Ontology supports a NOT modifier for stating that
a gene product was proved to be not associated with a GO term (e.g. for Homo sapiens,
APOA1 (uniprot:P02647) is not associated to “transforming growth factor beta receptor
signaling pathway” (go:0007179)). This modifier allows to make the distinction between
the situations where we do not know whether a gene product is annotated to a GO term
(absence of annotation) and the situations where we know that a gene product is not
associated to the GO term (annotation with the NOT modifier). Even if such modifiers
should be taken into account [140], I do not know of any widespread application that use
them (which of course does not mean that there are no such applications).
• The question of confidence is also related to missing information. The Gene Ontology
evidence codes4 and the associated decision tree5 were exploited by the IntelliGO semantic
similarity measure [187]. GO evidence codes were later extended to the Evidence Ontology
(ECO) [188] and inspired the Confidence Information Ontology [189].
4http://geneontology.org/page/guide-go-evidence-codes
5http://geneontology.org/page/evidence-code-decision-tree
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Chapter 5
Reasoning with similarity and
particularity
Outline
In addition to classification and deductive reasoning, life sciences data analysis also encompasses
comparison. By making explicit the relations between classes, ontologies make it possible to go
beyond simple annotation counting for determining what two elements have in common, or to
what extent these two elements are different.
A collaboration with Christian Diot focused on the comparison of the lipid metabolism
pathways for ducks and chicken. Ducks and geese produce foie gras when fattened whereas most
other bird species produce abdominal fat instead, which lower the meat quality and its market
value. Interestingly, foie gras is related to liver steatosis, a condition that can progress into fatty
liver disease, cirrhosis or liver cancer in mammals and particularly humans. In this context,
we supervised Charles Bettembourg’s PhD thesis on a generic method based on semantics for
the metabolic networks comparison across species. A major challenge was that most existing
methods focus on what is similar, whereas we were specially interested in the differences. We
proposed a method that first identifies the similar pathway steps and second identifies the
similar steps associated to some specific processes in one of the species. This led us to define
a semantic particularity measure as a complement to existing similarity measures (section 5.2),
and to determine an objective discretization method for determining whether two elements were
similar, and whether they are particular (section 5.3). The problem was further complicated by
the fact that chicken or ducks are not as thoroughly annotated as human or mice. This bias
rendered most of the classical similarity measures inadequate.
5.1 Principle
This section surveys the main categories of the numerous similarity measures and gives the
definition of the measures used in sections 5.2 and 5.3.
The general principle consists in quantifying the similarity between two elements according
to the annotations associated with each element. In certain domains, the process has also
been extended for comparing two sets of elements. Similarity values usually range from 0 (low
similarity) to 1 (perfect similarity).
Similarity is often seen as the dual notion of distance with the formula: distance = 1 −
similarity, with distance values ranging from 0 (high similarity) to 1 (low similarity). However
such distances are usually not proper distance metrics as they do not have the triangle inequality
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property. Note also that the perspectives are different as similarity focuses on what is common
between two elements, whereas distance focuses on what makes them different, so the connection
between similarity and distance may not be straightforward and the previous formula should
be seen as an approximation.
5.1.1 Comparing elements with independent annotations
5.1.1.1 Independent annotations with the same weight
Classic similarity measures are based on set operations over the annotations of two elements. If
A and B are the sets of annotations of the first and the second element respectively, the Jaccard
index is defined as :
J(A,B) =
|A ∩B|
|A ∪B|
A similar notion is the Dice–Sørensen coefficient :
D(A,B) =
2.|A ∩B|
|A|+ |B|
There is a correspondence between the Jaccard index and the Dice–Sørensen coefficient :
J =
D
2−D
D =
2J
1 + J
The Jaccard index and Dice–Sørensen coefficient both rely on two main assumptions: all the
annotations have the same weight, and all the annotations have the same frequency. These two
notions are different but not independent. Weight focus on the contribution of the annotation
for determining the similarity between two elements. This is related to informativeness or
granularity (a precise annotation conveys more information than a general or vague one). It
is an intrinsic property of the annotation. Frequency is corpus-dependent, and is therefore an
extrinsic property of annotations. Even if all the annotations had the same granularity, an
annotation that annotates most of the elements of a corpus would be considered to be less
informative than a rarer annotation. Of course, with annotations of different granularities, the
more general annotations tend to be also the most frequent.
5.1.1.2 Independent annotations with different weights
The cosine similarity is a simple measure where the elements A and B to be compared are
represented as vectors of n annotations. Each annotation has a fixed position in the vectors so
that the ith element of the vector of A refers to the same annotation as the ith element of the
vector of B.
similaritycosine(A,B) =
A.B
||A|| × ||B||
=
n∑
i=1
(Ai ×Bi)√
n∑
i=1
(Ai)2 ×
√
n∑
i=1
(Bi)2
Although the ith element of the annotation vector can be any real number (so cosine simi-
larity is in the [−1; 1] range), it is usually a positive number (so cosine similarity is in the [0; 1]
range). There are several classical strategies for determining the values of the annotation vector.
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A binary vector representing the absence or the presence of annotations makes the cosine
similarity applicable when all the annotations have the same weight (cf. section 5.1.1.1).
A more elaborate weighting scheme such as the“term frequency – inverse document frequency”
(tf-idf) allows to take into account both the importance of the annotation (possibly different
values for A and B), and the relative weights of each annotation (same value for A and B).
Term frequency indicates how important the annotation is to the element being compared.
There are several weighting variants such as binary, raw frequency or log-normalization. For a
text, this is typically the number of occurrences of a word divided by the number of words (for
being able to compare texts of different lengths). For a gene, this is typically 1 or 0, depending
on whether the gene is annotated or not. For a set of genes, this is typically the proportion of
the genes in the set annotated by the term (for being able to compare sets of different sizes).
Inverse document frequency indicates how important the annotation is in general, according
to a reference corpus. As mentioned previously, an annotation present in few documents is
more informative than a common annotation. There are also several weighting variants such
as the logarithm of the inverse frequency, i.e. the logarithm of the inverse of the proportion of
documents in the corpus annotated by the term.
tf-idf is simply the product of the two previous aspects, which emphasizes an over-representation
of rare annotations.

tf(annotation, document) =
Nb of occurrences of annotation in document
Nb of annotations of document
idf(annotation, Corpus) = −log |{d ∈ Corpus : annotation ∈ d}|
|Corpus|
tfidf(annotation, document, Corpus) = tf(annotation, document)× idf(annotation, Corpus)
5.1.2 Taking the annotations underlying structure into account
All the previous similarity measures assume that the annotations are independent. However, the
analysis can be further refined by using ontologies to also consider the relations between some
of the annotations. Figure 5.1 on the next page presents the Gene Ontology hierarchy between
three GO terms. This section shows how this hierarchy can be exploited by semantic similarity
measures to infer that the first two are biologically close (their similarity is 0.57), whereas they
are biologically different from the third (their similarity are respectively 0.08 and 0.11). Lee et
al. performed a comparison of three families of similarity based respectively on IC, ontology
structure and expert opinion on the SNOMED-CT ontology and found a poor agreement be-
tween IC-based metrics, whereas the metric based on ontology structure correlated best with
expert opinion [190]. This suggests that taking the ontology structure into account improves the
analysis, although whether this can be generalized to other ontologies and application contexts
remains an open question.
Within a given gene set, the genes sharing identical or similar GO annotations can be
grouped into clusters using two approaches [191]. The GSEA approach computes these clusters
considering the GO terms over-representation. The semantic similarity approach takes into
account GO properties to cluster genes considering the quantity and the importance of their
shared annotations [192, 193, 194, 195]. Both approaches are not exclusive, as semantic mea-
sures can be involved in GSEA in order to improve the analysis [196]. If the GO terms were
independent, the gene set characterization could be performed by a straightforward set-based
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Figure 5.1: Gene Ontology hierarchy between “protein ADP-ribosylation”, “translational initi-
ation” and “ion transport”. This hierarchy can be exploited by semantic similarity measures
to infer that the first two are biologically close, whereas they are biologically further from the
third. Dark blue edges represent “is a” and light blue edges represent “part of” relations (graph
generated by Amigo).
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approach such as the Jaccard index or Dice’s coefficient. However, GO terms are hierarchically-
linked. Consequently, the characterization needs to take into account the underlying ontological
structure of the GO annotations [140].
Semantic similarity measures rely on ontologies to systematically quantify the weight of the
shared elements. They exploit the formal representation of the meaning of the terms by con-
sidering the relations between the terms (e.g. for inferring new annotations that were implicit
as each term inherits all the properties of its ancestors) and by attributing different weights to
each term depending on how much information they convey. When working with annotation
databases, it should be routine practice to use the ontology hierarchy to infer implicit anno-
tation [140]. Gentleman developed a graph-based measure for the R package GOstats called
simUI [197]. simUI defines the semantic similarity between two sets of terms corresponding to
two sub-graphs of the ontology as the ratio of the number of terms in the intersection of those
graphs to the number of GO terms in their union, which corresponds to a simple adaptation of
the Jaccard index. However, with simUI, all the terms have the same weight, which introduces a
bias emphasizing the intersection as the more general terms tend to annotate more genes. Other
measures adopt different strategies to weight the terms. Pesquita et al. performed an extensive
review of the main semantic similarity measures [198] and identified two main categories, i.e.
node-based methods and edge-based methods, as well as a handful of hybrid methods. Blan-
chard et al. also performed an in-depth comparison of semantic similarities on subsumption
hierarchies without multiple inference [199].
5.1.2.1 Node-based semantic similarity
Node-based semantic similarity measures rely on how informative the terms are. Typically, they
consider that two terms sharing an informative lowest common ancestor are more similar than
two terms with a less informative lowest common ancestor, as seen in Fig. 5.1 on the facing
page.
Historically, Information Content (IC) value was used to quantify how informative a term is,
with the least frequent terms having the highest IC value. Terms frequencies were determined
using a reference corpus. The IC of a term t is its negative log probability P (t). When the
annotations are organized in an ontology such as GO, it is necessary to take into account
the subsumption hierarchy when computing this frequency in order to also consider implicit
annotations to the terms descendants [140].
IC(t) = −log(P (t))
This concept, borrowed from Shannon’s Information Theory, was used to measure similarities
using ontologies [200, 201, 202] such as WordNet [203]. To compare two terms, these methods
rely on their most informative common ancestor (MICA). For Resnik, the similarity of two terms
is simply the information content of their MICA. Lin also takes into account how far these two
terms are from their MICA. Pesquita et al. proposed to combine the graph-based simUI metric
with the IC of the terms involved in the computation [204]. In simGIC, each term is weighted
by its IC.
similarityResnik(A,B) = maxt∈(ancestors(A)∩ancestors(B))(IC(t))
similarityLin(A,B) =
2×maxt∈(ancestors(A)∩ancestors(B))(IC(t))
IC(A) + IC(B)
Ontologies are used twice when computing node-based semantic similarities: for determin-
ing the correct information content of annotations and for determining the most informative
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common ancestor. These methods developed in linguistics have been applied to GO [205, 206]
using the frequency with which a term annotates a gene as a marker of its rarity. Consequently,
the IC of a GO term is inversely proportional to the frequency with which it annotates a gene
using the Gene Ontology Annotations (GOA) database [138]. GOA specifies also how each
annotation has be attributed through Evidence Codes (EC). In their method called “IntelliGO”,
Benabderrahmane et al. use a weighting corresponding to each GO term EC in addition to
their IC [187].
Retrieving only the most informative common ancestor to compute a semantic similarity
ignores the possibility that two GO terms can share several common ancestors. These situations
result in a loss of information. A possible solution has been proposed that consists in using the
average of the IC values of all disjoint common ancestors (DCA) instead of the maximum IC of
this common set [207].
For the node-based methods relying on IC, the terms’ frequencies used to compute the
IC values depend on the corpus of reference. In the context of genes comparison, IC-based
methods have three main limits related to their dependence on a GOA-based corpus. First,
it can prove difficult or even impossible to obtain a relevant corpus. GOA provides single
and multi-species annotation tables. Although using a species-specific table is well-suited to
intra-species comparisons, it becomes problematic for cross-species comparisons. Second, using
a multi-species table (like the UniprotKB table) in these cases is biased towards the most
extensively annotated species such as human or mice. Third, the well-studied areas of biology
have high annotation frequencies and are therefore less informative and see their importance
downgraded, whereas the less-studied areas are artificially upgraded [208, 209, 210].
5.1.2.2 Edge-based semantic similarity
Edge-based semantic similarity measures use the directed graph topology to compute distances
between the terms to compare. Among the simplest, Rada distance is based on the shortest
path between the two terms [211], with extensions that rely on the average path among multiple
paths [198]. Other approaches take into account the length of the path between the root of the
ontology and the least common ancestor (LCA) of the terms, with the result that terms with
a deep common ancestor are more similar than terms with a common ancestor close to the
root [212, 213, 214, 215, 216]. The edge-based methods using depth as a proxy for precision are
not dependent on a particular corpus. This can be a strength when it is difficult or impossible
to determine a representative corpus, or a weakness when corpus-dependent frequencies are
relevant. Moreover, another constraint to consider is that in most ontologies, granularity is not
uniform so terms at the same depth can have different precisions; this is typically the case for
GO [217].
5.1.2.3 Hybrid semantic similarity
Pesquita et al. also identified“hybrid”methods that combine different aspects of node-based and
edge-based methods. In Wang’s method [193], each term has a “semantic value” that represents
how informative the term is, conforming to the node-based approach. However, the semantic
value of a term is obtained by following the path from this term to the root and summing the
semantic contributions of all the ancestors of this term. As the semantic value depends on
the ontology topology, it also conforms to the edge-based approach. Note that this alternative
approach is corpus-independent, so it is applicable when a relevant corpus cannot be computed
(for comparing elements from several species) or does not exist (for poorly studied species). The
relevance of the results obtained by this approach has previously been demonstrated [193, 198].
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For computing a term’s semantic value (SV), Wang first computes the semantic contributions
of the ancestors of the term. In the following formulas, SA(t) is the semantic contribution of
the term t to the term A and we is the semantic contribution factor for edge e linking a term t
with its child term t’. According to Wang, we use a semantic contribution factor of 0.8 for the
“is a” relations and 0.6 for the “part of” relations, and we added a 0.7 factor for the “[positively]
[negatively] regulates” relations. An additional study not presented here showed that the value
of the regulation factor had minimal impact (+/- 0.01) on the overall value.
{
SA(A) = 1
SA(t) = max{we ∗ SA(t′) | t′ ∈ children of (t)} if t 6= A
Then, for each target term to compare, the semantic value is the sum of the semantic
contributions of all its ancestors. Figure 5.2 shows an example of the semantic contributions
of the ancestors of GO:0043231 allowing to determine its semantic value: SV(GO:0043231) =
5.5952. The same operation for GO:0005622 gives SV(GO:0005622) = 2.92 (Fig 5.3 on the
following page). The more general a term (i.e. the less informative), the smaller its semantic
value.
1
0.8 0.8
0.64 0.64
0.384
0.512
0.3072
0.4096
Figure 5.2: Semantic contributions of the ancestors of GO:0043231. The terms closer
to GO:0043231 contribute more. The farther the ancestor, the smaller its contribution to the
term of interest. The semantic value of GO:0043231 is the sum of its ancestors’ semantic con-
tribution,
here SV(GO:0043231) = 5.5952.
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Figure 5.3: Semantic contributions of the ancestors of GO:0005622; here SV(GO:0005622) =
2.92.
SV (A) =
∑
t∈TA
SA(t)
The terms semantic values and their ancestors’ semantic contributions are used to compute
the semantic similarity of two GO terms A and B:
similarityWang(A,B) =
∑
t∈(TA∩TB)
(SA(t) + SB(t))
SV (A) + SV (B)
The semantic similarity of a GO term A and a set of GO terms G is the highest similarity
between A and each element of G:
similarityWang(A,G) = maxt∈G(similarityWang(A, t))
The semantic similarity of two sets of GO terms G1 and G2 is:
similarityWang(G1, G2) =
(
∑
t1∈G1
similarityWang(t1, G2)) + (
∑
t2∈G2
similarityWang(t2, G1))
|G1|+ |G2|
Pesquita et al. do not single out any particular semantic similarity measure as the best one,
as the optimal measure will depend on the data to compare and the level of detail expected in
the results. The main advantage of Wang’s method compared to purely node-based methods is
that the semantic value is not GOA-dependent, unlike information content. It is thus well-suited
to cross-species comparisons. As cross-species comparison is one of the key stakes in biology,
further development in the domain of semantic comparison should support such comparisons.
5.1.3 Synthesis
As we have seen, assessing the similarity of two elements can be greatly improved by using
ontologies in order to take into account their annotations underlying structure. However, sim-
ilarity alone is not enough for comparing biological pathways between non-model species. We
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also need to identify the pathway steps that are similar between the two species but for which
at least one of the two has some additional function. This sets up two challenges: being able to
quantify similarity and particularity, and being able to determine both whether two elements
are similar, and whether one of them has some particular function.
In the remainder of this chapter, section 5.2 presents a semantic particularity measure de-
signed to be combined with any semantic similarity measure. The joint use of similarity and
particularity allows to refine the comparison of sets based on the annotations of their elements.
We show how the two sets similarity and their respective particularity determine comparison
patterns (e.g. the two sets are similar and the second set presents a high particularity).
Section 5.3 presents a generic method for determining the optimal similarity and particularity
thresholds minimizing the proportions of false positive and false negative as well as the abnormal
comparison patterns.
5.2 Methodology: semantic particularity measure
This study focuses on the definition of a semantic particularity measure for comparing
sets of elements annotated by an ontology. We propose to combine our particularity
measure with a similarity measure to first identify the similar sets, and second identify
sets with additional functions from among the similar ones. This particularity measure
is initially applied to gene sets comparison according to the genes’ GO annotations.
We then show that the principle is generalizable to other ontologies.
In retrospect, this work is interesting because whereas semantic similarity has been
an active research domain over the last decade with countless measures and not a
single one outperforming the others, our approach allows to refine the analysis by also
considering the specificities that are inherently ignored by similarity. Our semantic
particularity measure is based on the general notion of informativeness, which can
be derived from any semantic similarity measure, so combining similarity and the
associated particularity can be performed with any similarity measure.
This study was originally published in: Charles Bettembourg, Christian Diot, and Olivier
Dameron. Semantic particularity measure for functional characterization of gene sets using
Gene Ontology. PLoS ONE, 9(1):e86525, 2014 [96].
5.2.1 Context
With the continued advance of high-throughput technologies, genetic and genomics data analy-
ses are outputting large sets of genes. The amount of data involved requires automated compar-
ison methods [4]. The characterization of these sets typically consists in a combination of the
following three operations [218, 219]: first, synthesize the over- and under-represented functions
of these genes [220, 221]; second, identify how these genes interact with each other [222]; third,
identify and quantify the common shared features and the differentiating features [223, 224].
A widely used method for genes sets study called “Gene Set Enrichment Analysis” (GSEA)
determines which gene features are over-represented in a gene set [225]. Numerous tools have
been developed in this purpose: BiNGO [226], GOEAST [227], ClueGO [228], DAVID [229], Ge-
neWeaver [230], GOTM [231]. See Hung et al. recent work for a review [232]. GSEA is useful for
clustering a set of genes into subsets sharing over-represented features. Among these features,
the biological processes (BP), molecular functions (MF) and cellular components (CC) annotat-
ing each gene are represented using the Gene Ontology (GO) [233]. GO is species-independent,
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and thus supports cross-species comparison [30]. The GO graph itself is also widely used for
genes semantic similarity analysis [234].
All the semantic similarity measures appear appropriate for identifying and quantifying
common features. However, as these measures are focusing on common features, they may
lead to an incomplete analysis when comparing genes having particular features along side
similar ones [235]. For example, parts A and B of Figure 5.4 respectively present the molecular
functions annotating the Exportin-5 orthologs of human (hsa) and rat (rno) and the Exportin-
5 orthologs of human and drosophila (dme). Wang’s method allows to compute cross-species
semantic similarity. The results on MF annotations are: Sim(hsa, rno) = 0.797 and Sim(hsa,
dme) = 0.726. This is consistent with the fact that globally, the Exportin-5 orthologs share the
same functions between hsa, rno and dme. However, there are also five times as many human-
specific MF terms compared to drosophila as compared to rats. It has been demonstrated
that Exportin-5 orthologs are functionally divergent among species [236]. The tiny difference
of semantic similarity (0.071) correctly reflects the fact that the orthologs share the same main
function, but is not sufficient to identify that some species also have additional functions.
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Figure 5.4: Representation of Exportin-5 orthologs annotations. Common terms between species
are displayed in blue. The terms annotating only the human ortholog are displayed in red. Part
A of this figure displays the MF annotations of the human and rat orthologs of Exportin-5. Part
B displays the MF annotations of the human and drosophila orthologs of Exportin-5. In this
example, there is no rat nor drosophila-specific term. The semantic similarity values obtained
in these cases do not reflect the difference of human particularity between each part.
5.2.2 Objective
We assume that considering only similarity measures is not enough to compare sets of annota-
tions. This analysis is valid for any set of annotations that refer to an ontology. We hypothesize
that gene set analysis can be improved by considering gene particularities in addition to gene
similarities. We propose a general definition and some associated formal properties. We pro-
pose also a new approach based on the notion of GO term informativeness to compute gene set
particularities.
The original study was composed of three use cases. Section 5.2.6 on page 113 summarizes
the second one.
• The first use case replicated Wang’s study on Saccharomyces cerevisiae tryptophan degra-
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dation when he defined his semantic similarity measure on GO. Our results showed that
Wang’s results are still valid. We also identified a benefit of using a particularity measure
in addition to a similarity measure for identifying particular functions between similar
genes.
• The second use case covered a larger dataset composed of 51 well annotated human genes
related to aquaporin-mediated transport in order to determine whether similar genes with
particular functions were a frequent situation. Our results showed that among similar
genes, some also have some particular function and that this situation can be observed
throughout the full range of similarity values.
• The third use case compared homolog genes across different species. Our results shows that
ortholog genes were, as expected, mostly similar. Again, we also identified some of them
having high particularity values that denote specific functions. Eventually, we identified
some orthologs that have diverged and present a low similarity and high particularities.
5.2.3 Definition of semantic particularity
The semantic particularity of a set compared to another is the value that reflects the importance
of the features that belong to the first set but not the second. To compare two genes, we rely on
the similarity and the respective particularities of their sets of annotations. The particularity
of a gene g1 annotated by the set Sg1 compared to a gene g2 annotated by the set Sg2 depends
on the annotations of Sg1 that are not related to any annotation of Sg2.
5.2.4 Formal properties of semantic particularity
Like for semantic similarity, we compute a value bounded by 0 (least particular) and 1 (most
particular). Four important properties arise from the semantic particularity definition:
• The semantic particularity is non-symmetric:
Par(Sg1, Sg2) = x ; Par(Sg2, Sg1) = x (Prop 1)
• Compared to itself, a set of annotations has no semantic particularity:
Par(Sg1, Sg1) = 0 (Prop 2)
If Sg1 = ∅, this comparison is meaningless.
• The semantic particularity of a set of annotations Sg1 (6= ∅) is maximal when it is com-
pared to an empty set of annotations:
Par(Sg1, ∅) = 1 (Prop 3.1)
And conversely:
Par(∅, Sg1) = 0 (Prop 3.2)
• The particularity of a set Sg1 of annotations compared to a set Sg2 does not depend on
the elements of Sg2 that do not belong to Sg1:
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Sg3 ∩ Sg1 = ∅ ⇒ Par(Sg1, Sg2) = Par(Sg1, Sg2 ∪ Sg3) (Prop 4)
5.2.5 Measure of semantic particularity
In order to compute the particularity of Sg1 compared to Sg2, we focus on the terms of Sg1 that
are not members of Sg2. This requires to address two problems: the terms are not independent,
and they do not convey the same amount of information.
Some of the terms of Sg1 that are not members of Sg2 may be linked in the graph. Taking
several linked terms into account would result in considering them several times. For example,
in Figure 5.4B, considering both “RNA binding” and “tRNA binding” would result in counting
twice the contribution of “RNA binding”. Therefore, we should only focus on the terms of Sg1
that do not have any descendant in Sg1 and that are not members of Sg2. Some of these terms
might be ancestors of terms of Sg2 and should be considered as common to Sg1 and Sg2. We
call Sg∗ the union of Sg and the sets of ancestors of each element of Sg. We call MPT(Sg1,
Sg2) the set of most particular terms of Sg1 compared to Sg2. MPT(Sg1, Sg2) is the set of
terms of Sg1 that do not have any descendant in Sg1 and that are not members of Sg2∗. In the
Figure 5.4B, MPT(hsa, dme) = {“tRNA binding”}. Note that MPT(hsa, dme) is composed of
one term and not five.
Using the set theory, we could define Par(Sg1, Sg2) as the proportion of elements of Sg1 that
belong to MPT(Sg1, Sg2). When computing card(MPT(Sg1, Sg2)), all the elements have the
same weight. However, considering the semantics underlying these elements, some of them may
be more informative than others and should ideally be emphasized. Different strategies, similar
to those already proposed for the computation of the semantic similarity, can be applied.
We then define PI(Sg1, Sg2), the particular informativeness of a set of GO terms Sg1 com-
pared to another set of GO terms Sg2, as the sum of the differences between the informativeness
(I) of each term tp of MPT(Sg1, Sg2) and the informativeness of the most informative common
ancestor (MICA) between tp and Sg2. The PI of a set of terms is the information that is not
shared with the other set.
PI(Sg1, Sg2) =
∑
tp∈MPT (Sg1,Sg2)
I(tp)− I(MICA(tp, Sg2)) (5.1)
In the Figure 5.4B, PI(hsa, dme) = I(tRNA binding) - I(binding). We have no sum in this
example since MPT(Sg1, Sg2) only contains one term.
We last normalize PI to compute Par(Sg1, Sg2), the semantic particularity of the set of
GO terms Sg1 compared to the set of GO terms Sg2. We define MCT(Sg1, Sg2), the set of
the most informative common terms of Sg1 and Sg2, as the set of the terms belonging to the
intersection of Sg1∗ and Sg2∗ that do not have any descendant either in Sg1∗ or in Sg2∗. In the
Figure 5.4B, MCT(hsa, dme) = {“protein transporter activity”, “protein binding”}. Par(Sg1,
Sg2) is the ratio of PI(Sg1, Sg2) and the sum of the informativeness of Sg1 most informative
terms (i.e. those Sg1-specific and those common with Sg2; the MICA in the PI formula for the
Sg1-specific guarantees that the informativeness of common terms is not counted twice).
Par(Sg1, Sg2) =
PI(Sg1, Sg2)
PI(Sg1, Sg2) +
∑
tc∈MCT (Sg1,Sg2) I(tc)
(5.2)
For the example of the Figure 5.4B, this formula becomes:
Par(hsa, dme) =
I(tRNA binding)− I(binding)
(I(tRNA binding)− I(binding)) + (I(p. trsp. activity) + I(protein binding))
(5.3)
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Several measures of informativeness have been proposed. The widely used Information Con-
tent (IC) family is based on annotations frequencies determined with an appropriate corpus
such as the GOA database. The most frequent terms are considered to be the least informative.
When considering Gene Ontology annotations, it is necessary to take the GO subsumption hi-
erarchy into account in order to also consider implicit annotations to the terms ancestors [140].
The alternative approach is corpus-independent. A term informativeness is a function of its dis-
tance to the root. It is typically used when a relevant corpus cannot be computed (for comparing
elements from several species) or does not exist (for poorly studied species). Wang’s Semantic
Value (SV) computes this type of informativeness. The relevance of the results obtained by this
approach has previously been demonstrated [193, 198].
As shown in the equation 5.3, four terms are involved in the calculation of the MF par-
ticularity of the human Exportin-5 ortholog compared to the drosophila Exportin-5 ortholog.
This comparison is cross-species, so a semantic value-based informativeness measure is relevant.
According to the previous formula, the semantic values of the terms involved in the equation 5.3
are: SV(tRNA binding) = 4.201, SV(binding) = 1.8, SV(protein transporter activity) = 2.952
and SV(protein binding) = 2.44. Consequently, we can compute: Par(hsa, dme) = 0.308.
Likewise, for Figure 5.4A, Par(hsa, rno) = 0.082.
5.2.6 Use case: Homo sapiens aquaporin-mediated transport
We aimed to study a large dataset in order to determine the frequency and the importance
of pairs of similar genes where (at least) one of them also has a high particularity value. We
used a dataset composed by 51 well-annotated human genes involved in the aquaporin-mediated
transport pathway for Homo sapiens. We used the list of all involved genes provided by the
Reactome database [237]. We computed the Wang similarity and S-Value-based particularities
for each pair of genes of this list. As the Human annotation database is one of the most
comprehensive, we also duplicated the study using Lin’s measure as an IC-based similarity, and
IC as a value of GO term informativeness for our specificity. Tables 5.1, 5.2 and 5.3 present the
average, standard deviation, minimum and maximum values of particularity measured in this
study for each branch of GO. We classified these statistics in 20 similarity categories containing
all the comparison results ranging from sim = 0.5 to sim = 0.999 with steps of sim = 0.025.
As similarity increases, particularity tends to decrease, as expected. In each 20 categories
in the human aquaporin-mediated transport pathway, some of the genes have an important
particularity compared to the others. This demonstrates that our method combining semantic
similarity and particularity identifies genes that cannot be identified using only a similarity
measure.
Figure 5.5 on page 115 illustrates this case giving the MF annotation graph of two couples
of genes: AQP8 and AQP5 in part A and AQP6 and AQP3 in part B. The corresponding
similarity and particularity values are presented in table 5.4 on page 116. Both pairs of genes
share the same set of common annotations (in blue), and their respective similarity values
were close (0.704 for AQP8 and AQP5; 0.696 for AQP6 and AQP3). As AQP8 has no specific
annotation, Par(AQP8, AQP5) = 0. Conversely, AQP5 only has two general specific annotations
and Par(AQP5, AQP8) = 0.19. However, AQP6 and AQP3 each has several precise specific
annotations:
Par(AQP6, AQP3) = 0.247 and Par(AQP3, AQP6) = 0.415. The two couples have close
similarity values regardless the method used but they show a very different particularity profile,
with much higher particularities between AQP6 and AQP3 than between AQP8 and AQP5.
The two distinct informativeness measures used to compute the particularity led to the same
conclusion.
These results confirm that among similar genes, some also have some particular functions,
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BP S-value-based particularity IC-based particularity
Similarity Average Std dev. Min Max Average Std dev. Min Max
[0.5-0.524] 0.401 0.2 0.013 0.844 0.562 0.223 0 0.904
[0.525-0.549] 0.386 0.174 0 0.794 0.532 0.284 0 0.89
[0.55-0.574] 0.347 0.199 0 0.707 0.497 0.244 0 0.886
[0.575-0.599] 0.352 0.198 0 0.798 0.502 0.241 0 0.895
[0.6-0.624] 0.315 0.203 0 0.671 0.495 0.208 0 0.794
[0.625-0.649] 0.292 0.145 0 0.629 0.437 0.25 0 0.882
[0.65-0.674] 0.299 0.162 0 0.615 0.439 0.258 0 0.876
[0.675-0.699] 0.229 0.15 0 0.529 0.451 0.216 0.039 0.839
[0.7-0.724] 0.228 0.166 0 0.631 0.403 0.239 0 0.859
[0.725-0.749] 0.22 0.145 0 0.501 0.35 0.233 0 0.727
[0.75-0.774] 0.202 0.108 0 0.482 0.403 0.207 0 0.775
[0.775-0.799] 0.178 0.118 0 0.563 0.319 0.222 0 0.671
[0.8-0.824] 0.177 0.106 0 0.418 0.31 0.209 0.043 0.646
[0.825-0.849] 0.125 0.071 0 0.327 0.258 0.184 0 0.589
[0.85-0.874] 0.105 0.131 0 0.418 0.201 0.136 0 0.625
[0.875-0.899] 0.061 0.066 0 0.248 0.179 0.123 0 0.651
[0.9-0.924] 0.039 0.061 0 0.211 0.207 0.156 0 0.614
[0.925-0.949] 0.041 0.067 0 0.248 0.193 0.181 0 0.572
[0.95-0.974] 0.032 0.041 0 0.111 0.099 0.076 0 0.196
[0.975-0.999] 0.005 0.006 0 0.015 0.077 0.152 0 0.519
Table 5.1: Particularity value statistics in 20 similarity values ranges from case 2 – BP measures.
and show that this situation can be observed throughout the full range of similarity values.
Therefore, a particularity measure is a relevant complement to a similarity measure in order to
identify similar elements that also present some particular trait.
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CC S-value-based particularity IC-based particularity
Similarity Average Std dev. Min Max Average Std dev. Min Max
[0.5-0.524] 0.353 0.233 0 0.846 0.621 0.244 0 0.911
[0.525-0.549] 0.36 0.214 0 0.819 0.707 0.15 0.185 0.977
[0.55-0.574] 0.33 0.187 0 0.799 0.64 0.202 0 0.897
[0.575-0.599] 0.341 0.185 0 0.752 0.613 0.194 0 0.896
[0.6-0.624] 0.317 0.183 0 0.754 0.621 0.165 0 0.888
[0.625-0.649] 0.268 0.18 0 0.706 0.592 0.207 0 0.852
[0.65-0.674] 0.28 0.177 0 0.656 0.553 0.227 0 0.888
[0.675-0.699] 0.24 0.177 0 0.583 0.495 0.241 0 0.845
[0.7-0.724] 0.13 0.159 0 0.543 0.466 0.24 0 0.825
[0.725-0.749] 0.196 0.151 0 0.579 0.428 0.268 0 0.82
[0.75-0.774] 0.134 0.122 0 0.484 0.383 0.246 0 0.819
[0.775-0.799] 0.15 0.127 0 0.489 0.391 0.267 0 0.768
[0.8-0.824] 0.144 0.093 0 0.269 0.19 0.187 0 0.625
[0.825-0.849] 0.133 0.123 0 0.421 0.352 0.231 0 0.73
[0.85-0.874] 0.146 0.152 0 0.373 0.255 0.216 0 0.624
[0.875-0.899] 0.051 0.051 0 0.11 0.145 0.152 0 0.381
[0.9-0.924] 0.067 0.085 0 0.269 0.095 0.095 0 0.189
[0.925-0.949] - - - - - - - -
[0.95-0.974] - - - - 0.131 0.131 0 0.262
[0.975-0.999] 0.012 0.012 0 0.024 0.049 0.049 0 0.098
Table 5.2: Particularity value statistics in 20 similarity values ranges from case 2 – CC measures.
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Figure 5.5: MF annotations of two couples of human aquaporins. Part A: AQP8 and AQP5 share
most of their annotations. Part B: AQP6 and AQP3 share numerous molecular functions, but
each gene also have particular functions. Note that the sets of common annotations are the same
in both situation, leading to close similarity values. The respective semantic particularity values
reflects AQP3 and AQP6 specific functions, enabling the identification of different patterns.
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MF S-value-based particularity IC-based particularity
Similarity Average Std dev. Min Max Average Std dev. Min Max
[0.5-0.524] 0.341 0.26 0 0.798 0.494 0.162 0.296 0.701
[0.525-0.549] 0.35 0.219 0 0.818 0.429 0.212 0 0.703
[0.55-0.574] 0.364 0.32 0 0.731 0.422 0.265 0 0.849
[0.575-0.599] 0.382 0.265 0 0.694 0.378 0.148 0.125 0.591
[0.6-0.624] 0.242 0.079 0.132 0.47 0.397 0.205 0 0.81
[0.625-0.649] 0.207 0.113 0 0.531 0.302 0.145 0.158 0.475
[0.65-0.674] 0.281 0.106 0.117 0.482 0.609 0.137 0.13 0.806
[0.675-0.699] 0.223 0.181 0 0.562 0.453 0.249 0 0.763
[0.7-0.724] 0.26 0.267 0 0.564 0.389 0.248 0 0.806
[0.725-0.749] 0.179 0.176 0 0.482 0.419 0.211 0 0.763
[0.75-0.774] 0.171 0.177 0 0.371 0.315 0.216 0 0.643
[0.775-0.799] 0.125 0.167 0 0.482 0.33 0.241 0 0.777
[0.8-0.824] 0.063 0.056 0 0.137 0.239 0.218 0 0.574
[0.825-0.849] 0.119 0.13 0 0.415 0.316 0.222 0 0.574
[0.85-0.874] 0.041 0.036 0 0.116 0.266 0.175 0 0.531
[0.875-0.899] 0.045 0.05 0 0.126 0.179 0.093 0.086 0.272
[0.9-0.924] 0.024 0.025 0 0.055 0.163 0.153 0 0.388
[0.925-0.949] 0.02 0.026 0 0.086 0.09 0.107 0 0.272
[0.95-0.974] 0.005 0.007 0 0.023 - - - -
[0.975-0.999] - - - - - - - -
Table 5.3: Particularity value statistics in 20 similarity values ranges from case 2 – MF measures.
SV-based AQP6 AQP3 IC-based AQP6 AQP3
Sim
AQP6 1 0.696
Sim
AQP6 1 0.81
AQP3 1 AQP3 1
Par
AQP6 0 0.247
Par
AQP6 0 0.531
AQP3 0.415 0 AQP3 0.388 0
SV-based AQP8 AQP5 IC-based AQP8 AQP5
Sim
AQP8 1 0.704
Sim
AQP8 1 0.8
AQP5 1 AQP5 1
Par
AQP8 0 0
Par
AQP8 0 0
AQP5 0.19 0 AQP5 0.13 0
Table 5.4: Similarity and particularity values of two couples of genes from case 2. The similarity
between AQP6 and AQP3 is very close to the similarity between AQP8 and AQP5 regardless
the method used (SV or IC-based). However, the particularity profile obtained for each couple
is very different. Again, the SV-based and IC-based methods led to the same conclusion.
5.3 Methodology: threshold determination for similarity and
particularity
As we have seen in Figure 5.5 on the previous page, AQP5 and AQP8 are similar, and so are
AQP3 and AQP6. However, AQP3 and AQP6 each exhibits some specific function, contrary
to AQP5 and AQP8. This interpretation is supported by the numeric values of their respective
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semantic semantic similarities and particularities, as shown in table 5.4 on the facing page.
In order to be able to automatize the interpretation of these values, we have to determine
the value above which two entities can be considered similar or particular.
This study focuses on a method for determining semantic similarity and particularity
thresholds for the interpretation of semantic comparisons. As we have seen in the
previous section, this interpretation consists in associating the similarity and partic-
ularity values to some similarity and particularity pattern (e.g. two genes are similar
and the second gene has a particular function). This section presents the general
principle for determining similarity thresholds on the Gene Ontology, and studies the
threshold robustness. We then show how this principle is also applicable for deter-
mining particularity thresholds on the Gene Ontology. Eventually, we performed an
extensive systematic comparison of the thresholds we computed with the traditional
0.5 over the HomoloGene database. This showed that in 5.4% of the comparisons, the
thresholds resulted in different patterns. Overall, the new thresholds increased the
detection of the “similar with some particularity” pattern, and decreased the number
of the inconsistent “similar and both particular” and “neither similar nor particular”
patterns. We then focused on the PPAR multigene family and showed that the simi-
larity and particularity patterns obtained with our thresholds discriminated orthologs
and paralogs better than those obtained using default thresholds.
In retrospect, this work is interesting because the interpretation of similarity mea-
sures usually hinges on implicit thresholds (e.g. “a similarity of 0.83 is high enough
to consider that two genes are similar”) or arbitrary ones (e.g. 0.5 for measures in
[0;1]). However, no systematic study had been carried on for determining what these
thresholds should be. This study proposes a generic method for determining the opti-
mal threshold for semantic similarity measures and their associated particularity. It is
applicable to any ontology and any semantic similarity and particularity measure. In
a previous study, we had shown that the ongoing evolution of ontologies such as GO
modifies their structure, which in turn can affect the threshold value [118]. Therefore,
the thresholds obtained by our method should be regularly updated.
This study was originally published in: Charles Bettembourg, Christian Diot, and Olivier
Dameron. Optimal threshold determination for interpreting semantic similarity and particular-
ity: Application to the comparison of gene sets and metabolic pathways using GO and ChEBI.
PloS ONE, 10(7):e0133579, 2015.
The original article performed the study on the three axis of the Gene Ontology: Biological
Process (BP), Cellular Component (CC) and Molecular Function (MF). Only BP is detailed
here.
The original article also shows that our threshold determination method is applicable to
other ontologies such as the Chemical Entities of Biological Interest ontology (ChEBI) [238].
This is not detailed here.
5.3.1 Context
In the previous section, we proposed to combine semantic similarity measures and a new seman-
tic particularity measure to improve the results of gene set analysis [96]. Data analysis often
hinges on a qualitative interpretation of the similarity values in order to contrast similar and
dissimilar pairs of genes. This discretization of the similarity and particularity values makes the
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interpretation easier. It determines whether a functional difference between two genes is or is
not marginal.
The main focus of studies to date has been on defining the measures, but there is no
extensive study on the interpretation of the values obtained with these measures.
There has neither been any systematic analysis of the optimal threshold value separating similar
from dissimilar. As a result, interpretation is frequently based on either an implicit threshold
(for example: “a similarity of 0.83 is high enough to consider that two genes are similar” without
mentioning when a value reaches this point) or an arbitrary one (typically 0.5 for measures in
[0;1] even though no mathematical property of the measures supports this choice).
There are cases where a threshold of 0.5 may be ill-adapted. For example, the similarity
value between protein tyrosine kinase 2 (PTK2) and Ubiquitin B (UBB) is 0.502 using Wang’s
similarity measure on their Biological Processes (BP) annotations. This value is just above the
intuitive mid-interval threshold. These two genes are well annotated, with 73 and 79 distinct
BP annotations, respectively. According to Entrez Gene, PTK2 is involved in cell growth
and intracellular signal transduction pathways triggered in response to certain neural peptides
or cell interactions with the extracellular matrix while UBB is required for ATP-dependent,
nonlysosomal intracellular protein degradation of abnormal proteins and normal proteins with
rapid turnover. These processes cannot be considered “similar”. Consequently, the 0.502 value
of similarity should not lead to consider PTK2 and UBB as similar genes according to the BP
they participate in.
The main factors influencing the similarity values are: granularity differences in GO, GO
topology differences between BP, MF and CC, quantity and “quality” of gene annotations, GO
temporal evolution [118]. There is a need for a systematic study of semantic measure values
in order to determine optimal similarity and particularity thresholds for the qualitative part of
functional gene set analysis. Note that the method for determining these thresholds should also
be applicable to all semantic similarity categories as well on other ontologies outside GO.
5.3.2 Objective
We propose a generic method to define suitable thresholds based on analysis of the distributions
of similarity values. We then extend this method to the semantic particularity measure. We
show that our method is applicable to a node-based and a hybrid semantic similarity measure on
the Gene Ontology as well as to the corresponding semantic particularity measures. We study
the robustness of our method by applying it to multiple sets of genes. We evaluate our method
by determining whether the new thresholds lead to different interpretations, and whether these
new interpretations are biologically relevant.
5.3.3 Similarity threshold
5.3.3.1 Method for determining similarity thresholds
We first present the general process. We then provide more details about steps two and three.
General process Figure 5.6 on page 120 illustrates the process for determining a similarity
threshold. This process is composed of three steps:
1. Define at least two different groups of genes for species of interest. Within a group, the
genes should share some common characteristics. Genes from different groups should share
as few characteristics as possible.
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2. (a) In each group, compute the similarities between each pair of genes (i.e. the intra-
group similarities). Gather all the similarity results to obtain an S distribution of
similar genes.
(b) Compute the similarities between each combination of a gene from the first group
and a gene from a second group (i.e. the inter-group similarities). Gather all the
similarity results to obtain an N distribution of non-similar genes.
3. If the S and N distributions have no overlap between the ranges (min, max), define the
threshold τsim using any value between τS (the lowest value of S) and τN (the highest
value of N). Else, there are some false negatives (FN) and some false positives (FP):
(a) Compute the proportion of FN in the S distribution for all samples of the similarity
threshold between τN to τS . In this step, consider every value under the similarity
threshold as a FN.
(b) Compute the proportion of FP in the N distribution for all samples of the similarity
threshold between τN to τS . In this step, consider every value above the similarity
threshold as a FP.
(c) For each possible threshold value, sum the FN and FP proportions obtained in steps
3a and 3b. The similarity threshold τsim is the threshold that minimizes this sum.
Constitution of the S and N distributions We ran a statistical test to determine whether
the S and N distributions obtained at step 2 are significantly different. As we cannot consider
that the S and N variances are similar, we used an unequal variance t-test (Welch’s t-test) which
is the recommended test when considering different-sized distributions like S and N. Welch’s
t-test performs better than Student’s t-test when the variances are unequal yet still performs
on a par with the Student’s t-test when the variances are equal [239]. If the test concludes that
the S and N distributions are non significantly different, the process has to be restarted at its
first step.
Overlap of the S and N distribution The minimization at step 3c has to be done on FN
and FP proportions as the N and S distributions have different sizes.
When comparing the distributions of similar genes (S) to non-similar genes (N), if the
minimum value of S is smaller than the maximum value of N, then the S and N distributions
overlap and any threshold would lead to FPs or FNs.
Figure 5.7 on page 121 illustrates the case without overlap, where min(S) = a, max(N) = b
and a > b. A similarity value greater than a means that the genes compared are similar. A
similarity value lower than b means that the genes compared are non-similar. A similarity value
between a and b means that the genes compared are nearly similar and thus require expert
opinion to interpret the result.
Figure 5.8 on page 121 illustrates the case where the S and N distributions overlap, meaning
that there are some FPs (i.e. pairs of genes from N that are non-similar but that have a similarity
value greater than a) and FNs (i.e. pairs of genes from S that are similar but have a similarity
value lower than b). In this case, a similarity value lower than a means that the genes compared
are non-similar. A similarity value greater than b means that the genes compared are similar.
Again, expert opinion would be required to interpret the result in this interval. However, in
this case, it is possible to determine the threshold value that minimizes both FP and FN.
We established a general framework that defines three thresholds values:
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Figure 5.6: Flowchart for threshold determination. 1) Define at least two distinct groups of
genes expected to be similar. 2) Compute the intra- and inter-group similarities and compile
the results into S and N distributions. If these two distributions are significantly different, the
groups of genes are relevant. 3) If S and N do not overlap, define threshold τsim using any value
between τS (the lowest value of S) and τN (the highest value of N). Else, considering every
value under the threshold as FN and every value above the threshold as FP, compute the FN
proportion in the S distribution (3a) and the FP proportion in the N distribution (3b) for all
samples of the similarity threshold between τN to τS . 3c) For each possible threshold value,
sum the FN and FP proportions obtained in steps 3a and 3b. The similarity threshold τsim is
the one that minimizes this sum.
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• τS = max(a, b) is the threshold value above which the two compared genes are similar.
There can not be any FP above τS , but there may be some FN below τS if a < b.
• τN = min(a, b) is the threshold value under which the two compared genes are non-similar.
There cannot be any FN below τN , but there may be some FP above τN if a < b.
• τsim is the threshold value located between τS and τN that that minimizes the proportion
of FP and FN. As τsim gets closer to τS , there will be more FN and fewer FP. Conversely,
as τsim gets closer to τN , there will be more FP and fewer FN. τsim has to be computed
using the proportions of FP and FN as the S and N distributions have different sizes.
Similar Non-similar
0
0.25
0.5
0.75
1
Threshold
range
a
b
Figure 5.7: Ideal case of threshold determination. The threshold should be located between
the lowest whisker of the similar distribution (a) and the upmost whisker of the non-similar
distribution (b).
Similar             Non-similar
0
0.25
0.5
0.75
1
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b
Figure 5.8: Overlap case of threshold determination. The similar and non-similar boxes overlap.
In this case, there are false-positive and false-negative results between the lowest whisker of the
similar distribution (a) and the upmost whisker of the non-similar distribution (b).
We applied this method to compute Lin’s and Wang’s semantic similarity thresholds on GO,
as well as the corresponding IC-based and SV-based semantic particularity thresholds on GO.
For all the pairs of genes compared, we used the GO annotations from the August 2013 version
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of GOA. We computed Lin’s similarity with the GOSemSim R package [240] (version 1.18.0)
using its GO and IC tables and the best-match average approach to compare genes. Pesquita
et al. showed that the best-match average approach performs best [198]. We computed Wang’s
similarity, IC-based particularity and SV-based particularity using an in-house implementation
of each measure and the August 2013 version of GO.
5.3.3.2 BP similarity threshold using two groups of similar genes
We studied the similarity values obtained when comparing genes known to be functionally close
and genes without functional proximity. This study was performed using a hybrid semantic
similarity measure (Wang) and a node-based measure (Lin).
Figure 5.9 on the facing page presents the distribution of the BP similarity values obtained for
two intra-family comparisons and the corresponding inter-family comparisons. The two PAN-
THER families were “neurotransmitter gated ion channel” (pthr18945) and “tyrosine-protein
kinase receptor” (pthr24416).
As expected, similarity values obtained using either Wang’s (Figure 5.9A) or Lin’s measure
(Figure 5.9B) were significantly higher in the intra-family comparisons than the inter-family
comparisons (Welch’s t-tests). We observed an overlap between the S and N distributions,
which corresponds to the situation shown in Figure 5.8 on the previous page. τN was located
at the lowest whisker of the intra-family S blue box, i.e. 0.096 with Wang’s measure and 0.364
with Lin’s measure. τS was located at the upmost whisker of the inter-family N yellow box, i.e.
0.519 with Wang’s measure and 0.588 with Lin’s measure.
We also determined the optimal similarity threshold value τsim that minimizes the sum of
FP and FN proportions. Figure 5.10 on page 124 reports the results for Wang’s and Lin’s
measures. The minimum ordinate value of the curves gives the threshold for BP using Wang’s
(0.42) and the Lin’s (0.49) measures, respectively.
We used a similar approach for CC and MF; see original article.
5.3.3.3 Robustness of threshold determination
The more groups we build to constitute the S and N distributions, the more reliable the thresh-
olds obtained become. We generalized the above-described process using six groups of similar
genes for BP in order to determine τS , τN and τsim for Wang’s and Lin’s measures.
We computed the S distribution gathering the similarity values of each pair of genes inside
six different PANTHER families. These families were “histone h1/h5 (pthr11467)”, “g-protein
coupled receptor” (pthr12011), “neurotransmitter gated ion channel” (pthr18945), “tyrosine-
protein kinase receptor” (pthr24416), “phosphatidylinositol kinase” (pthr10048) and “sulfate
transporter” (pthr11814). We computed the fifteen distributions corresponding to all the com-
binations of genes similarity values from two of the previous six families. Each of these distri-
butions is composed of the similarity values between each gene from the first family and each
gene from the second family. We combined all these inter-family similarity values into a global
N distribution.
In each previous case, the S and N distributions overlapped so defining a threshold in
this interval yields some FPs and some FNs. We determined the optimal similarity threshold
value that minimizes the sum of FP and FN proportions. Figure 5.11 on page 124 reports the
results for Wang’s SV-based measure and for Lin’s IC-based measure. The minimum ordinate
value of each curve gives the threshold for BP, MF and CC using Wang’s and Lin’s measures,
respectively. These similarity thresholds differed according to similarity measure used. They
also differed between BP, MF and CC. This can be explained by the different level of complexity
between these three branches [118]. It is possible to use one of the three proposed thresholds
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Figure 5.9: Intra- and inter-family semantic similarity distributions using two families of similar
genes. Part A presents the results obtained using Wang’s measure and part B presents the
results obtained using Lin’s measure. In both parts, the left side separately presents the two
intra-family distributions in blue and the inter-family distribution in yellow. The right side
presents the S distribution that gathers all the intra-family similarity values in blue and the N
distribution that gathers all the inter-family similarity values in yellow.
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Figure 5.10: Determination of Wang’s similarity threshold (left) and Lin’s similarity threshold
(right) using two families of similar genes. The minimum of false-positive and false-negative
proportions gives the similarity threshold (τsim).
(τN , τS and τsim) depending on the accuracy needed to interpret the semantic similarity results.
None of these thresholds is equal to the intuitive “default” threshold of 0.5.
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Figure 5.11: Determination of Wang’s similarity threshold (left) and Lin’s similarity thresh-
old (right). The minimum of false-positive and false-negative proportions gives the similarity
threshold (τsim). The overlapping parts of the boxplots (between τN and τS) are shown in the
lower part of the figure. The thresholds are located between the similar and non-similar boxes.
We validated our study using a leave-one-out approach that consisted in successively re-
computing the thresholds using all the sets but one. This approach provides an evaluation of
threshold stability.
The thresholds varied slightly over the different datasets. BP similarity threshold varied
between 0.4 and 0.435. MF similarity threshold remained stable at 0.41, except when not
taking into account the family of genes related to neurotransmitter gated ion channels (0.49).
CC similarity threshold was between 0.475 and 0.515.
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5.3.4 Particularity threshold
5.3.4.1 Method for determining particularity thresholds
In addition to the similarity thresholds determination, we used the same approach to compute
semantic particularity thresholds on BP, CC and MF in order to determine the comparison
profile of two genes G1 and G2. The procedure consisted in comparing each value of the triple
(Similarity(G1,G2); Particularity(G1,G2); Particularity(G2,G1)) with its respective threshold
(noted“+”if the value is greater than the threshold, and“-”otherwise). The results of comparing
two genes on their similarity and particularity values can be classified into eight distinct patterns
described in Table 5.5. A comparison should not result in a “+ + +” nor a “- - -” pattern.
Indeed, a “+ + +” pattern would mean that the two genes compared share enough features to
be considered similar yet, at the same time, that each have enough particular features to both
be considered particular. Conversely, a “- - -” pattern would mean that the two genes compared
are neither similar nor particular.
Notation sim(A, B) par(A, B) par(B, A)
+ + + > τsim > τpar > τpar
+ + - > τsim > τpar < τpar
+ - + > τsim < τpar > τpar
+ - - > τsim < τpar < τpar
- + + < τsim > τpar > τpar
- + - < τsim > τpar < τpar
- - + < τsim < τpar > τpar
- - - < τsim < τpar < τpar
Table 5.5: Patterns of similarity and particularity. The results of a semantic comparison of gene
annotations can be classed into eight macro-patterns according to similarity and particularity
values. The first sign is a “+” if the similarity is greater than or equal to the similarity threshold
τsim, or a “-” otherwise. The two other signs depends on the two particularity values, a “+” for
a particularity greater than the particularity threshold τpar or a “-” otherwise.
We applied the threshold determination process described in Figure 5.6 on page 120 to
obtain a particularity threshold. For the first step, we composed the same gene groups as those
used to compute the similarity threshold. For the second step, we computed all the intra-group
and inter-group particularity values between all possible pairs of genes. At the third step, we
did not consider any FPs nor FNs as genes belonging to the same group can have some degree of
particularity even if they are similar. However, knowing the similarity threshold, we computed
the proportion of “+ + +” and “- - -” patterns found in the results while particularity threshold
varied. We computed the particularity threshold τpar using the similarity threshold τsim. For
step 3c, we summed the “+ + +” and “- - -” proportions for each possible particularity threshold
value. The particularity threshold τpar was the one that minimized this sum.
5.3.4.2 Computation of particularity thresholds
The variation of the “+ + +” and “- - -” profiles in our datasets was studied using the similarity
threshold τsim obtained in the previous section and sampling the value of τpar, the particularity
threshold. Table 5.6 on the following page gives the particularity thresholds (τpar) minimizing
the sum of “+ + +” and “- - -” patterns for SV-based and IC-based approaches.
These thresholds differed between BP, MF and CC and between approaches (Figure 5.12).
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SV-based particularity threshold IC-based particularity threshold
BP 0.515 0.68
MF 0.485 0.66
CC 0.335 0.6
Table 5.6: Semantic SV-based and IC-based particularity thresholds. These thresholds minimize
the proportions of non-informative “+ + +” or “- - -” patterns according to Table 5.5.
We performed the leave-one-out study in order to assess stability of the particularity threshold
by removing one gene set from our datasets and re-computing the particularity threshold. This
analysis was performed on BP, MF and CC. The thresholds varied slightly among the different
datasets:
• BP particularity threshold was between 0.49 and 0.515 ;
• MF particularity threshold was between 0.35 and 0.485 ;
• CC particularity threshold was between 0.28 and 0.335.
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Figure 5.12: Determination of the SV-based particularity threshold (left) and the IC-based
particularity threshold (right). The minimum of “+ + +” and “- - -” pattern proportions gives
the particularity threshold.
5.3.5 Evaluation of the impact of the new threshold on HolomoGene
The evaluation study involved first quantifying the extent of the changes resulting from using
the threshold computed by our method instead of the default 0.5 and then determining whether
these changes are biologically relevant.
5.3.5.1 Large-scale evaluation of the impact of threshold changes
We evaluated the impact of our new GO similarity and particularity thresholds over the whole
HomoloGene database intra-group gene comparisons. HomoloGene is a system that automati-
cally detects homologs, including paralogs and orthologs, among the genes of 21 fully-sequenced
eukaryotic genomes [241].
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Table 5.7 summarizes the results for BP. It provides the number of pairs of genes changing
from one pattern of Table 5.5 to another using τsim and τpar instead of the default value of
0.5. We have not distinguished the “+ + -” and “+ - +” categories nor the “- + -” and “- - +”
categories as the order of particularity values in the results of this study is meaningless. All
categories of the pattern described in Table 5.5 were impacted by the change of threshold. The
greatest size increase concerned the “+ + - or + - +” category (+26.2% for BP). The number
of “+ + +” and “- - -” cases, that are the least-informative cases, decreased (-11.2% for BP).
BP
. 
+ - - + + - or
+ - +
+ + + - + + - + - or
- - +
- - - Total using
0.5 thresholds
+ - - 268,471 0 0 0 0 0 268,471
+ + - or + - + 1,780 54,168 0 0 0 0 55,948
+ + + 7 270 2,623 0 0 0 2,900
- + + 2 154 2,254 10,374 304 1 13,089
- + - or - - + 177 16,027 0 0 32,578 102 48,884
- - - 2,883 0 0 0 0 1,401 4,284
Total using
new thresholds
273,320 70,619 4,877 10,374 32,882 1,504 T= 393,576
Table 5.7: Evolution in patterns in results on HomoloGene intra-group BP compar-
isons. Numbers of pairs of genes changing from one pattern to another when considering our
optimal similarity and particularity thresholds instead of the default value of 0.5. The most
important transition consists in 16,027 results moving from the “- + - or - - +” category (size
decreased by 32.7%) to the “+ + - or + - +” category (size increased by 26.2%). The new
thresholds give more “+ + +” results but fewer “- - -” results. Globally, the sum of the numbers
of the “+ + +” and “- - -” patterns has decreased (-11.2%).
Overall, on BP, CC and MF, the change of thresholds:
• deeply impacted the distribution the HomoloGene intra-group comparison results between
the different patterns;
• resulted in important transition from the “- + - or - - +” to the “+ + - or + - +” patterns;
• resulted in fewer “+ + +” and “- - -” cases.
Analysis of relevance on the PPAR multigene family
We measured similarity and particularity values of PPARα, PPARβ and PPARγ between six
species. Each gene was only annotated by one or two CC terms, so we kept CC results out of
this study. All our similarity values were greater than τsim (which is not surprising as we are
considering genes from the same family). Consequently, in order to emerge similarity differences
between orthologs and paralogs, we had to use the more stringent τS . This threshold guarantees
that the results above it indicate two similar genes. However, the only conclusion that can be
inferred for the gene comparisons resulting in values between τsim and τS is that there is doubt
over whether these genes are similar. The results of inter-orthologs comparisons systematically
matched a “+ - -” pattern, as expected. In contrast, the results of inter-paralog comparisons
included some values lower than τS and greater than τpar, resulting in“+ + -”, “- + -”and“- - +”
patterns. Consequently, the thresholds we computed for similarity and particularity measures
resulted in patterns consistent with the ortholog conjecture for the PPAR gene family.
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5.4 Synthesis
What we learned
• Similarity and particularity metrics allow to provide an objective measure for the com-
parison of two elements.
• This process can be improved by using ontologies in order to take existing knowledge into
account.
• Using semantic particularity as a complement to semantic similarity further refine the
analysis when peculiarities are also of biological interest.
• Having a numeric value for similarity and particularity is good because it supports ranking
the elements to compare. In our study, we were interested in sorting the pathway steps
from the most similar to the least, and among the similar ones, from the most particular
to the least.
• Surprisingly, the next step in analysis involved a coarse discretization in order to dis-
tinguish the similar elements from the dissimilar ones, and the particular from the non-
particular. Although this is done on a regular basis in life science articles, no sound method
existed to determine how similar (resp. particular) two elements should be for being con-
sidered similar (resp. particular). We proposed an empirical method applicable to any
similarity and particularity metrics, over any ontology. This method generated threshold
that are different from the usual implicit thresholds, biologically-relevant, rather robust
(i.e. choosing a slightly different threshold only has a small impact on the performances)
and that can be recomputed when ontologies evolve.
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Chapter 6
Conclusion and research perspectives
Since 2003, my research interests have gradually evolved from the representation of symbolic
knowledge in semantically-rich formalisms and the associated reasoning to the development of
similarity and particularity-based reasoning on semantically simpler ontologies. This transition
resulted from both my growing interest in bioinformatics, and from the fortunate conjunction
at that time of biological data becoming increasingly available as part of the (open) linked data
initiative (which is more difficult in the medical domain), and of the release of SPARQL1.1.
Indeed, in bioinformatics answering biologically-relevant questions involves data integration
and comparison rather than classification, and, as we have seen, SPARQL1.1 supports most of
the needs for querying and integrating data annotated with simple ontologies.
In this context, the reasoning methods I developed gave encouraging preliminary results
on several projects Dyliss is currently involved in. However, both our production and usage
of linked data is still fragmentary, ad hoc and incomplete. It is becoming clear that in each
project, we are facing the same limitations.
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My research perspectives build on my previous works to tackle the challenges of pro-
ducing and querying linked data, as well as developing semantic-based methods for
analyzing complex life science data.
The first strategic requirement consists in setting up an environment for representing
our research data as linked data, ideally with the support of the GenOuest platform.
This task encompasses the conversion of data as well as the development of a virtual
research environment. Beyond the engineering aspect, the open research challenge lies
in the development of a consistent data and metadata management methodology.
The second strategic requirement consists in querying these data. Again, we expect
that some data analysis patterns are common to several projects, which requires to
store and share them, independently from the datasets. Moreover, we should be able
to formulate new relevant biological questions that used to be out of reach when data
were more scarce and when combining and processing data was more difficult than it
currently is (and will be as we make progress on the first requirement). Eventually,
the combination of structurally and semantically-rich data becoming available and of
complex queries call for tools capable of abstracting this complexity for the user.
The third strategic requirement focuses on methods for analyzing the data uncovered
by the complex queries of the previous requirement. The results of such queries are
typically so large and complex that they are themselves useless, until we develop ded-
icated analysis methods. Again, this is a general problem, so I expect these methods
to hinge on a core of generic reasoning primitives that will probably involve domain
knowledge for interpretation and will be applicable to multiple projects, at least for
metabolic network analysis.
6.1 Producing and querying linked data
Over the last few years, most of the major life science data and knowledge consortia have pro-
vided access to some RDF version of their data: pathway databases such as Reactome [237],
Wikipathway [242], *CYC [243] are available in the BioPAX format [244, 245, 246] (as they re-
main incomplete, their integration is desirable but remains a challenge of its own [247, 248, 249]).
Others are even providing dedicated SPARQL endpoints that will support federated queries:
Uniprot1 [250], resources from the EBI2 [251] (currently BioModels, BioSamples, ChEMBL, Ex-
pression Atlas and Reactome and others are in preparation) or PubChemRDF [252]. Moreover,
initiatives such as identifiers.org3 simplify the integration of life science data identifiers from
different sources [64]. Eventually, repositories such as bio2rdf4 [61, 63] and BioPortal5 [49] offer
some uniform access to respectively 35 datasets and 442 ontologies.
However, all these are typically resources that we use when analyzing our data, but none
our data themselves are currently in RDF. This makes the analysis cumbersome as we have to
develop ad hoc conversion scripts that hamper exploratory work.
I intend to address the following two challenges that we encounter repeatedly:
• incorporate the data we work with into the linked data framework for our direct
benefit (analyzing our data better and giving them a better visibility) as well as for the
1http://sparql.uniprot.org/
2https://www.ebi.ac.uk/rdf/platform
3http://identifiers.org/
4https://github.com/bio2rdf
5http://bioportal.bioontology.org/
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benefit of the community [8]
• when (linked) data are here, we still have to invent the querying that takes full
advantage of the linked data framework. This encompasses two problems: (1) a
bioinformatics one about formulating new biological questions that are relevant but used
to be out of reach for lack of available data and querying capabilities [253], and (2) a
computer science one about providing an infrastructure for representing these data and
for supporting their new querying (which will most probably involve the Semantic Web).
I expect to focus on the first one but will rely extensively rely on the second one, with
some possible marginal contributions.
6.1.1 Representing our data as linked data
Incorporating our data in the linked data framework consists in storing and sharing our data
as well as linking them to other resources such as genes, pathways, RNA fragments, taxons,
molecules or proteins. While data storage will consist in using available technical solutions such
as Virtuoso6 or Fuseki7, making explicit the relations to other resources and integrating every-
thing into an E-Science context that remains to be developed goes beyond simple engineering.
As we see below, this challenge is common to many projects.
6.1.1.1 Converting data into RDF
MiRNAdapt on aphids The MiRNAdapt project8 led by Denis Tagu from INRA aims at
studying how aphids’ gene expression adapt to changes of the local environment such as sea-
sons, and particularly genic regulation during pea aphid embryogenesis. The project produced
large quantities of data about messenger RNA, microRNA, piRNA and long non-coding RNA
expression levels as well as epigenetic marks such as histone and DNA methylation. These data
are stored in 16 tabulated flat files totaling 6,160,765 lines. Analyzing these data requires to
be able to query them uniformly even if they were obtained separately, as well as connecting
then with external resources [254]. Currently, the biologists import the files as spreadsheets for
being able to process them. The processing must be manually adapted and repeated for each
new query, which usually takes between two and three hours each time before computation can
take place.
Since 2014, with Fabrice Legeai, Anthony Bretaudeau and Charles Bettembourg, we im-
ported the information in RDF (45,278,179 triples) and stored it in a triplestore [101]. This
process only needs to be done once. We were then able to write SPARQL queries for each 6 use
cases, which demonstrated that SPARQL has the necessary expressivity. Writing each query
took only a few minutes, and the queries can be reused and adapted, which simplifies analysis,
particularly exploratory hypotheses. For this proof of concept, the flat file conversion in RDF
was performed with ad hoc scripts. We are investigating how to streamline this process, e.g.
using tarql9 or directly in the triplestore10.
EPICLUB on Brassicaceae The EPICLUB project led by Mélanie Jubault from INRA
aims to determine the respective parts of epigenetics and genetics in Brassicaceae (cabbages,
broccoli, cauliflower, Brussels sprouts, radishes,...) response to clubroot, a common disease
6http://virtuoso.openlinksw.com/
7https://jena.apache.org/documentation/fuseki2/
8http://www6.rennes.inra.fr/igepp_eng/RESEARCH-TEAMS/Ecology-and-Genetics-of-
Insects/Projects/MiRNAdapt2
9http://tarql.github.io/
10http://virtuoso.openlinksw.com/dataspace/doc/dav/wiki/Main/VirtCsvFileBulkLoader
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caused by a protist called Plasmodiophora brassicae. The project requires an infrastructure for
managing and integrating a large quantity of data including Brassicaceae genome sequences with
their orthology and synteny relations, resistance major genes and QTL, and transcriptomics,
metabolomics and epigenomics data. Currently, the data are available as text and csv files as
well as spreadsheets. With Aurélie Évrard and Mélanie Jubault, we will follow an approach
similar to the MiRNAdapt project.
Patient care trajectories The PEPS platform (plateforme pharmaco-épidémiologie des pro-
duits de santé) led by Emmanuel Oger (CHU Rennes) aims at providing an infrastructure
for performing large scale pharmacoepidemiology studies based on French national medico-
administrative databases such as SNIIRAM (Système National d’Information Inter-Régime de
l’Assurance Maladie, the French equivalent to National Health Insurance Cross-Schemes In-
formation System NHI-CIS) for healthcare reimbursement (e.g. drug prescriptions, medical
transports) and PMSI (Programme de Médicalisation des Systèmes d’Information) from hos-
pital discharge information systems (e.g. diagnosis and procedures). In collaboration with
Nolwenn Le Meur and Yann Rivault (EHESP), we focused on detecting complications for pa-
tients having an day surgery (i.e. a surgery that does not require an overnight hospital stay)
between January and December 2012, and their follow-up data over 2013. The dataset con-
cerned 1,389,271 patients and 1,636,445 instances of procedure. We wanted to determine which
patients had an outpatient surgery, and among them which ones had a pattern suggesting a
possible complication (for example an antibiotics prescription or another hospitalization in the
following days). The data were too big for being handled by R (which was not a surprise),
and our need to use ontologies about procedures, drugs or diseases made the use of a relational
database impractical.
We converted the data in RDF and linked with ontologies such as ATC for drugs, CCAM
for procedures and ICD10 for diagnosis. We wrote SPARQL queries to retrieve the patients of
interest and their related information [105]. We used R to perform the statistical analysis in
order to identify determinants of complications. As in the two previous projects, this turned
out to be a relevant solution that supported the need for data integration and data analysis on
large datasets. Further work will continue on data representation and on data analysis with
the beginning of Yann Rivault’s PhD thesis that will focus on the analysis of patients’ care
trajectories. This will expand a previous work with Gautier Defossez and Alexandre Rollet
on the temporal representation of care trajectories of breast cancer patients using data from a
regional information system [255], and will benefit from a collaboration with Thomas Guyet,
David Gross-Amblard and Yann Dauxais (IRISA).
Synthesis These projects require some graph querying and traversal capabilities, as well as
some integration with other resources, for which RDF is well adapted [22]. Some of the analysis
methods in use or in development also require some graph topology functions such as finding the
maximal cliques, or involve Answer Set Programming, for which RDF may not be the optimal
data representation format. Determining whether the data should be stored natively in RDF
and exported to other formalisms, or the other way around remains to be investigated for the
definition of Dyliss data management plan.
With the help of the GenOuest11 engineers, these data should be deployed on the GenOuest
platform.
11http://www.genouest.org/
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6.1.1.2 Incorporating linked (meta)data into a Virtual Research Environment
All the efforts presented in the previous section are not specific to our team. As we have seen
in sections 1.1 and 1.2, life sciences is one of the many domains concerned with the data deluge.
Researchers are generating increasing quantities of data in data silos and we are all trying
as hard as we can to make things even worse by interconnecting these silos. In translational
research, accessing and combining data is a challenge as important as the biological questions we
try to answer. We have seen throughout this manuscript that the Semantic Web is valuable for
automatically processing the data in order to answer biological questions [50]. All the efforts for
managing the data of the projects presented in the previous sections also suggest that manual
data management specific to each project will fail globally because of both the
quantity and the complexity. Tending the scientific information ecosystem should
be done systematically.
E-Science is “both the pursuit of global, collaborative in silico science and the computa-
tional infra-structure to support it.” [256]. In this context, systematic data management relies
on metadata associated to the raw data as well as the data produced along the processing
steps of the analysis. This is typically supported by Virtual Research Environments (VRE). In
bioinformatics, the data processing steps are usually handled by a workflow engine associated
with the VRE, such as the Taverna [257] engine with myExperiment [258], or more recently
Galaxy12 [259] and its data manager [260] with HubZero13.
With the VRE providing an integrated framework for storing the data and the associated
metadata, as well as workflow descriptions that can be executed on the data, the next challenge
lies in metadata generation. Currently, these metadata are optional: they are not required by
any step of the analysis and except for the most simple ones such as the date or the creator, it
is up to the user to provide them to the VRE for meeting traceability requirements of for an
easier data retrieval. However, this will never scale-up for handling large quantities of data.
With Yvan Le Bras (plateforme GenOuest), Alban Gaignard (institut du thorax Nantes),
Audrey Bihouée (plateforme bioinformatique BiRD Nantes), François Moreews (INRA Rennes)
and Olivier Collin (plateforme GenOuest), we are working on integrating a semantically-rich
metadata (typically based on PROV14, ISA [261] and EDAM [262]) generation capability into
the VRE data management. We hypothesize that the metadata associated with the result of
the execution of a workflow can be automatically determined from the annotations of the input
data and of the workflow and we propose to embed this capability into the workflow engine
itself [263].
Among the strategies we are considering, I propose to:
• create a generic “semantic metadata wrapper” service taking as parameters (1) the iden-
tifier of a “regular service”, (2) a semantic description of this regular service (the service
identifier can be a part of the semantic description) and of its parameters and (3) a se-
mantic description of the workflow invoking the regular service. The semantic wrapper
service is responsible for invoking the regular service, and for generating the metadata
associated with the result.
• create a service converting a “regular” workflow into a “semantic metadata-enabled” work-
flow by embedding each service of the original workflow into its semantic metadata wrapper
counterpart.
This solution is compatible with any workflow engine, and does not require to hack into the
internals of the engine. It requires a minimal amount of manual annotation: once for each
12https://galaxyproject.org/
13https://hubzero.org/
14http://www.w3.org/TR/prov-o/
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service and once for each workflow. Moreover, a user can use the regular version of the services
when creating a new workflow and then generate the semantically-enabled version for production
purpose once he is satisfied. Eventually, the generic wrapper that can possibly be refined using
an approach similar to inheritance by creating as many specific wrappers generating special
annotations and calling the generic wrapper for handling the general annotations.
6.1.2 Querying linked data
In all the projects mentioned in Section 6.1.1.1, writing SPARQL queries greatly simplifies the
analysis. However, in spite of the benefits, this in turn suffers from two main limitations: (1)
writing these queries requires a mental representation of the data underlying structure, i.e. what
kinds of entities are present and what are the typical relations between them, and (2) not all
end-users are willing to take up learning SPARQL, and find it all the more difficult to do so
because they also lack (1).
Representations of the structure of the data available at SPARQL end-points are typically
provided by additional diagrams (e.g. for Uniprot15, Reactome16 or ChEMBL17). However,
these diagrams are hand-crafted and not always available, which makes the manual exploration
of an endpoint cumbersome.
When a diagram is available, the user still has to write SPARQL queries, which (s)he may
not be familiar with. This typically consists in writing the SPARQL code in the text area of a
website. The most user-friendly solutions feature syntax-highlighting but are still regarded as
“too technical”, even if some typical example queries and templates are provided. Initiatives such
as Sparklis18 aim at making exploration easier [264]. Sparklis allows the user to build a query
step by step by iteratively selecting the relation and the neighbor of a node of interest It was
still perceived as lacking ergonomy. Moreover, because of performance constraints, infrequent
properties and neighbors may not be presented for a node of interest, which may give the
misleading impression that some information is not present in the data.
I propose an unified solution to both problems based on the representation of the data present
on a triplestore as a graph, and on a query-building principle using paths on the abstraction
graph. Of course this solution should be generic, and will be applicable (among others) to all
the projects mentioned in Section 6.1.1.1.
6.1.2.1 RDFmap: building an abstraction graph of data
RDFmap aims at building automatically a graph-based abstraction of a dataset that would be
similar to the hand-crafted diagrams used currently.
The general principle consists in identifying the main classes, and in creating a link between
two classes if an instance of the first class is associated to an instance of the second class. The
whole process can be performed as a SPARQL query. The first results are encouraging. Some
work is still required for improving identification of the main classes and for determining which
relations between them should be represented.
6.1.2.2 AskOmics: building SPARQL queries as paths on the abstraction graph
AskOmics is being developed by Charles Bettembourg and Fabrice Legeai as a contribution to
the MiRNAdapt project [101], but should be applicable to any RDF dataset.
15http://sparql.uniprot.org/images/diagrams/uniprot.jpg
16https://www.ebi.ac.uk/rdf/sites/ebi.ac.uk.rdf/files/documents/reactome_simplified.png
17https://www.ebi.ac.uk/chembl/extra/RDF/chembl_18_rdf_summary.png
18http://www.irisa.fr/LIS/ferre/sparklis/
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It is based on an abstract representation of the MiRNAdapt data which was created manually
but should be replaced by the result of RDFmap in the future. AskOmics uses D3.js19 to provide
a visual representation of the abstraction as a graph. By starting from a node of interest and
iteratively selecting its neighbors, the user creates a path on the abstraction graph. This path
can then be transformed into a SPARQL query that can be executed on the original dataset.
This approach presents several benefits. First, the abstraction graph only needs to be
generated once and does not need to be computed on-the-fly for each node, contrary to Sparklis.
Second, the whole query building only takes place on the abstraction graph, which is much
smaller than a typical RDF dataset. Third, intermediate count() queries can be executed on
the dataset to provide on-the-fly hints to the user (or for debugging assistance). Fourth, the
same principle can be applied on an optional (manually-generated) “interface layer” on top the
abstraction graph in order to hide parts of the abstraction that may not be relevant to the user
or to provide “shortcuts” in order to avoid property paths (i.e. composition of relations) ; there
can be different interface layers depending on the types of users.
6.2 Analyzing data
I joined the Dyliss team at IRISA in 2013. The team focuses on bioinformatics and systems
biology. The main goal in biology is to characterize groups of genetic actors that control the
phenotypic answer of non-model species when challenged by their environment. Unlike model
species, only a limited prior-knowledge is available for these organisms [30] together with a small
range of experimental studies (culture conditions, genetic transformations). To accommodate
these limitations, the team explores methods in the field of formal systems, more precisely in
knowledge representation, constraints programming, multi-scale analysis of dynamical systems,
and machine learning. Our goal is to take into account both the information on physiological
responses of the studied species under various constraints and the genetic information from their
long-distant cousins.
The challenge to face is thus incompleteness: the limited range of physiological or genetic
known perturbations is combined with an incomplete knowledge of living mechanisms involved.
We favor the construction and study of a “space of feasible models or hypotheses” including
known constraints and facts on a living system rather than searching for a single optimized
model. We develop methods allowing a precise investigation of this space of hypotheses. There-
fore, the biologist will be in position of developing experimental strategies to progressively shrink
the space of hypotheses and gain in the understanding of the system. This refinement approach
is particularly suited to non-model organisms, which have specific and little known survival
mechanisms. It is also required in the framework of an increasing automation of experimenta-
tions in biology.
By exploring the complete space of models, our approach typically produces numerous can-
didate models compatible with the observations. My contribution consists in investigating
to what extent domain knowledge can further refine the analysis of the set of mod-
els by identifying classes of similar models, or by selecting the models that best fit
biological knowledge. We anticipate that this will be particularly relevant when studying
non-model species for which little is known but valuable information from other species can be
transposed or adapted.
Sections 6.2.1 and 6.2.2 present ongoing works on the selection of relevant candidates when
reconstructing metabolic pathways and on the analysis of TGF-β signaling pathways. Although
the application domains are different, the reasoning method is strikingly similar in both cases.
19http://d3js.org/
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Section 6.2.3 presents my medium to long range main research goal, that consists in defining a
more generic analysis framework combining topological and semantics information.
6.2.1 Selecting relevant candidates when reconstructing metabolic pathways
This work is a contribution to the Idealg project20 (investissement d’avenir). It is a collaboration
with Sylvain Prigent, Anne Siegel and Pierre Vignet. The idealg project aims at having a better
overall understanding of the three groups of macroalgae (green, red and brown) in order to
develop the algae sector in Brittany. This includes especially the study of species specific to
each of the three major groups of algae, Ectocarpus siliculosus in the case of brown algae.
A part of this projects consists in proposing a complete metabolic network for Ectocarpus
siliculosus. A metabolic network is the complete set of physical and physiological reactions that
explain the overall functioning of a cell. This metabolic network has to have a good quality
and has to be compatible with biological observations. It must especially be able to explain
the presence of 56 compounds of interest for biologists. Reconstructing metabolic networks is
a labor-intensive task requiring numerous biological experiments. Most current efforts relied
massively on experts manual intervention either in plants [265, 266, 267] or in animals [268].
Ectocarpus siliculosus not being a “model species”, numerous portions of metabolic path-
ways are unknown [30]. The traditional approach is not applicable in this context because the
data are too scarce, would take too long to produce and lack a large-enough community to
validate. A classic strategy consists in completing the pathways using reactions observed in
other species. However, there are many reactions from many species, spread in several com-
plementary databases [247]. Determining the best candidates from a biological point of view
requires incorporating prior knowledge [269] but remains an open challenge, specially for large
scale networks [270, 271, 272, 273]. Existing symbolic knowledge represented in ontologies can
contribute to address the problem of missing information [274, 275] and the problem of pro-
cessing large quantities of interdependent data [45]. A previous study used MetaCyc [276] as
a source of candidate reactions to complete the metabolic network [99]. The smallest set of
MetaCyc reactions to be added to the reconstructed network in order to produce the 56 target
proteins of interest is composed of 42 reactions. However, a systematic exploration produced
2400 possible minimal sets that are all structurally equivalent. Together, these 2400 candidate
sets cover 70 reactions, so they have a large overlap.
We have developed a knowledge-based method that reduces the number of candidate sets
from 2400 to 48. It consists in creating a graph of mutually-exclusive reactions (i.e. couples
of reactions that do not belong to any candidate metabolic network) in order to retrieve the
maximal cliques. Composing a candidate network requires to select one of the reactions for
each clique. We then developed a reasoning method based on ontologies in order to determine
for each clique a subset of the reactions that fit best with biological knowledge. Eventually, we
only select the candidate networks composed of these reactions. We are currently performing
a formal evaluation of this strategy on Escherichia coli by artificially degrading metabolic
networks before reconstructing them (i.e. to assess whether we selected the relevant candidates
and discarded the not-so relevant ones) and investigating further enhancements.
6.2.2 Analyzing TGF-β signaling pathways
This project is a collaboration with Nathalie Théret with whom I supervise Jean Coquet’s PhD
thesis, Geoffroy Andrieux, Anne Siegel and Jacques Nicolas. The transforming growth factor
beta 1 (TGF-β1) protein plays a major role in immune response and in tumor development, as an
20http://www.idealg.ueb.eu/
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antagonist in the early stages and as a promoter in the advanced stages [277]. TGF-β pleiotropic
effects are linked to the complex mechanisms regulating its activity. These mechanisms are
therefore potential therapeutic targets.
Geoffroy Andrieux developed the most exhaustive discrete model of TGF-β signaling path-
ways. It contains 9,248 reactions composed of 9,177 components. This model allowed him to
identify 15,934 sets of influence composed of chemical reactions and activating some of the 145
genes influenced by TGF-β [278]. The size and the internal complexity of this network prevent
its exploitation by biologists.
We are conducting a systematic analysis in order to identify:
• sets of genes activated by similar sets of influence. The relevance of these gene sets will
depend on the biological processes of the diseases associated with the genes.
• families of similar sets of influence (i.e. activating the same genes or genes involved in
similar processes).
• genes or sets of influence common to several sets and playing the role of interface. Such
elements are of potential interest for understanding the transition of TGF-β role from
tumor antagonist to tumor promoter.
This analysis consists in a systematic search of associations, and also relies on external domain
knowledge such as biological processes or diseases. This knowledge is used both in the search
of association and on the interpretation of results.
The analysis consists in determining cliques of genes activated by the same sets of influence,
and cliques of sets of influence activating the same genes. We then determine the cliques
homogeneity according to biological processes or diseases, and select the most interesting for
further analysis by biologists.
6.2.3 Data analysis method combining ontologies and formal concept analy-
sis
The method for selecting candidates after metabolic pathways reconstruction (section 6.2.1) and
the method for analyzing signaling pathways (section 6.2.2) both consist of a topological analysis
of a domain-dependent graph, followed by a semantic-based method for grouping solutions of for
reducing their number. I intend to develop a refined and unified analysis method. The Confocal
project (PEPS CNRS FaSciDo 2015) with Anne Siegel, Jacques Nicolas et Nathalie Théret,
Jean Coquet, Amedeo Napoli (LORIA Nancy) and Élisabeth Rémy (Institut de Mathématiques
de Luminy) is a first step in this direction.
In the biomedical domain, the classical approaches for analyzing annotated elements rely on
domain knowledge and semantic similarity values in oder to perform hierarchical clustering [279,
280, 22]. Because data are noisy and incomplete, as mentioned previously, special approaches
have been developed [281, 282].
Limitation 1: classical biclustering methods do not permit partial overlap of clusters, which
is not compatible with the pleiotropic nature of some genes.
Formal concept analysis (FCA) performs an exhaustive search of maximal sets of elements
sharing the same attributes [283]. It addresses the previous limitation and is a relevant alterna-
tive because the lattice represents several levels of precision from numerous small sets of genes
having many influence sets in common, to fewer larger gene sets sharing fewer influence sets.
Contrary to biclustering, the lattice also supports the identification of partially overlapping clus-
ters. Compared to the maximal cliques, it allows us to perform a finer-grain analysis. FCA has
already been successfully applied to the analysis of gene expression data [284] and to signaling
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networks modeling [285]. Eren et al. have shown that clustering algorithms capable of finding
more than one model are more likely to find biologically-relevant clusters [279]. However, FCA
also suffers from the following limitations, even if recent breakthrough in the Orpailleur team
concerned the combination of biclustering and FCA [286, 287] and a concept stability measure
for identifying relevant concepts [288, 289].
Limitation 2: FCA assumes that the elements are independent, whereas we would like to
take relations extracted from ontologies into account.
Limitation 3: FCA’s exhaustive search generates numerous formal concepts, not all of
them being informative (specially the large and the small ones) or biologically-relevant [290].
Limitation 4: FCA is sensitive to noisy and incomplete data. Pensa and Boulicaut devel-
oped a fault-tolerant technique that they applied to gene expression analysis [291].
I will focus on using ontologies to guide formal concept analysis for identifying relevant
associations among data. This will involve using ontologies (1) before FCA for enriching anno-
tations, and (2) after FCA for identifying semantically-homogeneous clusters that either match
existing knowledge (for validation purpose), or do not (for discovery purpose).
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[79] Gwenaëlle Marquet, Olivier Dameron, Stephan Saikali, Jean Mosser, and Anita Burgun.
Grading glioma tumors using OWL-DL and NCI thesaurus. In Proceedings of the Amer-
ican Medical Informatics Association Conference AMIA’07, pages 508–512, 2007.
[80] Anand Kumar, Yum Lina Yip, Barry Smith, and Pierre Grenon. Bridging the gap between
medical and bioinformatics: an ontological case study in colon carcinoma. Computers in
biology and medicine, 36(7-8):694–711, 2005.
[81] Franck W. Hartel, Sherri de Corronado, Robert Dionne, Gilberto Fragoso, and Jennifer
Golbeck. Modeling a description logic vocabulary for cancer research. Journal of Biomed-
ical Informatics, 38:114–129, 2005.
[82] Julian Seidenberg and Alan Rector. Web ontology segmentation: analysis, classification
and use. In Proceedings of the World Wide Web Conference (WWW’06), pages 13–22,
2006.
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Marc Cuggia. OWL model of clinical trial eligibility criteria compatible with partially-
known information. Journal of Biomedical Semantics, 4(1), 2013.
[96] Charles Bettembourg, Christian Diot, and Olivier Dameron. Semantic particularity
measure for functional characterization of gene sets using Gene Ontology. PLoS ONE,
9(1):e86525, 2014.
[97] Charles Bettembourg, Christian Diot, and Olivier Dameron. Optimal threshold determi-
nation for interpreting semantic similarity and particularity: Application to the compari-
son of gene sets and metabolic pathways using GO and ChEBI. PloS one, 10(7):e0133579,
2015.
[98] Frederic Herault, Annie Vincent, Olivier Dameron, Pascale Le Roy, Pierre Cherel, and
Marie Damon. The longissimus and semimembranosus muscles display marked differences
in their gene expression profiles in pig. PloS one, 9(5):e96491, 2014.
[99] Sylvain Prigent, Guillaume Collet, Simon M Dittami, Ludovic Delage, Floriane Ethis de
Corny, Olivier Dameron, Damien Eveillard, Sven Thiele, Jeanne Cambefort, Catherine
Boyen, Anne Siegel, and Thierry Tonon. The genome-scale metabolic network of ectocar-
pus siliculosus (EctoGEM): a resource to study brown algal physiology and beyond. The
Plant journal : for cell and molecular biology, 80(2):367–381, 2014.
[100] Jean Coquet, Geoffroy Andrieux, Jacques Nicolas, Olivier Dameron, and Nathalie Theret.
Analysis of tgf-beta signalization pathway thanks to topological and semantic web meth-
ods. In Journées Ouvertes Biologie, Informatique et Mathématiques (JOBIM 2015), poster
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IC (Ingénierie des Connaissances) PFIA, 2015.
[102] Philippe Finet, Régine Le Bouquin-Jeannès, and Olivier Dameron. La télémédecine dans
la prise en charge des maladies chroniques [in french]. Techniques Hospitalières, (740),
2013.
[103] Philippe Finet, Régine Le Bouquin-Jeannès, Olivier Dameron, and Bernard Gibaud. Re-
view of current telemedicine applications for chronic diseases: Toward a more integrated
system? IRBM, 2015. In press.
[104] Philippe Finet, Bernard Gibaud, Olivier Dameron, and Régine Le Bouquin-Jeannès. In-
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Pour cela, j’utilise les technologies du Web Sémantique pour intégrer ces données qui sont souvent
distribuées, et pour combiner différents types de raisonnement : déduction, classification, comparaison...
L’application principales concerne la caractérisation fonctionnelle et la comparaison de voies méta-
boliques et de voies de signalisation.
Déroulement de carrière
depuis septembre 2005 : Mâıtre de conférences, Université de Rennes 1.
janvier 2004 – juin 2005 : Postdoctorant. Stanford Medical Informatics group, Université de Stanford
(Californie, États-Unis d’Amérique). Responsable : Mark Musen.
octobre 2000 – décembre 2003 : Doctorat Modélisation, représentation et partage de connaissances ana-
tomiques sur le cortex cérébral – Université de Rennes 1, directeur : Bernard Gibaud.
1999 – 2000 DEA informatique médicale, Université de Rennes 1. 1er/14.
1998 – 1999 Service militaire.
1995 – 1998 Élève ingénieur INSA Rennes, département informatique.
Activités de responsabilités (administratives et en recherche sur toute
la carrière)
Recherche
2015–présent : Membre nommé de la section 65 du CNU
2015 : Responsable du PEPS CNRS Fondements et applications de la science des données
« confocal » (concepts formels, connaissances ontologies et étude de liaisons).
2014–présent : Coordinateur du thème « Biologie-santé » de l’IRISA.
2007 : Jury de thèse de Sandrine Pawlicki (Approche bioinformatique des mécanismes d’agré-
gation et de polymérisation des protéines amylöıdes).
2005–2013 : Création et co-responsabilité du thème « Réseaux d’Expression Génétique : in vivo,
in vitro et in silico » au sein de l’IFR 140.
2005 : Comité d’organisation 8eme conf. internationale Protégé.
2004 : Comité d’organisation 7eme conf. internationale Protégé.
Enseignement
Responsabilités de formations
depuis septembre 2012 : Co-responsable du master 2 « Bioinformatique et génomique ».
2008–2012 : Co-responsable du parcours « Bioinformatique » du master 2 « Modélisation des
systèmes biologiques ».
2007–2012 : Responsable du master 1 recherche « Méthodes et Traitements de l’Information Bio-
médicale et Hospitalière ».
2010–2012 : Co-responsable du master 2 « Méthodes et Traitements de l’Information Biomédicale
et Hospitalière ».
Responsabilités d’UE
depuis septembre 2005 : Responsable des UE « Bases de mathématiques et probabilité » et « Méthodes
en informatique » du master 1 « Santé publique ».
depuis septembre 2006 : Responsable de l’UE « Méthodes Web avancé en biomédical » du master 2
recherche « Santé publique ».
depuis septembre 2006 : Responsable de l’UE « Principes de programmation et algorithmique » du
master 1 « Bioinformatique et génomique ».
depuis septembre 2008 : Responsable de l’UE « Standardisation des connaissances et bio-ontologies »
du master 2 « santé publique ».
depuis septembre 2011 : Responsable du module « eSanté » en troisième année de cycle ingénieur ESIR.
depuis septembre 2012 : Responsable de l’UE « Gestion de projet informatique » du master 1 « Bioin-
formatique et génomique ».
depuis septembre 2015 : Co-responsable de l’UE « Bioinformatique » ENS Rennes.
Fig. 1 – Volume des enseignements annuels. La charge normale est de 192h équivalent TD. J’étais en
demi-délégation à l’INRIA en 2014–2015 et 2015–2016 et ne devait donc que 96h equivalent TD lors de
cette période.
Encadrement
– Doctorats : 5 (dont 3 en cours)
– Stages ingénieurs : 1
– Stages master2 : 7
– Stages master1 : 9
mars – juin 2006 : Stage master 1 Bioinformatique : Élodie Roques.
janvier – juin 2006 : Stage master 2 recherche Informatique médicale : Ihssène Belhadj.
février – juin 2006 : Stage master 2 professionnel Traitement de l’information médicale et hospitalière :
Nicolas Cottais
janvier – juin 2007 : Stage master 2 recherche Bioinformatique : Élodie Roques.
2007–2010 : Doctorat Nicolas Lebreton (bourse MENRT) : « Réalisation d’ontologies de tâches
et de domaine en bioinformatique et utilisation de la sémantique pour l’appariement
semi-automatique de Services Web ». Co-encadrement avec Anita Burgun.
avril – juin 2008 : Stage master 1 bioinformatique : Léa Joret.
janvier – juin 2009 : Stage master 2 recherche bioinformatique : Léa Joret.
avril – juin 2009 : Stage master 1 bioinformatique : Charles Bettembourg.
janvier – juin 2010 : Stage master 2 recherche bioinformatique : Charles Bettembourg.
juillet 2010 – mai 2011 : Stage ingénieur CNAM : Pascal van Hille.
2010 – 2013 : Doctorat Charles Bettembourg (bourse MENRT) : « Comparaison inter-espèces de
voies métaboliques : application à l’étude du métabolisme des lipides chez le poulet,
la souris et l’homme ». Co-encadrement avec Christian Diot (INRA).
avril – juin 2011 : Stage master 1 bioinformatique : Walid Bedhiafi.
avril – septembre 2011 : Stage master 2 CCI : Nicolas Schnell.
avril – juin 2012 : Stage master 1 Bioinformatique et génomique : Jérémy Rio.
avril – juin 2013 : Stage master 1 Bioinformatique et génomique : Ayité Kougbeadjo.
octobre 2013 – Doctorat Philippe Finet (ingénieur en CDI à la DSI du CHU Alençon-Mamers) :
« Production et transmission des données de suivi des patients dans un contexte de
télémédecine et intégration dans un système d’information pour l’aide à la décision ».
Co-encadrement avec Régine Le Bouquin-Jeannes du LTSI.
avril – juin 2014 : Stage master 1 Bioinformatique et génomique : Dominique Mias-Lucquin.
avril – juin 2014 : Stage master 1 Bioinformatique et génomique : Löıc Bourgeois.
octobre 2014 – Doctorat Jean Coquet (bourse MENRT) : « Semantic-based reasoning for biological
pathways analysis ». Co-encadrement avec Jacques Nicolas
mars – août 2015 : Stage master 2 Statistiques pour l’entreprise : Yann Rivault (co-encadré avec Nolwenn
Le Meur, EHESP).
avril – juin 2015 : Stage master 1 Bioinformatique et génomique : Pierre Vignet.
octobre 2015 – Doctorat Yann Rivault (contrat ANSM) : « ». Co-encadrement avec Nolwenn Le
Meur (EHESP)
Distinctions, rayonnement scientifique et relation avec le monde indus-
triel
Distinctions
janvier – décembre 2004 : Lauréat bourse INRIA de stage postdoctoral à l’étranger.
2011 : L’article « Comparison of OWL and SWRL-based ontology modeling strategies for the
determination of pacemaker alerts severity » a été sélectionné pour le Best paper award
de la conférence AMIA (American Medical Informatics Association). Une version
étendue a été soumise à un journal.
2014 – 2015 : demi délégation INRIA.
2015 – 2016 : demi délégation INRIA.
Rayonnement scientifique
2005–2011 : Participation à l’animation des « Protégé Short Course » et « Protégé-OWL Short
Course ». Il s’agit de sessions payantes de formation à destination d’un public d’in-
dustriels et d’académiques, organisées par le Stanford Medical Informatics group. J’ai
participé à leur création leur de mon stage postdoctoral et j’ai ensuite été régulière-
ment invité pour animer une partie de ces formations jusqu’en 2011.
avril 2009 : Séminaire invité LRI, Orsay.
mai 2010 : Présentation BreizhJUG : Introduction to the semantic Web
octobre 2011 : Journée de la plateforme bioinformatique GenOuest – Présentation Contributions of
ontologies to life sciences
novembre 2011 : École thématique biologie intégrative BioGenOuest – Présentation caractérisation et
comparaison fonctionnelles de listes de gènes : apport de la sémantique.
août 2014 article « La bioinformatique avec biopython » dans le hors-série Python de GNU/Linux
magazine
décembre 2014 : Séminaire invité LINA, Nantes.
février 2015 : Séminaire invité Institut de recherche sur les maladies génétiques Imagine, Paris
mars 2015 : Séminaire invité ENS Rennes
2014–2015 : Blog bioinfo-fr.net : articles « Gephi pour la visualisation et l’analyse de graphes » 1,
« Gérer les versions de vos fichiers : premiers pas avec git » 2 et « Git : cloner un
projet, travailler à plusieurs et créer des branches » 3
Fig. 2 – Nombre et type de publications par années
1. http://bioinfo-fr.net/gephi-pour-la-visualisation-et-lanalyse-de-graphes
2. http://bioinfo-fr.net/git-premiers-pas
3. http://bioinfo-fr.net/git-usage-collaboratif
Fig. 3 – Évolution des publications
Publications parues ou acceptées : liste exhaustive
Bilan :
– H-index : 15
– 18 articles dans des journaux indexés par PubMed ou Web of science
– 4 en premier auteur
– 5 en dernier auteur
– 21 articles longs dans des conférences internationales indexés par PubMed ou Web of science avec
comité de lecture
– 6 en premier auteur
– 1 en dernier auteur
Articles indexés dans PubMed ou Web of science
[1] Olivier Dameron, Bernard Gibaud, and Xavier Morandi. “Numeric and Symbolic Representation
of the Cerebral Cortex Anatomy: Methods and preliminary results”. In: Surgical and Radiologic
Anatomy 26.3 (2004), pp. 191–197.
[2] Daniel L. Rubin, Olivier Dameron, Yasser Bashir, David Grossman, Parvati Dev, and Mark A.
Musen. “Using ontologies linked with geometric models to reason about penetrating injuries”. In:
Artificial Intelligence in Medicine 37.3 (2006), pp. 167–176.
[3] Olivier Dameron, Mark A. Musen, and Bernard Gibaud. “Using semantic dependencies for consis-
tency management of an ontology of brain-cortex anatomy”. In: Artificial Intelligence in Medicine
39.3 (2007), pp. 217–225.
[4] Amrapali Zaveri, Luciana Cofiel, Jatin Shah, Shreyasee Pradhan, Edwin Chan, Olivier Dameron,
Ricardo Pietrobon, and Beng Ti Ang. “Achieving High Research Reporting Quality Through the
Use of Computational Ontologies”. In: Neuroinformatics 8.4 (2010), pp. 261–271.
[5] A Burgun, A Rosier, L Temal, J Jacques, R Messai, L Duchemin, L Deleger, C Grouin, P Van Hille,
P Zweigenbaum, R Beuscart, D Delerue, O Dameron, P Mabo, and C Henry. “Decision support in
telecardiology: An ontology-based patient-centered approach”. In: IRBM 32.3 (2011), pp. 191–194.
[6] Charles Bettembourg, Christian Diot, Anita Burgun, and Olivier Dameron. “GO2PUB: Querying
PubMed with Semantic Expansion of Gene Ontology Terms”. In: Journal of biomedical semantics
3.1 (2012), p. 7.
[7] Marc Cuggia, Jean-Charles Dufour, Oussama Zekri, Isabelle Gibaud, Cyril Garde, Catherine Bohec,
Régis Duvauferrier, Dominique Fieschi, Paolo Besana, Laurent Charlois, Annabel Bourdé, Nico-
las Garcelon, Jean-Francois Laurent, Marius Fieschi, and Olivier Dameron. “ASTEC Automatic
Selection of clinical Trials based on Eligibility Criteria”. In: IRBM (2012).
[8] Olivier Dameron, Charles Bettembourg, and Nolwenn Le Meur. “Measuring the Evolution of On-
tology Complexity: the Gene Ontology Case Study”. In: PLoS ONE 8.10 (2013), e75993.
[9] Olivier Dameron, Paolo Besana, Oussama Zekri, Annabel Bourdé, Anita Burgun, and Marc Cuggia.
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Fieschi, Catherine Bohec, Annabel Bourdé, Laurent Charlois, Cyril Garde, Isabelle Gibaud, Jean-
Francois Laurent, Oussama Zekri, and Marius Fieschi. “ASTEC: A System for Automatic Selection
of Clinical Trials”. In: Proceedings of the American Medical Informatics Association Conference
AMIA. 2011, p. 1729.
[18] Olivier Dameron, Pascal van Hille, Lynda Temal, Arnaud Rosier, Louise Deléger, Cyril Grouin,
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2008.
[8] Cyril Grouin, Arnaud Rosier, Olivier Dameron, and Pierre Zweigenbaum. “Une procédure d’ano-
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Ouvertes Biologie, Informatique et Mathématiques (JOBIM 2015), poster session. 2015.
[15] Philippe Finet, Bernard Gibaud, Olivier Dameron, and Régine Le Bouquin-Jeannès. “Interopéra-
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Associations : Président d’une crèche parentale (février 2010 – juin 2011) ;
Trésorier de l’« association voile recherche-enseignement Rennes » (depuis 2012).
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